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A mathematical model for onchocerciasis and its treatment with ivermectin
Evans Otieno Omondi
Department of Mathematical Sciences,
University of Stellenbosch,
Private Bag X1, Matieland 7602, South Africa.
Thesis: MSc. (Mathematics)
December 2016
Onchocerciasis is a human disease that is caused by the filirial worm Onchocerca volvu-
lus. It occurs close to oxygen rich flowing streams and rivers in the inter-tropical zones.
The disease is a serious public health problem and any control interventions must be ef-
fective so as to eliminate it from the population. A rational control intervention method
is through mass administration of ivermectin. In this study, a non-linear mathematical
model is formulated to model the transmission dynamics and spread of onchocerciasis
disease. First, a mathematical model is formulated to evaluate the impact of long term
mass treatment of onchocerciasis with ivermectin. The model basic reproduction num-
ber is computed and the stability analysis presented. The model is found to exhibit a
backward bifurcation so that for R0 less than unity is not sufficient to eradicate the dis-
ease from the population and the need is to lower R0 to below a certain threshold, Rc0
for effective disease control. Optimal control theory is applied to investigate the control
strategies for eliminating onchocerciasis using time dependent controls. The charac-
terization of the optimal control is carried out via the Pontryagin’s Maximum Princi-
ple. The simulation results demonstrate that the maximum implementation of vector
control, personal protection strategies and enhanced mass treatment with ivermectin
strategies in the epidemic are of very critical impacts in the optimal control. This gives
a theoretical interpretation to the practical experiences that the insecticide and use of
insect repellents are important in the control of onchocerciasis. The model is extended
ii
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to assess the effectiveness of mass administration using impulsive differential equations
since the treatment itself is considered to be impulsive. The basic reproduction num-
ber is derived and we establish that the global dynamics are completely determined by
the values of R0. The disease-free equilibrium is globally asymptotically stable for basic
reproduction number R0 < 1, while for R0 > 1, a unique endemic equilibrium exists
and is globally asymptotically stable. We then use the model to determine the thresh-
old for the proportion of infected individuals that reduces the infection in the human
(host) population. Finally, we present numerical simulations results. Sensitivity anal-
ysis reveals that the most sensitive parameters in the onchocerciasis epidemic are the
human transmission contact rate βh , the vector transmission contact rate βv and vector
death rate µv. The numerical results show that efficiency of the mass administration of
ivermectin contributes a greater impact on the disease dynamics and moves the system
towards the disease free state.
Keywords: Onchocerciasis, ivermectin, mathematical model, reproduction number,backward
bifurcation, optimal control, impulsive equations, sensitivity, simulations, population.
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Opsomming
’N Wiskundige model vir onchocerciasis en die behandeling daarvan met
ivermektien
( A mathematical model for onchocerciasis and its treatment with ivermectin )
Evans Otieno Omondi
Departement Wiskundige Wetenskappe,
Universiteit van Stellenbosch,
Privaatsak X1, Matieland 7602, Suid Afrika.
Tesis: MSc. (Wiskunde)
Desember 2016
Onchocerciasis is ’n menslike siekte wat veroorsaak word deur die filariese wurm On-
chocerca volvulus. Dit kom voor naby suurstofryke vloeiende strome en riviere in inter-
tropiese sones. Hierdie siekte is ’n ernstige publieke gesondheidsgevaar en enige kont-
role ingrypings moet effektief wees om dit uit die bevolking uit te wis. ’n Rasionele kont-
role ingrypingsmetode is die massa toedien van ivermektien. In hierdie studie word ’n
nie-lineêre wiskundige model geformuleer om die oordrags- en verspreidingsdinamika
van die onchocerciasis siekte te modelleer. Eerstens word ’n wiskundige model gefor-
muleer om die impak van langtermyn massabehandeling van onchoncersiasis met iver-
mektien te bepaal. Die model se basiese voortplantingsgetal word bereken en die stabi-
liteitsanalise word aangebied. Die model word bevind om ’n terugwaardse bifurkasie
ten toon te stel sodat die voorwaarde R0 kleiner as eenheid nie genoeg is om die siekte
uit die bevolking uit te wis nie en dat dit nodig is om R0 te verlaag tot onder ’n sekere
drumpel Rc0 vir effektiewe siektekontrole. Optimale kontrole teorie word met tydaf-
hanklike kontroles toegepas om die kontrole strategieë om onchocerciasis uit te wis te
bestudeer. Die karakterisering van die optimale kontrole word uitevoer met Pontryagin
se Maksimumbeginsel. Die uitslae van die simulasie wys dat die maksimum uitvoering
van vektorkontrole, persoonlike beskermingstrategieë en verbeterde massabahandeling
iv
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met ivermektien strategieë in die epidemie van kritiese belang is in die optimale kont-
role. Dit gee ’n teoretiese verklaring vir die praktiese ondervinding dat insekgif en die
gebruik van (insek) afweermiddels belangrik is in die kontrole van onchocerciasis. Die
model word uitgebrei om die effektiwiteit van massa toedien vas te stel deur die gebruik
van impulsiewe differensiaalvergelykings aangesien die behandeling self as impulsief
beskou word. Die basiese voorplantingsgetal word afgelei en ons bevestig dat die glo-
bale dinamika volledig bepaal word deur die waardes van R0. Die siektevrye ewewig
is globaal asimptoties stabiel wanneer die voortplantingsgetal R0 < 1, terwyl daar vir
R0 > 1 ’n unieke endemiese ewewig bestaan wat globaal asimptoties stabiel is. Ons
gebruik dan die model om die drumpel van persentasie van besmette individue te be-
paal wat die besmetting in die menslike (gasheer) bevolking verminder. Laastens bied
ons uitslae van numeriese simulasies aan. Sensitiwiteitsanalise toon aan dat die mees
sensitiewe parameters in die onchocerciasis epidemie die menslike oordragsverhouding
βh, die vektoroordragskontakverhouding βv en die vektordoodsverhouding µv is. Die
numeriese uitslae toon dat die die effektiwiteit van massa toedien van ivermektien ’n
groter invoed op die siekte se dinamika het en die stelsel na die siektevrye toestand be-
weeg.
Sleutelwoorde: Onchocerciasis, ivermektien, wiskundige model, voortplantingsgetal, terug-
waardse bifurkasie, optimale kontrole, impulsiewe vergelykings, sensitiwiteit, simu-
lasies, bevolking.
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Chapter 1
Introduction
1.1 Background to onchocerciasis
Onchocerciasis is a vector-borne parasitic disease. This is a human disease caused by the
filirial (thread like) worms Onchocerca volvulus in human hosts and is transmitted by the
blackfly (Simulium damnosum) [87]. It occurs close to oxygen rich flowing streams and
rivers in the inter-tropical zones [24, 47]. This is because the egg, larvae and pupa stages
of Simulium damnosum are aquatic giving rise to the common name of river blindness.
The prevalence of infection and disease in a community is related to the proximity to
riverine breeding sites of the black flies. The highest burden of infection and disease are
in communities adjacent to rivers. Prevalence of infection rises with age until around
30 years, after which infection profiles vary between geographical region and sex, with
higher rates of microfilaridermia and morbidity reported in men than in women [8].
Studies show that about 90% of onchocerciasis cases occur in Africa and are predomi-
nantly found in West Africa. It is also found in six countries in Latin America and in
Yemen in the Arabian Peninsula [98]. Onchocerciasis is a serious public health prob-
lem. It is a major constraint to social and economic development [21, 37]. This disease is
responsible for ugly skin disease with depigmentation, severe unrelenting itching and
blindness [23, 97]. Figure 1.1 shows the world distribution of onchocerciasis disease.
Figure 1.1 (a) shows the African countries with endemic onchocerciasis. Countries par-
ticipating in the former Onchocerciasis Control Program region in West Africa are shown
in yellow and those participating in the African Program for Onchocerciasis Control are
shown in brown. Figure 1.1 (b) shows the endemic foci in Latin America.
1
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(a) Africa countries (b) Latin America
Figure 1.1: World distribution of Onchocerca volvulus: Source [96].
1.2 Life cycle of Onchocerca volvulus
Onchocerciasis is caused by Onchocerca volvulus and is transmitted from person to per-
son by blackflies that belong to genus Simulium [2]. The only natural definitive host of
Onchocerca volvulus is human. The intermediate host is a black-fly in the genius Simulium
[52]. The infection of onchocerciasis begins at the third larvae stage (L3) [20]. An infected
blackfly (genius Simulium) introduces the filarial larvae into the skin of the human host
during blood meal. The L3 larvae develops into adult filariae in the subcutaneous tissues
and reside in nodules in subcutaneous connective tissues. The worms mature slowly
and may require as long as a year to reach full size [32]. The adult worms can live in the
nodules for approximately 15 years [20, 47, 55]. Fertilised female worms can produce
millions of embryos (microfilariae) [47]1. The microfilariae are found in the skin and
in the lymphatics of connective tissues where they can live as long as 30 months [60].
During blood meal, the microfilariae are ingested by blackfly. Most of the microfilariae
ingested die or are digested together with the blood meal. Few penetrate the wall of the
blackfly’s stomach and migrate from the blackfly’s midgut through the hemocoel to the
thoracic muscles. In 6-13 days, the microfilariae then develop into first-stage larvae (L1),
moult into stage two larvae (L2) and subsequently into infective third-stage larvae (L3)
[52]. The (L3) larvae migrate to the blackfly’s proboscis and infect another human when
the blackfly takes a blood meal. Upon gaining entry into a human host, the L3 worms
develop into adults in 1-3 months. After initial infection, microfilariae from the adults
will appear in 10-20 months [52].
1Each female can produce 1000 to 3000 microfilariae per day.
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The life span of Simulium damnosum is short and last only for 2-3 weeks [68]. The life
expectation of Onchocerca volvulus larvae in the Simulium damnosum is estimated to be
14-28 days [60]. The earliest appearance of microfiliariae in humans2 after a primary in-
fection is about 6-7 months [55]. It was estimated in the Cameroon forest that 80% of the
infective larvae escape from the fly and 40% of the infective flies become non-infective
[60]. Figure 1.2 gives the summary of the life cycle of Onchocerca volvulus.
Figure 1.2: Life cycle of Onchocerca volvulus relevant for the model considered in this
thesis project: Source [20].
1.3 Pathology of onchocerciasis
Onchocerca volvulus has a long-term persistence pathology. This is attributed to the fact
that it has developed a highly adaptive mechanisms of immune evasion [16]. The spec-
trum of onchocerciasis manifestation in the infected individuals varies and the diver-
sity in the clinical responses is associated with the intensity and the type of immune
responses to the Onchocerca volvulus parasite [16, 48, 84]. The appearance of onchocer-
ciasis pathology is linked to the reactions to moribund microfilariae in the skin or the
2The total microfilarial load in highly infected human hosts is more than 100 million.
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eye. Studies indicate that the most severe disease manifestation is elicited by the death
of microfilariae passing through the cornea [39, 42, 47, 48]. During the migration of
microfilariae, they invade the conjunctiva, cornea and the posterior regions of the eye
[16, 17, 47]. Continued exposure of the cornea leads to the inflammation of the iris which
results in permanent visual impairment and sometimes blindness [16].
Patients suffering from human onchocerciasis are classified into three groups: 1) asymp-
tomatic individuals, persons with so called generalized onchocerciasis (GEO) who have
palpable nodules in their skin; 2) patients with severe pathology (termed hyperreactive
form) and 3) putative immune individuals who never develop any signs of parasitemia
or clinical onchocerciasis, despite their lifelong exposure to the parasite [83]. It is be-
lieved that most of the affected individuals in the areas where this disease is endemic
belong to the asymptomatic form of onchocerciasis. Patients with chronic infection can
develop depigmentation (leopard skin) and loss of skin elasticity and structure, lead-
ing to signs of premature skin ageing (eg, lizard skin or hanging groin) [62]. A rare
form of skin disease can happen in immunologically hyperactive individuals with se-
vere chronic papular dermatitis, hyperpigmentation [16]. In addition, these individuals
are characterised by low numbers of parasites and increased immune responses, partic-
ularly of the Th2 type [16, 27, 86].
Figure 1.3 shows the effect of onchocerciasis disease in an infected human. Figure 1.3
(a) depicts a sclerosing keratitis. It is known as ocular onchocerciasis and begins with
microfilariae migration to the cornea. Early infection usually presents with a tearing,
irritated conjunctivitis, often with a hypersensitivity to light. Figure 1.3 (b) shows on-
chocercal punctate keratitis with dead microfilariae in cornea surrounded by white cell
infiltrate [75]3. Figure 1.3 (c) shows the pathology of onchocerciasis associated with the
skin. This is the typical dermatitis and is known as onchodermatitis. This pathogenesis
comes with mild itching or discolouring of the skin.
3White cell infiltrates form around dead microfilariae in the cornea, causing "snowflake opacities,".
Punctate keratitis is reversible.
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(a) Ocular onchocerciasis
(b) Punctate keratitis (c) Onchodermatitis
Figure 1.3: Pathology of Onchocerca volvulus: Source [42].
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1.4 Treatment strategies
The struggle to eradicate onchocerciasis is currently led by the African Program of on-
chocerciasis Control (APOC) [43]. The main control measure for the eradication of on-
chocerciasis in the countries where the disease is endemic such as Ghana is through com-
munity directed treatment with ivermectin. The drugs are distributed by MectizanTM
Donation Program (MDP) by Merck and Co., Inc., [22]. Ivermectin is an antimicrofilar-
ial agent that acts as both the primary and secondary form of prevention for individ-
uals with onchocerciasis. It degenerates intrauterine microfilariae thereby suppressing
the release of new microfilariae for up to 3-4 months after which it is still possible to
continue producing microfilariae until it dies naturally [63]. The standard dose of iver-
mectin is 150µg/kg and children who weigh 15 kg or more are eligible. Ivermectin leads
to hyperpolarisation of glutamate-sensitive channels and immobilisation of microfilar-
iae [95]. Ivermectin, when given four times every year for consecutive years, can have
a moderate macrofilaricidal effect [29]. However, the macrofilaricidal effect is too min-
imal and for successful control of onchocerciasis, repeated treatment with ivermectin
spanning for 10-15 years has to be administered to correspond to the life span of adult
worm [38]. The following control programmes have been used in the fight to eradicate
onchocerciasis:-
• The Onchocerciasis Control Programme (OCP, 1974 to 2002) - The OCP was an
international partnership that applied aerial larviciding of rivers for vector control
covering 11 West African countries [11, 41].
• The Onchocerciasis Elimination Program in the Americas (OEPA, 1991 to 2012) -
The OEPA comprised of partnerships between the governments of the endemic
countries, the Pan American Health Organization (PAHO), the Carter Center, Li-
ons Clubs International, the Bill and Melinda Gates Foundation, and the Mectizan
Donation Program. Used mass ivermectin therapy every six months to fight on-
chocerciasis [43].
• The African Program for Onchocerciasis Control (APOC, 1995 to 2025) - The pro-
gram covers 19 African countries using annual ivermectin treatment delivered by
community distributors chosen by the communities themselves [43].
The treatment of onchocerciasis is designed to reduce morbidity and mortality by ensur-
ing that rapid and complete eradication of onchocerciasis infection is achieved so that
fatal and severe disease situations including cases of chronic infections are prevented.
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Another important objective of effective treatment of onchocerciasis with ivermectin is
to reduce the human reservoir of infection so that disease transmission can be minimised
[87]. APOC aims to tackle onchocerciasis infection through mass administration of iver-
mectin for 15-17 years. In support of the fight against onchocerciasis, WHO4 has set the
time frame for the elimination of onchocerciasis and other neglected tropical diseases to
be 2020-2025 [57, 87].
In APOC countries, ochocerciasis treatment is done through the community directed
treatment with ivermectin programs (CDTI) [46] 5. For example, studies in hyperen-
demic foci in Mali, Cameroon and Senegal indicate that 15 to 17 years of annual mass
administration of ivermectin had eliminated onchocerciasis transmission and that mass
treatment could be safely stopped [25]. This provides an evidence that onchocerciasis
elimination will be dependent on administration of ivermectin to the endemic areas 6.
1.5 Motivation and objectives of the study
1.5.1 Motivation
In Sub-Sahara Africa, onchocerciasis remains a major health challenge. In Ghana for
instance, 3, 400, 000 in 3204 communities in 66 endemic districts are at risk of acquir-
ing onchocerciasis [59]. Many strategies have been used to eradicate this disease from
the population. Mass administration of ivermectin has remained the main strategy in
the fight against onchocerciasis. Several epidemiological research work on onchocercia-
sis have focused on the EPIONCHO7 model to understand the dynamics of this disease
and its treatment in the population [10, 87, 88, 89, 90]. Unlike other vector-borne diseases
such as malaria, very minimal research work has been done on the mathematical mod-
elling of onchocerciasis [47]. In this work, onchocerciasis disease model is formulated
and the model extended to incorporate compartments with individuals on treatment.
The effectiveness of ivermectin treatment is analysed using impulsive differential equa-
tions. In addition, we introduce optimal control theory to investigate optimal control
strategies for controlling onchocerciasis using insect repellent and both insecticide and
larvicide as system control variables.
4World Health Organisation.
5Annual mass treatment with ivermectin through community-directed treatment is preferred as a good
and less expensive method for controlling onchocerciasis in endemic African countries with assistance from
APOC.
6Elimination of onchocerciasis is considered successful when the microfilaria prevalence in skin snips
is less than 5% [25].
7Onchocerciasis transmission model.
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1.5.2 Objectives
The main objective of this thesis is to model the infection dynamics and optimal control
of onchocerciasis and its treatment.
The specific objectives are;
• To develop a mathematical model to describe the dynamics of onchocerciasis in
both the human and the vector populations, and to carry out a detailed mathe-
matical analysis of the model in order to gain the understanding of the model be-
haviour based on the computation of the model basic reproduction number, equi-
librium points and their corresponding stability analysis.
• To carry out numerical simulations of the model and establish the conditions for
the persistence of onchocerciasis in the populations.
• To investigate the conditions under which onchocerciasis epidemics would persist
or die out in the population.
• To carry out sensitivity analysis so as to establish the key vital parameters in the
model.
• To investigate the effect of time-dependent control (policies) on the dynamics of
onchocerciasis epidemics.
• To explore the effect of ivermectin treatment on onchocerciasis through impulsive
treatment.
1.6 Mathematical preliminaries
1.6.1 Basic reproduction number
Basic reproduction number, R0, is the threshold for many mathematical models. It is
defined as the expected number of secondary cases of infections arising from a single
infected case in a completely susceptible population during the entire period of infec-
tiousness [36]. Basic reproduction number is a key concept in epidemiology. It serves as
a threshold parameter that predicts whether an infection dies out or persists [36]. When
R0 < 1, then, on average, infectious individuals introduced in a population produce less
than one new infection during their period of infectiousness. The disease may therefore
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be eradicated from the population. When R0 > 1, introduction of an infectious individ-
ual in the population produces more than one new cases of infection. In this case the
disease persists in the population. In this work, we adopt the method of next genera-
tion method in computing the model reproduction number as is described by Van den
Driessche and Watmough [92].
1.6.2 Optimal control technique
Optimal control theory is a mathematical tool derived from the calculus of variation.
Application of optimal control is vital to decision making in terms of viable control
strategies to be employed to eradicate the epidemic [82]. There is usually a general
assumption that there exists a way to control the state variable(s) y, through a suitable
control u. The ultimate goal is to adjust control u to minimize or maximize a given ob-
jective function J(u(t), y(t), t) [58]. Various methods exist for calculating the optimal
control for specific models. For instance, Pontryagin’s Maximum Principle allows for
the calculation of the optimal control for an ordinary differential equation system with
given constraints [44]. According to Lenhart and Workman [51], a general optimal con-
trol problem is constructed as follows;
max
u
[
φ(T, x(T)) +
∫ T
0
g(t, x(t), u(t))dt
]
, (1.6.1)
where x = [x1(t), x2(t), · · · , xn(t)] and u = [u1(t), u2(t), · · · , um(t)] are state and control
variables, respectively. The following system of first order ordinary differential equa-
tions describe the dynamics of the state and control variables
dx
dt
= f (t, x(t), u(t)), x0 = x(0), 0 ≤ t ≤ T. (1.6.2)
1.6.3 Impulsive differential equations
An impulsive differential equation is usually defined as an ordinary differential equa-
tion coupled with a difference equation [3]. Impulsive differential equations are very
helpful in studying many biological systems and population dynamics that have sud-
den change in their states [4, 28, 65]. In epidemiology, impulsive differential equations
assess the vaccination programme that consists of periodical repetitions of impulsive
vaccinations in a population, on all the age cohorts. At each vaccination time a constant
fraction of susceptible people is vaccinated. Mathematically these equations take the
form
x′(t) = f (t, x(t)), h(t, x(t)) 6= 0,
∆x(t) = I(t, x(t)), h(t, x(t)) = 0,
(1.6.3)
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where ∆x(t) = x(t+) − x(t−). Here, x(t+) is the value immediately after impulsive
effect. Thus, as long as we have h(t, x(t)) 6= 0, then the evolution of of the state is
governed by the ordinary differential equations. At such time that h(t, x(t)) = 0, then
the state undergoes an impulse and instantly changes by some amount I(t, x(t)).
1.7 Thesis outline
In this thesis, our work is organised as follows: In Chapter 2, we provide literature
review based on mathematical models of onchocerciasis and EPIONCHO models. In
Chapter, 3 we derive the deterministic model and its analytical solutions. We also in-
troduce time-dependent controls (policies) in the model and discuss the effects of the
controls on the dynamics of the model. Numerical simulation results are also presented
and discussed. In Chapter 4 we provide the analysis of the model with impulsive ef-
fect. In Chapter 5 we give relevant discussion and conclude our work with relevant
recommendation for further research work.
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Literature Review
Understanding the dynamics of onchocerciasis is very vital in the fight towards its erad-
ication. In order to develop a plausible mathematical model that captures the dynamics
of this disease in the population, it is important to understand the biological evolution
of this disease as well as the appropriate mathematical tools that give logical qualitative
and quantitative results. In this section we review related models that have been used
to explain the transmission dynamics of onchocerciasis and its treatment.
2.1 Mathematical models
Oguoma and Acho [68] modelled the spread and control of onchocerciasis in Tropical
Countries and looked at a case study in Nigeria. They adopted a deterministic approach
in their model. The objective of their work was to assess the prevalence and intensity
of microfilariae of Onchocerca volvulus in Imo River Basin, Imo state, Southeastern Nige-
ria. The human population was sub-divided into three compartments and the vector
population sub-divided into two compartments. They carried out stability analysis and
used homotopy decomposition method to solve the mathematical sets of equations de-
rived from the model. The stability analysis from their study indicated that it would be
possible to eradicate the parasite Onchocerca volvulus within a definite time. The study
results from their numerical simulations showed that both the number of susceptible
human and vector sub-populations decreased and the infective human and vector sub-
populations increased. This reflects a real world biological situation and therefore hav-
ing a disease free population is feasible given treatment with ivermectin in a hygienic
environment that does not allow the breeding and survival of blackflies.
11
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Basáñez and Ricárdez-Esquinca [7, 9] did a study on models for the population biology
and control of human Onchocerciasis. Their aim was to evaluate the various interven-
tions combining the removal of adult worms (nodulectomy) and the microfilaricidal and
the sterilizing effect of ivermectin. They used a model comprising three ordinary differ-
ential equations describing the rate of change with respect to time of the mean number
of adult worms, mean number of microfilariae per person and the mean number of L3
larvae per fly.
Basáñez and Ricárdez-Esquinca derived a threshold condition for disease control in-
volving the vector biting rate and the basic reproduction number. They estimated that
the annual biting rate for the Simulium onchraceum s.l is 7665 bites per person per year.
This is the minimum below which human onchocerciasis would be unable to become
endemic in Central America since the basic reproduction number R0 would be less
than unity. The study showed that the threshold biting rate for endemic onchocercia-
sis in West Africa lies between 288 and 720 bites per person per year for the savannah
Simulium damnosum s.l. The R0 of Onchocerca volvulus varies between 3 and 167. They
related this to the ocular morbidity and thus predicted a serious recrudescence even af-
ter 20 years of successful vector control.
Poolman and Galvani [74] modelled the targeted ivermectin treatment for controlling
river blindness. They obtained the basic reproduction number R0 which they defined as
the lifetime number of adult female worms produced by each female worm. They per-
formed numerical simulations through to infection equilibrium for four different treat-
ment regimens and compared them to the corresponding baseline, that is, 30%, 60% and
90% of the target population. Their results indicated a settlement into a stable equilibria.
This showed a linear relationship between R0 and mean population worm burden arises
from density-dependent reproduction. They also discovered that ivermectin treatment
of the uniform population results in coverage dependent percentage decreases in the
mean worm burden relatively across R0 and between levels of coverage.
Omade et al. [70] modelled onchocerciasis dynamics using an SIR model with demog-
raphy. The study was conducted in Mubi Village of Gombe state in Northern Nigeria.
They used Euler method in providing the numerical solutions to their model. They as-
sumed that the population is dynamic and those who come into the susceptible class
did so mainly through birth. In addition, it was also assumed that there is no inherited
immunity amongst the susceptible individuals and the recovered individuals become
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permanently immune to the disease. The entire model however, worked on the black
box model of the disease in which differential behaviour, steady state calculation and
disease free equilibrium in terms of R0 were obtained. In this model they established
that about 52% of the population are susceptible to the disease and about on average
50% infection rate is recorded within 14 days after which it declines. The recovery rate
recorded in the model is about 37%. It was observed that the endemic onchocerciasis
poses a serious risk to the endemic community in the Northern part of Nigeria as its
susceptible level is 55% with a high infection rate of 50% on average.
Jimmy and Horst [60] presented a mathematical model to study the dynamics of on-
chocerciasis under three ways in which the human and the animal disease can inter-
fere. The three ways include: vector diversion, waste parasites on the wrong host, and
cross-immunity. They used cross-immunity reaction to give the model the qualitative
behaviour of a standard competition model. Their model comprises a system of six
equations, which they then reduced to four using quasi-static state approximation. Their
model had up to four equilibria, trivial, coexistence and two boundary equilibria. These
equilibria exhibited the following stability properties: there is no coexistence equilib-
rium and only the volvulus boundary equilibrium is stable, there is no coexistence equi-
librium and only ochengi boundary equilibrium is stable, both boundary equilibria are
stable and coexistence equilibrium unstable (bi-stability), the coexistence equilibrium is
stable and both boundary equilibria are unstable, and there exists a continuum of coex-
istence equilibria. These possibilities of equilibria all held when the basic reproduction
ratios of both Onchocerca volvulus and Onchocerca ochengi were greater than unity. They
did global stability for the disease free equilibrium and concluded that the disease both
in the animal and the vector could be eradicated provided R0 is kept below unity.
2.2 EPIONCHO model
Onchocerciasis transmission model (EPIONCHO) has been used extensively by many
researchers in explaining the dynamics and treatment of onchocerciasis [10, 87, 88, 89,
90]. Basáñez et.al. [10] investigated the potential long-term consequences of a vacci-
nation programme on human onchocerciasis. They used EPIONCHO to investigate the
impact of vaccination in areas where loiasis and onchocerciasis are co-endemic and iver-
mectin is contraindicated. This model describes the rate of change with respect to time
and host age of the mean number of fertile and non-fertile female adult worms per host,
the mean number of microfilariae per milligram of skin, and the mean number of L3 lar-
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vae per simuliid fly. The model was refined to include age and sex structure of the host
population; the population level effects of a single and multiple treatments with iver-
mectin and increased programmatic realism related to patterns of treatment coverage
and systematic non-compliance. Their modelling results indicated that deployment of
onchocerciasis vaccine would have a substantial beneficial effect in Onchocerca volvulus-
L loa co-endemic areas where it may not be possible to deliver ivermectin. However,
these benefits take a considerable time to accrue since vaccinated individuals need to
age through the population into more heavily exposed population age group. Their re-
sults indicated that after 15 years of vaccination, the overall mean microfilarial load in
the population is projected to decrease by 30% in highly hyper and hyper-endemic on-
chocerciasis foci and by 32% in mesoendemic foci.
Turner et al. [87] on the other hand conducted the study on modelling the impact of
ivermectin on river-blindness and its burden of morbidity and mortality in African Sa-
vannah. Their analysis was underpinned by a deterministic onchocerciasis transmission
model (EPIONCHO) as used by Basáñez et al. [10]. They then performed sensitivity
analysis by varying the rate of decay (mean duration between 5 and 50 years) accord-
ing to the range considered previously in the modelling of the Schistosomiasis vaccine
as well as choosing a more modest 60% coverage of the vaccine. Their results indi-
cated that in the absence of control interventions, onchocerciasis poses a high disease
burden which is linearly related to pre-control endemicity level. In addition, they estab-
lished that long-term annual ivermectin distribution on onchocerciasis prevalence and
intensity decreases with increasing levels of baseline (pre-control) endemicity. They es-
tablished that higher therapeutic coverage and high compliance has a high impact on
the elimination of onchocerciasis from the population. This implies that the proportion
of the population that sometimes does not comply with the treatment will become very
important in the elimination of the parasite from the population. They concluded that
the long-term annual ivermectin treatment is highly effective in reducing the morbidity
and excess mortality associated with onchocerciasis. The results from Turner et. al. [89]
indicate that the biting rates decrease as age increases. It also indicates that the vaccine
against onchocerciasis could markedly decrease the chance of onchocerciasis infection
re-spreading to areas where treatment has been stopped.
In addition to the mathematical and EPIONCHO models, related studies have been car-
ried out to measure the effectiveness treatment of onchocerciasis with ivermectin. For
example, Moses et.al [46] carried out study to investigate the effect of fifteen years of
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annual mass treatment of onchocerciasis with ivermectin in the interruption of trans-
mission of onchocerciasis in the west region of Cameroon. They identified issues that
could be improved upon in order to attain and sustain the desired treatment coverage
of at least 90% of UTG1. They obtained the results in Table 2.1.
Table 2.1: Comparing reported and validated (through surveys) UTG treatment cover-
age in West Region from 2003 to 2010 [46].
Year 2003 2004 2005 2006 2007 2008 2009 2010
Reported coverage 102.6 94.4 91.2 97.6 98.3 95.8 98.5 98.3
Verified through surveys 93.2 93.2 96.7 98.6 90.2 91.4 88.2 83.5
The samples from 2003 to 2010 are; 2370, 2370, 2305, 2436, 2453, 694, 713 and 506 respec-
tively. They established that annual mass treatment with ivermectin for 15 years had
considerably reduced microfilaria and nodule prevalence in all the sentinel communi-
ties of West Region of Cameroon. In addition to treatment, they suggested that comple-
mentary strategic options should be adopted as elimination becomes the goal in Africa.
2.3 Our research
From the literature, it is shown that many epidemiological models have been used to ex-
plain the dynamics of onchocerciasis and its elimination from the population. However,
a few mathematical models are available from the literature. Based on the problem we
have described so far, our objective is to derive a mathematical model that can specifi-
cally characterise the dynamics of the disease in endemic regions with special interest in
its transmission and control. We will employ relevant techniques to analyse the model
with the aim of determining possibilities of elimination of the disease.
1Ultimate Treatment Goal.
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Mathematical model
3.1 Introduction
One of the purposes of modelling epidemics is to provide a rational basis for policies
designed to control the spread of a disease. The inclusion of practical optimal strate-
gies in models allow for the assessment of the intervention of public health authorities.
Optimal control is a powerful mathematical tool in decision making that involves em-
ploying appropriate strategies to eradicate epidemics from the population [56]. The
decisions include determining the proportion of the population that should be treated
as time evolves in a given epidemic to minimize both the number of infections in the
population and the implementation cost. Optimal control has been used to study the
dynamics of some diseases such as malaria and West Nile virus [13, 14, 69]. For instance,
in [18, 81], optimal control was used to investigate the best strategy for educational cam-
paigns during the outbreak of an epidemic and at the same time minimizing the number
of infected humans. It has also been applied in modelling Leukemia [1, 64]. However,
to the author’s best knowledge, optimal control has not been applied to onchocerciasis
disease transmission.
In this Chapter, we develop a mathematical model for onchocerciasis disease transmis-
sion with control strategies. The aim is to gain some insights into the best intervention
for minimizing and eventual elimination of onchocerciasis from the population. The
intervention strategies we incorporate into the model are, personal protection against
black-fly, enhanced treatment and insecticide spraying. Three control functions are used
, one for vector reduction, one for human protection and another for the reduction of mi-
crofilarie in the body following treatment with ivermectin. We characterize the optimal
control problem analytically by applying Pontryagin Maximum Principle. We analyse
16
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the model analytically and numerically to find out the threshold conditions under which
it is optimal to eradicate onchocerciasis. The asymptotic dynamics of a onchocerciasis
disease model using the autonomous model formulated are also studied.
3.2 Model formulation
We consider a habitat with two interacting populations. The two populations are hu-
mans (as hosts) and the black-flies (as vectors). The human population is partitioned
into six compartments: the susceptible human compartment; SH, referring to individ-
uals not infected with onchocerciasis but are at risk of infection, the exposed compart-
ment; EH, referring to the individuals that have been exposed to onchocerciaisis through
bites but not infectious, the infectious compartment; IH, referring to individuals with
onchocerciaisis infection, the susceptible human on ivermectin treatment compartment;
ST, the exposed human on ivermectin treatment compartment; ET, and the infectious
human on ivermectin treatment compartment; IT . The black-fly population is parti-
tioned into three compartments: susceptible vector; SV , referring to black-flies that have
never been in contact with infected human and have not picked up microfilariae but are
at risk of picking up microfilariae during blood meal from an infected human, the ex-
posed vector compartment; EV , referring to vector that has picked up microfilariae from
an infective human during blood meal but does not transmit the infection and the infec-
tive vector compartment; IV , referring to the vector with the infective L3 larvae stage.
Individuals and the vector move from one compartment to another as their disease sta-
tus evolve. The total human and vector populations at any given time, t, are respectively
given by;
N = SH(t) + EH(t) + IH(t) + ST(t) + ET(t) + IT(t) and V = SV(t) + EV(t) + IV(t).
(3.2.1)
We assume that the transmission of onchocerciaisis in susceptible hosts is only through
contact with infectious vector. We also assume that susceptible vector becomes infec-
tious as a result of contact with infectious hosts during blood meal. The population un-
der study is assumed to be large enough to be modelled deterministically. The constant
recruitments of new susceptible human and susceptible vector are given by b1 and b2
respectively. Assuming β is the black-fly biting rate, that is, the average number of bites
per black-fly per unit, the rate of infection per susceptible black-fly can be represented
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by
λv(t) =
qβ(IH + κ IT)
N
, (3.2.2)
where q is the transmission probability from infectious human to black-flies and κ is
the modification parameter which measures the relative ability of individuals in class IT
to cause new infections relative to those in compartment IH. We assume here that the
individuals under treatment have a slightly lower probability to initiate new infections,
thus, 0 ≤ κ ≤ 1. Assuming that the total number of bites made by black-flies equals to
the number of bites received by humans, then the average number of bites per human
per unit time is βVN . Assuming that the transmission probability per bite from infectious
black-flies to human is p, the rate of infection per susceptible human is given by
λh(t) =
pβV
N
IV
V
=
pβIV
N
. (3.2.3)
We then introduce βh = pβ and βv = qβ parameters to simplify the infection rates
per susceptible human and vector respectively. The individuals in class EH progress
to the infectious class IH at the rate γ. Individuals on ivermectin treatment in class ST
acquire infection at the rate δλh. Here, δ ∈ [0, 1], defines the reduced effect of infection
of the susceptible individuals on ivermectin as a result of treatment. Individuals in class
ET progress to infectious class on ivermectin IT at the rate ργ, where ρ ∈ [0, 1] is the
reduced effect of progression to class IT as a result of treatment. The rate of treatments
for individuals is given by α. We assume relapse of individuals under treatment due to
waning of the drug at the rate ϕ. We also assume natural mortality rates given by µh
and µv for the human and vector populations respectively.
We further assume that individuals under treatment have no immunity to the disease
upon treatment. In addition, we assume that infected vectors and human do not recover
from the infection during the modelling time. The dynamics in the human hosts and
vector populations is represented in the schematic diagram in Figure 3.1.
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Figure 3.1: A compartmental representation of the model for onchocerciasis and its treat-
ment.
3.2.1 Model equations
Given the dynamics described in Figure 3.1, the following system of non-linear ordinary
differential equations, with non-negative initial conditions, describes the dynamics of
onchocerciaisis epidemics.
˙SH = b1 + ϕST − λhSH − (α+ µh)SH,
E˙H = λhSH + ϕET − (α+ γ+ µh)EH,
˙IH = γEH + ϕIT − (α+ µh)IH,
S˙T = αSH − δλhST − (ϕ+ µh)ST,
E˙T = αEH + δλhST − (ργ+ ϕ+ µh)ET,
I˙T = αIH + ργET − (ϕ+ µh)IT,
S˙V = b2 − λvSV − µvSV ,
E˙V = λvSV − (η + µv)EV ,
˙IV = ηEV − µv IV ,

(3.2.4)
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subject to the following initial conditions
SH(0) ≥ 0, EH(0) ≥ 0, IH(0) ≥ 0, ST(0) ≥ 0, ET(0) ≥ 0, IT(0) ≥ 0,
SV(0) ≥ 0, EV(0) ≥ 0, IV(0) ≥ 0.
(3.2.5)
Table 3.1: Description of parameters used in the model.
Parameter Description
b1 Human recruitment rate.
µh Natural death rate of the human (host) .
βh The rate of transmission of the disease from black-fly to human.
γ Transfer rate from EH to IH class.
α Rate of mass administration of ivermectin.
ϕ Waning rate of ivermectin .
κ, ρ, δ Modification parameters.
b2 Vector recruitment rate.
βv The rate of transmission of the disease from human to blackfly.
η Transfer rate from EV to IV class.
µv Natural death rate of the black-fly.
3.2.2 Model assumptions
1. There is a constant recruitment to the susceptible human population as well as the
susceptible black-fly population.
2. Transmission takes place only from infectious black-flies to susceptible humans
and from infectious humans to susceptible black-flies.
3. Infected black-flies do not live long enough to recover from infection.
4. Human hosts do not have immunity to the disease.
5. The waning of the ivermectin after the mass treatment occurs at the same rate in
all the treated classes.
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3.3 Model analysis
In this section, we analyse the general properties of the system (3.2.4) with positive
initial conditions. The system (3.2.4) describes the population dynamics both in human
and black-fly populations.
3.3.1 Positivity of solutions of the model
The system (3.2.4) describes the human and black-fly population. It is therefore impor-
tant to show that all the state variables describing the dynamics of the populations will
be non-negative. In particular, we prove that all solutions of the system (3.2.4) with non-
negative initial conditions will remain non-negative for all t > 0. We have the following
theorem.
Theorem 3.3.1. For non-negative initial conditions of system (3.2.4), the solutions (SH, EH, IH,
ST, ET, IT, SV , EV , IV) of the system (3.2.4) are all non-negative for all time t ≥ 0.
Proof. For the equations in the system (3.2.4), let us take t∗ as the maximum time for the
epidemics. This implies that;
t∗ = sup{t > 0 : SH > 0, EH > 0, IH > 0, ST > 0, ET > 0, IT > 0,> 0, SV > 0, EV > 0, IV > 0}.
Thus, t∗ ≥ 0. Then, from the first equation of the system (3.2.4), we obtain
˙SH = b1 + ϕST − λhSH − (α+ µh)SH ≥ −
(
λh + (α+ µh)
)
SH,
SH(t∗) ≥ SH(0) exp
{
−
(∫ t∗
0
λh(m)dm + (α+ µh)t∗
)}
.
This implies that SH(t∗) ≥ 0 for all time t ≥ 0. Similarly, from the seventh equation of
the system (3.2.4), we have
S˙V = b2 − λvSV − µvSV = b2 − (λv + µv)SV . (3.3.1)
Equation (3.3.1) can be written as
d
dt
(
SV exp
{∫ t
0
λv(u)du + µvt
})
= b2 exp
{∫ t
0
λv(u)du + µv(t)
}
,
Integrating both sides from t = 0 to t = t∗, we obtain
SV(t∗) exp
{∫ t∗
0
λv(u)du + µvt∗
}
− SV(0) =
∫ t∗
0
b2 exp
{∫ x
0
λv(x)dx + µvy
}
dy,
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then multiplying both sides by exp
{
−
∫ t∗
0
λv(u)du− µvt∗
}
, we have
SV(t∗) = SV(0) exp
{
−
∫ t∗
0
λv(u)du− µvt∗
}
+ exp
{
−
∫ t∗
0
λv(u)du− µvt∗
}
×
∫ t∗
0
b2 exp
{∫ x
0
λv(x)dx + µvy
}
dy > 0.
Hence, SV(t∗) ≥ 0 for all t∗ ≥ 0. Therefore, SH(t∗) and SV(t∗) being the sum of pos-
itive terms are positive. Using the same argument, it can be shown that the quantities
EH, IH, ST, ET, IT, EV , and IV are all positive for all t > 0. Thus, the solutions of (3.2.4)
remain positive for all t ≥ 0.
3.3.2 Invariant region
Lemma 3.3.2. Let (SH, EH, IH, ST, ET, IT, SV , EV , IV) be the solutions of the system (3.2.4)
with initial conditions given in (3.2.5) and the biological feasible region given by the set Ω =
ΩH ×ΩV where
ΩH =
{
(SH, EH, IH, ST, ET, IT) ∈ R6+ : N ≤
b1
µh
}
, ΩV =
{
(SV , EV , IV) ∈ R3+ : V ≤
b2
µv
}
.
Proof. Adding the equations in the system (3.2.4) gives
N˙ = b1 − µhN, V˙ = b2 − µvV. (3.3.2)
It can then be shown that
lim
t→∞ sup N ≤
b1
µh
and lim
t→∞ sup V ≤
b2
µv
. (3.3.3)
Hence, the set Ω is positively invariant, that is, all the solutions in Ω remain in Ω for
t > 0. We thus conclude that Ω is an attracting set.
Therefore every solution of the system (3.2.4), with initial condition in Ω remains there
for t > 0. In addition, in Ω, the usual existence, uniqueness and continuation results
hold for the system. The system (3.2.4) is thus both mathematically and epidemiologi-
cally well-posed in the regionΩ. Hence, it is sufficient to study the dynamics of the flow
generated by the system (3.2.4) in Ω. The the right hand side of the system (3.2.4) is lo-
cally Lipschitz continuous implying that the local existence and uniqueness of solutions
is ascertained.
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3.4 Existence and stability of the equilibrium points
Equilibrium points or steady state solutions are the points at which the differential equa-
tions of the system (3.2.4) equal to zero.
3.4.1 Disease-free equilibrium
The disease-free equilibrium (DFE) points are steady state solutions that depict the ab-
sence of infection in both the human and black-fly populations. This implies that at
onchocerciasis-free equilibrium (E0), EH = IH = ET = IT = EV = IV = 0. Solving the
first, forth and seventh equations of the model system (3.2.4) we obtain
E0 =
(
b1
Q1 (1−Φ1) , 0, 0,
b1α
Q1Q3 (1−Φ1) , 0, 0,
b2
µv
, 0, 0
)
, (3.4.1)
where
Q1 = α+ µh, Q2 = α+ γ+ µh, Q3 = ϕ+ µh, Q4 = ργ+ ϕ+ µh,
Q5 = η + µv, Φ1 =
ϕα
Q1Q3
.
3.4.2 Basic reproduction number
The basic reproduction number is defined as the average number of secondary cases of
human/vector onchocerciasis infections generated by a typical infected human/vector
in an otherwise disease free population [92]. The basic reproduction number (R0) of the
system (3.2.4) is computed using the next generation matrix method (NGM). Here the
matrix F denotes the rates of appearance of new infections and V transfer of infection
into and out of any compartment respectively. The matrices are given by
F =

βh IV SH
N
0
δβh IV ST
N
0
βv IHSV
N +
κβv ITSV
N
0

, V =

Q2EH − ϕET
−γEH + Q1 IH − ϕIT
−αEH + Q4ET
−αIH − ργET + Q3 IT
Q5EV
−ηEV + µv IV

We then evaluate both F and V by taking the partial derivatives of the terms in F and
V at the disease-free equilibrium to obtain a non-negative square matrix F and a non-
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singular matrix V.
F =

0 0 0 0 0 βhµhQ1(1−Φ1)
0 0 0 0 0 0
0 0 0 0 0 βhµhαδQ1Q3(1−Φ1)
0 0 0 0 0 0
0 b2βvµhµvb1 0
b2βvκµh
µvb1
0 0
0 0 0 0 0 0

, V =

Q2 0 −ϕ 0 0 0
−γ Q1 0 −ϕ 0 0
−α 0 Q4 0 0 0
0 −α −ργ Q3 0 0
0 0 0 0 Q5 0
0 0 0 0 −η µv

The basic reproduction number (R0) which is the the spectral radius of the next genera-
tion matrix FV−1 is given by;
R0 =
√
R0 =
√
Rh0R
v
0, (3.4.2)
where
Rh0 =
βhγµ
2
h(Φ3 + αδ(ακϕ+ Q2ρ(Q1κ + ϕ)))
b1Q21Q2Q
2
3Q4(1−Φ1)2(1−Φ2)
, Rv0 =
b2βvη
Q5µ2v
, Φ2 =
αϕ
Q2Q4
,
Φ3 = Q3[αϕ(δ+ ρ) + Q1ακρ+ Q4(Q3 + ακ)].
The basic reproduction number R0, determines whether onchocerciasis dies out or per-
sists in the population. The square root in (3.4.2) agrees with the findings of [53]. This
is a biological requirement in the human-vector host model system since the parasite
passes through two types of individuals to complete its life cycle. Note that Rv0 is the
contribution of the vector population to the overall infection while Rh0 is the contribu-
tion of the human population. The following theorem follows directly from [26, 92].
Theorem 3.4.1. The disease-free equilibrium of the system (3.2.4) exists and is locally asymp-
totically stable ifR0 < 1, and unstable otherwise.
The disease free steady states has a strong influence on the behaviour of the disease
transmission dynamics in the population. This implies that if we are looking into elim-
inating onchocerciasis from the population, we have to establish the conditions neces-
sary for the onchocerciasis free equilibrium to be stable. Epidemiologically, results in
3.4.1 implies that when R0 < 1, on average each infected individual infects fewer than
one individual and the disease dies out. On the other hand, if R0 > 1, on average each
infected individual infects more than one other individual and we would expect the
disease to spread.
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3.5 Existence of the disease persistent steady states
Let S∗H, E
∗
H, I
∗
H, S
∗
T, E
∗
T, I
∗
T, S
∗
V , E
∗
V , I
∗
V be non-trivial the solutions to the endemic equilib-
rium points. Setting all the equations of the system (3.2.4) to zero and expressing the
state variables in terms of the forces of infections λh and λv, we have
S∗H =
b1(Q3 + δλ∗h)
Q1Q3(1−Φ1) + λ∗h(Q1δ+ Q3 + δλ∗h)
,
E∗H =
b1λ∗h(αδϕ+ Q4(Q3 + δλ
∗
h))
Q2Q4(1−Φ2)(Q1Q3(1−Φ1) + λ∗h(Q1δ+ Q3 + δλ∗h))
,
I∗H =
γb1λ∗h(δλ
∗
h (αρϕ+ Q3Q4) + Q2αδρϕ+ Q3 (αϕ(δ+ ρ) + Q3Q4))
Q1Q2Q3Q4(1−Φ1)(1−Φ2)(Q1Q3(1−Φ1) + λ∗h(Q1δ+ Q3 + δλ∗h))
,
S∗T =
αb1
Q1Q3(1−Φ1) + λ∗h(Q1δ+ Q3 + δλ∗h)
,
E∗T =
αb1λ∗h(Q3 + δ(Q2 + λ
∗
h))
Q2Q4(1−Φ2)(Q1Q3(1−Φ1) + λ∗h(Q1δ+ Q3 + δλ∗h))
,
I∗T =
αb1γλ∗h
(
αδϕ+ Q4
(
δλ∗h + Q3
)
+ ρQ1
(
δ
(
λ∗h + Q2
)
+ Q3
))
Q1Q2Q3Q4(1−Φ1)(1−Φ2)(Q1Q3(1−Φ1) + λ∗h(Q1δ+ Q3 + δλ∗h))
,
S∗V =
b2
λ∗v + µv
, E∗V =
b2λ∗v
Q5(λ∗v + µv)
, I∗V =
b2ηλ∗v
Q5µv(λ∗v + µv)
.

(3.5.1)
From the results in (3.5.1), we have the following two cases describing the existence of
the steady states;
Case 1: λ∗h = λ
∗
v = 0.
This corresponds to the disease-free state treated in (3.4.1), where there is no infection.
Case 2: λ∗h 6= λ∗v 6= 0.
This is the scenario in which there is infection in both the population (hosts and vector
populations). We describe this state using the following denotation.
E1 = (S∗H, E
∗
H, I
∗
H, S
∗
T, E
∗
T, I
∗
T, S
∗
V , E
∗
V , I
∗
V).
Substituting the expressions for the state variables I∗V , I
∗
H and I
∗
T in (3.5.1) into the ex-
pressions for the forces of infection in (3.2.2) and (3.2.3) then simplifying we obtain the
following polynomial.
Ψ2λ∗2h +Ψ1λ
∗
h +Ψ0 = 0, (3.5.2)
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where
Ψ2 = Q5b1δµv[Q1Q2Q3Q4µv(1−Φ1)(1−Φ2) + βvµhγ(αρ (κQ1 + ϕ) + Q4 (ακ + Q3))],
Ψ1 = −[b2γδηβhµ2hβv(αρ(κQ1 + ϕ) + Q4(ακ + Q3))− b1Q5µv(γµhβv(α2δκϕ
+ αδρQ2(κQ1 + ϕ) + Q3(αϕ(δ+ ρ) + ακρQ1 + Q4(ακ + Q3)))
+ Q1Q2Q3Q4(1−Φ1)(1−Φ2)(δQ1 + Q3)µv)],
Ψ0 = b1Q21Q2Q
2
3Q4Q5µ
2
v(1−Φ1)2(1−Φ2)[1−R0].
The existence and the number of endemic equilibria for the system (3.2.4) is determined
by the existence of, and the number of positive roots of the quadratic equation given
in (3.5.2). The roots to the quadratic equation (3.5.2) can be obtained by the quadratic
formula given by
(λ∗h)1,2 =
−Ψ1 ±
√
Ψ21 − 4Ψ2Ψ0
2Ψ2
. (3.5.3)
We note that Ψ0 > 0 if R0 < 1, Ψ0 = 0 if R0 = 1 and Ψ0 < 0 if R0 > 1. If Ψ0 < 0,
then ∆ = Ψ21 − 4Ψ2Ψ0 > 0 and equation (3.5.2) has a unique positive solution hence the
system (3.2.4) has a unique endemic equilibrium . IfR0 < 1 then Ψ0 > 0 and by adding
the conditions Ψ1 < 0 and ∆ > 0, we get two positive real equilibria . If R0 = 1, then
Ψ0 = 0 and there is a unique non-zero solution of (3.5.2) which is positive if and only if
Ψ1 < 0.
The following theorem summarizes the existence of the endemic equilibria of the system
(3.2.4).
Theorem 3.5.1. The system (3.2.4)
1. has no endemic equilibrium ifR0 < Rc0 whereRc0 is referred to as criticalR0.
2. has a unique endemic equilibrium in Ω ifR0 > 1.
3. has two endemic equilibria for some parameter values ofRc0 < R0 < 1. In this range, one
endemic equilibrium and the disease-free equilibrium are locally stable.
4. has one positive equilibrium for R0 = 1 provided Ψ1 < 0 and ∆ > 0, otherwise there is
no positive equilibrium.
5. has no endemic equilibrium otherwise.
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Proposition 3.5.2. The system (3.2.4) has a backward bifurcation at R0 = 1 if and only if
Ψ1 < 0 and ∆ > 0.
Epidemiologically, proposition 3.5.2 implies that bringing R0 below unity does not suf-
fice for the eradication of onchocerciasis. From the analysis of the existence of the en-
demic equilibrium, we have established that the system (3.2.4) exhibits backward bi-
furcation when R0 < 1. The existence of backward bifurcation indicates that in the
neighbourhood of 1, for R0 < 1, a stable disease-free equilibrium coexists with two
endemic equilibria, that is , a smaller equilibrium (smaller number of infectious indi-
viduals) which is unstable and a larger equilibrium (with a larger number of infectious
individuals) which is stable. These two endemic equilibria disappear by saddle-node
bifurcation when the basic reproduction R0 is decreased below the critical value Rc0. In
order to achieve a epidemiological goal of disease eradication, R0 must be brought be-
low the critical value Rc0. To obtain the critical value Rc0, we set the discriminant ∆ of
the polynomial (3.5.2) to zero and makeR0 the subject of the relation. Thus, we have
Rc0 = 1−
Ψ21
4Ψ2[b1Q21Q2Q
2
3Q4Q5µ2v(1−Φ1)2(1−Φ2)]
. (3.5.4)
3.5.1 Bifurcation analysis
This is a qualitative change in the behaviour of a dynamical system produced by vary-
ing a parameter in the equation [67]. Backward bifurcation is an important phenomenon
in compartmental epidemiological models. This phenomenon has been observed in nu-
merous disease transmission models [30, 34, 45, 93]. Wang [93] studied backward bifur-
cation of an epidemic model with treatment. He demonstrated that his model exhibits
backward bifurcation behaviour. The existence of such a bifurcation suggests that the
basic reproduction number itself is not enough to characterize or decide whether on-
chocerciasis will prevail or not and if the disease will become endemic also depends on
the initial sizes of the involved population. Thus, it is important to identify the back-
ward bifurcation and establish its threshold. We carry out bifurcation analysis to study
the behaviour of the system (3.2.4) based on the results in (3.5.2) through numerical
simulation over chosen parameter values. It is important to note that the existence of
bi-stability is not easy to simulate numerically. This is because a small interval of R0
is required for the occurrence of backward bifurcation and very small range of param-
eters has to be chosen. The qualitative backward bifurcation diagram describing the
behaviour of R0 = 1 is presented in Figure 3.2 where βh is taken as the bifurcation pa-
rameter. The result indicates that in the backward bifurcation, if R0 is below unity then
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the disease control depends on the initial sizes of the various sub-populations of the
system (3.2.4). However, reducingR0 below the saddle-node bifurcation valueRc0, may
result in disease eradication. This is guaranteed provided that the disease-free equilib-
rium is globally asymptotically stable. Figure 3.3 is obtained after increasing the rate of
mass administration of ivermectin to 1. The biological interpretation of this is that in-
creasing treatment can lead to disappearance of backward bifurcation curve and in this
case lowering R0 below one is sufficient to eliminate the disease from the population.
So when the rate of mass treatment is high enough we will have a forward bifurcation
and lowering R0 below unity would be sufficient to make the disease-free equilibrium
globally stable.
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Figure 3.2: Description of the backward bifurcation of the system (3.2.4) with βh as the
bifurcation parameter. We considered b1 = 10, b2 = 50, µh = 0.000150,γ = 0.0097, βv =
0.000127, µv = 0.09800, η = 0.0884, ϕ = 0.002, α = 0.40, κ = 0.005, δ = 0.0025, ρ =
0.0013.
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Basic reproduction number, R0
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Figure 3.3: Description of forward bifurcation of the system (3.2.4) for parameter values
κ = 0.02, α = 1 and all other parameters as used in Figure 3.2.
3.6 Global stability of the disease-free equilibrium
Since the system (3.2.4) has two endemic equilibria when R0 < Rc0, it implies that the
disease-free equilibrium is globally stable if and only ifR0 < Rc0. We therefore establish
the global stability of the disease-free equilibrium, E0 using a Lyapunov function for
R0 < Rc0.
Theorem 3.6.1. The disease-free equilibrium E0 of system (3.2.4) is globally asymptotically
stable ifR0 < Rc0 and unstable otherwise.
Proof. Let L(EH, IH, ET, IT, EV , IV) = Φ4EH +Φ5 IH +Φ6ET +Φ7 IT +Φ8EV +Φ9 IV , be a
candidate Lyapunov function for some non-negative values ofΦ4,Φ5,Φ6,Φ7,Φ8 and Φ9.
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The time derivative of L is given by;
L˙ = Φ4E˙H +Φ5 ˙IH +Φ6E˙T +Φ7 I˙T +Φ8E˙V +Φ9 ˙IV ,
= Φ4
(
βh IVSH
N
+ ϕET −Q2EH
)
+Φ5(γEH + ϕIT −Q1 IH)
+Φ6
(
αEH +
δβh IVST
N
−Q4ET
)
+Φ7(αIH + ργET −Q3 IT)
+Φ8
(
βv IHSV
N
+
κβv ITSV
N
−Q5EV
)
+Φ9(ηEV − µv IV),
= (Φ5γ+Φ6α−Φ4Q2)EH +
(
Φ7α+Φ8
βvb2µh
µvb1
−Φ5Q1
)
IH + (Φ4ϕ+Φ7ργ−Φ6Q4)ET
+
(
Φ5ϕ+Φ8
κβvb2µh
µvb1
−Φ7Q3
)
IT + (Φ9η −Φ8Q5)EV
+
(
Φ4
βhµh
Q1(1−Φ1) +Φ6
βhδαµh
Q1Q3(1−Φ1) −Φ9µv
)
IV .
Evaluating the coefficients of the suitable Lyapunov function such that the coefficients
of IH, ET, IT, EV , and IV are equal to zero we obtain
Φ4 =
Q21Q
2
3b1(1−Φ1)2Q4Q5µ2v − βhβvµ2hb2ηγαδρ(Q1κ + ϕ)
Q1Q3βhb1µhµv(1−Φ1)(Q3Q4 + αϕδ) , Φ5 =
βvµhb2η(Q3 + ακ)
Q1Q3b1µv(1−Φ1) ,
Φ6 =
Q21Q
2
3(1−Φ1)2Q5b1µ2vϕ−Q3βhβvb2ηγρ(Q1κ + ϕ)
Q1Q3βhb1µhµv(1−Φ1)(Q3Q4 + αϕδ) , Φ7 =
βvµhb2η(ϕ+ Q1κ)
Q1Q3b1µv(1−Φ1) ,
Φ8 = η, Φ9 = Q5.
Using these coefficients, the time derivative of the Lyapunov function is given by
L˙ =
(
Q1Q2Q3Q4Q5µv(1−Φ1)(1−Φ2)
βhµh(Q3Q4 + αϕδ)
)
[R0 − 1]EH < 0, (3.6.1)
It follows that L˙ < 0 for R0 < Rc0 and L˙ = 0 if and only if IH = ET = IT = EV =
IV = 0. Therefore, L is a Lyapunov function in Ω = (SH, EH, IH, ST, ET, IT, SV , EV , IV).
Since, Ω is invariant and attracting, it follows that the largest possible invariant set in
{(SH, EH, IH, ST, ET, IT, SV , EV , IV) ∈ Ω : L˙ = 0}, is the singleton {E0f }. According to
La-Salle’s invariance principle [50], E0 is globally attractive. Therefore, the disease-free
equilibrium E0 is globally asymptotically stable when R0 < Rc0. This completes the
proof.
In the case of the occurrence of a backward bifurcation in the system (3.2.4), the above
result shows that in order to eliminate onchocerciasis, the basic reproduction R0 must
be lower than the thresholdRc0 which is strictly less than unity.
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3.7 Application of optimal control
3.7.1 Formulation of optimal control
In this section, we formulate a model framework that minimizes onchocerciasis infection
in the human population. In the system (3.2.4), the recruitment rates in each susceptible
population is modified to include the density effects. Thus, the density dependent fac-
tors for the recruitment rates are b1(N) for the host population and b2(V) for the vector
population. Personal protection efforts through wearing insect repellents such as N, N-
Diethyl-meta-toluamide (DEET) on exposed skin, wearing long sleeves and long pants
during the day when black-flies bite, and wearing permethrin-treated clothing mini-
mizes or eliminates black-fly-human contacts [71]. Insecticide spraying with larvicide
and adulticide ensures that the breeding sites of the black-flies are minimized. We thus
define some linear control functions ui(t) such that ui(t) = 1, i = 1, 2, 3. It is important
to note that controls are fully effective when ui(t) = 1 and not effective control when
ui(t) = 0. The forces of infection λh and λv corresponding to human population and
vector population respectively are reduced by factor (1− u1), where u1(t) measures the
level of successful exposure prevention efforts. The control u1(t) represents the use of
alternative prevention measures to minimize or eliminate the black-fly-human contacts.
Such measures include the use of insect repellents, wearing protective coats and long
sleeves and wearing permethrin-treated clothing amongst other. The mass administra-
tion of ivermectin as a control is modelled by u2. The factor u2 can be viewed as the
coverage of ivermectin. The factor u3(t), represents the level of larvicide and adulticide
use for the elimination of black-flies from the breeding sites. This implies that the repro-
duction rate of the black-fly population is reduced by a factor of (1− u3(t)). We assume
that, larvicidal spraying increases the mortality rate of the black-flies at a rate propor-
tional to the control factor u3(t). It is further assumed that the per capita mortality rate
of the vector is r0u3(t), where 0 ≤ r0 ≤ 1 is the proportion of effective adulticide spray-
ing. Taking into account the assumptions and extensions made above, we therefore find
the most effective strategy that reduces the onchocerciasis infection in the population at
a minimum cost. Using bounded lebesgue measurable control, the objective functional
to be minimized is given by
J(u1, u2, u3) =
∫ T
0
(A1EH + A2 IH + A3V +
1
2
(B1u21 + B2u
2
2 + B3u
2
3))dt (3.7.1)
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subject to the state system given in (3.2.4). The dynamics of the control that minimizes
the objective functional J(u1, u2, u3) is given by
˙SH = b1N + ϕST − λhSH(1− u1)− (u2α+ µh)SH,
E˙H = λhSH(1− u1) + ϕET − (u2α+ γ+ µh)EH,
˙IH = γEH + ϕIT − (u2α+ µh)IH,
S˙T = u2αSH − δλhST(1− u1)− (ϕ+ µh)ST,
E˙T = u2αEH + δλhST(1− u1)− (ργ+ ϕ+ µh)ET,
I˙T = u2αIH + δγET − (ϕ+ µh)IT,
S˙V = b2V(1− u3)− λvSV(1− u1)− µvSV − r0u3SV ,
E˙V = λvSV(1− u1)− (η + µv)EV − r0u3EV ,
˙IV = ηEV − µv IV − r0u3 IV ,

(3.7.2)
with the following initial conditions
SH(0) ≥ 0, EH(0) ≥ 0, IH(0) ≥ 0, ST(0) ≥ 0, ET(0) ≥ 0, IT(0) ≥ 0,
SV(0) ≥ 0, EV(0) ≥ 0, IV(0) ≥ 0.
(3.7.3)
We endeavour to minimize the exposed and infectious human populations (EH, IH),
the black-fly population and the cost of implementing the control by use of possible
minimum variables ui, i = 1, 2, 3. This functional includes the number of exposed, in-
fectious and the black-fly population, respectively, as well as the social costs related to
the resources needed for personal protection 12 B1u
2
1,enhanced mass administration of
ivermectin 12 B2u
2
2 and spraying of larvicide and adulticide operations
1
2 B3u
2
3. This im-
plies that we are minimizing the number of exposed, infectious human and susceptible,
exposed and infectious black-fly populations as well as the cost based on the implemen-
tation of the control functions. The quantities A1 and A2 represent the cost associated
with minimizing the exposed and infected human population respectively while A3 rep-
resent the cost associated with minimizing total black-fly population. The quantity T is
the time period of intervention. The quantities B1, B2 and B3 represent the weight con-
stants for personal protection, enhanced mass administration of ivermectin and spray-
ing of larvicide and adulticide operations. According to [44, 69] the costs associated
with A1EH, A2 IH and A3V are linear while the cost control functions 12 B1u
2
1,
1
2 B2u
2
2 and
1
2 B3u
2
3 should be non-linear and take the quadratic form. We assume that the costs of
implementation of the control policies are proportional to the square of the correspond-
ing control function. We seek to minimize the objective functional over the given time
interval [0, T]. In particular, the aim of the optimal control problem is to seek optimal
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control functions (u∗1(t), u
∗
2(t), u
∗
3(t)) such that
J(u∗1 , u
∗
2 , u
∗
3(t)) = minU
J(u1, u2, u3), (3.7.4)
where U = {u1, u2, u3|0 ≤ ui(t) ≤ 1, i = 1, 2, 3} is the control set and is Lebesgue mea-
surable. Pontryagin’s Maximum Principle is used to solve this optimal control problem
and the derivation of the necessary conditions. First we prove the existence of an opti-
mal control for the system (3.7.2) and then derive the optimality system.
3.7.2 Existence of control problem
In order to find the optimal solution, we first find the Lagrangian and Hamiltonian for
the optimal control problem (3.7.1) and (3.7.2). The Lagrangian of the optimal control
problem is given by
L = A1EH + A2 IH + A3V +
1
2
(B1u21 + B2u
2
2 + B3u
2
3). (3.7.5)
We seek for the Lagrangian minimum value. In order to accomplish this, we define the
Hamiltonian, H for the control problem. This is given by
H = L(EH , IH , V, u1, u2, u3) + λ1 ˙SH + λ2E˙H + λ3 ˙IH + λ4S˙T + λ5E˙T + λ6 ˙IT + λ7S˙V
+ λ8E˙V + λ9 ˙IV ,
= A1EH + A2 IH + A3V +
1
2
(B1u21 + B2u
2
2 + B3u
2
3)
+ λ1
[
b1N + ϕST − λhSH(1− u1)− (u2α+ µh)SH)
]
+ λ2
[
λhSH(1− u1) + ϕET − (u2α+ γ+ µh)EH
]
+ λ3
[
γEH + ϕIT − (u2α+ µh)IH
]
+ λ4
[
u2αSH − δλhST(1− u1)− (ϕ+ µh)ST
]
+ λ5
[
u2αEH + δλhST(1− u1)
− (ργ+ ϕ+ µh)ET
]
+ λ6
[
u2αIH + δγET − (ϕ+ µh)IT
]
+ λ7
[
b2V(1− u3)− λvSV(1− u1)− µvSV − r0u3SV
]
+ λ8
[
λvSV(1− u1)− (η + µv)EV − r0u3EV
]
+ λ9
[
ηEV − µv IV − r0u3 IV
]
.

(3.7.6)
Theorem 3.7.1. There exists an optimal control u∗ = (u∗1 , u
∗
2 , u
∗
3) ∈ U such that
J(u∗1 , u
∗
2 , u
∗
3) = min
(u1,u2,u3)∈U
J(u1, u2, u3), (3.7.7)
subject to the control system (3.7.2) with the initial conditions (3.7.3).
Proof. We prove the existence of the optimal problem following the results in [33, 54].
It is clear that the system of equations given by (3.7.2) is bounded and the state vari-
ables are non-negative. In this minimizing problem, the control set U is convex and
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closed by definition. The optimal system is bounded which determines the compact-
ness needed for the existence of the optimal control. The integrand in the objective
functional, A1EH + A2 IH + A3V + 12 (B1u
2
1 + B2u
2
2 + B3u
2
3), is clearly convex on the con-
trol set U. Moreover, we can easily see that, there exists, β > 1 and positive numbers
c1, c2 satisfying
J(u1, u2, u3) ≥ c1(|u1|2 + |u2|2 + |u3|2)
β
2 − c2, (3.7.8)
because, the state variables are bounded. This completes the proof.
3.7.3 Optimality of the system
In order to find the optimal solution, we employ Pontryagin’s Maximum Principle [73]
to the Hamiltonian (3.7.6), such that if (x, u) is an optimal solution of an optimal con-
trol problem, then there exists a non-trivial vector λ = (λ1,λ2, · · · ,λn) satisfying the
following inequalities.
dx
dt
=
∂H(t, x, u,λ)
∂λ
, 0 =
∂H(t, x, u,λ)
∂u
, λ
′
= −∂H(t, x, u,λ)
∂x
. (3.7.9)
We, now derive the necessary conditions to the Hamiltonian in (3.7.6) that optimal con-
trol functions and corresponding states must satisfy.
Theorem 3.7.2. Let S∗H, E
∗
H, I
∗
H, S
∗
T, E
∗
T, I
∗
T, S
∗
V , E
∗
V and I
∗
V be the solutions of the corresponding
optimal control problem (3.7.1)-(3.7.2) associated with the optimal control variables (u∗1 , u
∗
2 , u
∗
3).
Then, there exists adjoint variables λi, i = 1, 2, · · · , 9 satisfying
dλ1(t)
dt
=
βh
N
(λ1 − λ2)(1− u1)IV + (λ1 − λ4)u2α+ λ1µh,
dλ2(t)
dt
= (λ2 − λ3)γ+ (λ2 − λ5)u2α+ λ2µh − A1,
dλ3(t)
dt
= (λ3 − λ6)u2α+ βvN (λ7 − λ8)(1− u1)SV + λ3µh − A2,
dλ4(t)
dt
=
δβh
N
(λ4 − λ5)IV(1− u1) + (λ4 − λ1)ϕ+ λ4µh,
dλ5(t)
dt
= (λ5 − λ2)ϕ+ (λ5 − λ6)ργ+ λ5µh,
dλ6(t)
dt
= (λ6 − λ3)ϕ+ λ6µh + βvκN (λ7 − λ8)SV(1− u1),
dλ7(t)
dt
= −b2λ7(1− u3) + βvN (λ7 − λ8)(1− u1) (IH + κ IT) + λ7µv + λ7r0u3 − A3,
dλ8(t)
dt
= −b2λ7(1− u3) + (λ8 − λ9)η + λ8µv + λ8r0u3 − A3,
dλ9(t)
dt
= −b2λ7(1− u3) + βhN (λ1 − λ2)(1− u1)SH +
δβh
N
(λ4 − λ5)(1− u1)ST + λ9µv
+ λ9r0u3 − A3,

(3.7.10)
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with transversality conditions (or boundary conditions)
λi(T) = 0, i = 1, 2, · · · , 9, (3.7.11)
expressed as
u∗i =

0 if ui ≤ 0,
ui if 0 < ui < 1,
1 if ui ≥ 1.
(3.7.12)
In addition, the control functions u∗1 , u
∗
2 and u
∗
3 are represented by
u∗1 = max
{
min
{
βh(λ2 − λ1)I∗VS∗H + δβh(λ4 − λ5)I∗VS∗T + βv(λ8 − λ7)(I∗H + κ I∗T)S∗V
NB1
,
1
}
, 0
}
,
(3.7.13)
u∗2 = max
{
min
{
α[(λ1 − λ4)S∗H + (λ2 − λ5)E∗H + (λ3 − λ6)I∗H ]
B2
, 1
}
, 0
}
, (3.7.14)
u∗3 = max
{
min
{
λ7b2V∗ + r0(λ7S∗V + λ8E
∗
V + λ9 I
∗
V)
B3
, 1
}
, 0
}
. (3.7.15)
Proof. To determine the adjoint equations and the transversality conditions, we mini-
mize the Hamiltonian H with respect to the controls (u∗1 , u
∗
2 , u
∗
3) at the optimal control
functions. Setting SH(t) = S∗H(t), EH(t) = E
∗
H(t), IH(t) = I
∗
H(t), ST(t) = S
∗
T(t), ET(t) =
E∗T(t), IT(t) = I
∗
T(t), SV(t) = S
∗
V(t), EV(t) = E
∗
V(t) and IV(t) = I
∗
V(t) and differentiating
the Hamiltonian (3.7.6) with respect to SH, EH, IH, ST, ET, IT, SV , EV and IV , respectively,
we obtain (3.7.10). Solving the equations
∂H
∂u1
= 0,
∂H
∂u2
= 0,
∂H
∂u3
= 0, (3.7.16)
on the interior of the control set using the optimality conditions and the property of the
control set U, we derive (3.7.13)-(3.7.15). Due to the fact that the state and the adjoint
functions are bounded and the Lipschitz structure of the ordinary differential equations,
we obtain the uniqueness of the optimal control. This completes the proof.
The formulas (3.7.13)-(3.7.15) for u∗ are the characteristics of the optimal control. The
optimal control are found by solving the optimality system, that consists of the state sys-
tem (3.7.2), the adjoint system (3.7.10), the initial conditions (3.7.3), boundary conditions
(3.7.12) and the characteristic of the optimal control (3.7.13)-(3.7.15). In order to solve the
optimality system, we use the initial and transversality conditions alongside the charac-
terization of the optimal control (u∗1 , u
∗
2 , u
∗
3) given in (3.7.13)-(3.7.15). Furthermore, the
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second derivative of the Lagrangian with respect to u1, u2 and u3, respectively, are pos-
itive indicating that the optimal control problem is minimum at controls u∗1 , u
∗
2 and u
∗
3 .
We thus obtain the optimal control through numerical simulation.
3.8 Numerical simulations
In this section, we discuss the numerical solutions of the optimality system (3.7.2) and
the corresponding optimal control strategies. In order to solve the optimality system we
employ the standard two-boundary point method described in [51]. In our numerical
simulations, we first start by solving the state equations (3.7.2) using Runge-Kutta forth
order forward in time with a guess for the controls over simulated time. Based on the
transversality conditions (3.7.12), the adjoint equations are solved by backward method.
The time varying control values are found by entering the calculated values of the state
and adjoint variables in the characterization of optimal controls (3.7.13)-(3.7.15). Convex
combination is used to update the control values. In this case, the average of the new
and old control values is taken. The convergence is acquired when the values of the
variables in the new iteration and the previous iteration are insignificantly close.
3.8.1 Parameter estimation
In this section, we consider average parameter values that encompass features of on-
chocerciasis disease including rate of infection, incubation period, length of infections
period in the vector and host populations. Although estimates of some parameters are
given in Table 3.2, here we give additional explanation and description of some of the
parameters based on available literature and with reference to Ghana which is one of
the onchocerciasis endemic countries.
1. The average birthrate in Ghana was estimated to be 31.09 births/1,000 popula-
tion in 2015 and 30.60 births/1,000 population in 2014 according to the World Fact
Book by Central Intelligence Agency [85] and Ghana Statistical Service report on
Demographic and Health Survey [35] respectively. Thus, the recruitment rate is
estimated from the range 0.0000819 ≤ b1 ≤ 0.000108 per day.
2. The natural human death rate is estimated based on average life of 50-70 years in
accordance to Central Intelligence Agency and 2014 demographic data released by
Ghana Statistical Service estimates of life expectancy at birth respectively [35, 85].
The black-fly death rate is estimated based on the average life span lasting for 2-3
weeks, to as long as 85 days [31, 68].
Stellenbosch University  https://scholar.sun.ac.za
37 3.8. Numerical simulations
3. It takes 34 to 2 years for the worm to mature and release enough microfilariae to
be detectable in the skin of the human host [52, 66, 76]. Therefore, a reasonable
estimate of the incubation rate γ is 0.00137 ≤ γ ≤ 0.00365 per day. On the other
hand, the average incubation period in the black-fly is 1-2 weeks [52, 72, 76]. Thus,
a reasonable value for η is 0.0714 ≤ η ≤ 0.1667 per day.
4. The modification parameters (κ, δ and ρ) have been estimated to be between 0 and
1 due to the reduced ability of individuals to cause infections following ivermectin
treatment.
5. The rate of protection following mass administration of ivermectin α is estimated
to be between 0% and 100%.
6. We balance the host populations and control functions by arbitrarily choosing
weight contstant values A1 = A2 = A3 = 1, B1 = 10, B2 = 10, B3 = 10 in the
objective functional (3.7.1). These weight parameters determine the importance of
variables in the objective functional [51]. The estimate for rate constant r0 is given
as 0.06.
For illustration purpose, we consider the parameter estimates in Table 3.2 with the fol-
lowing initial conditions;
SH(0) = 16200, EH(0) = 1500, IH(0) = 100, ST(0) = 2000, ET(0) = 300,
IT(0) = 10, SV(0) = 2500, EV(0) = 250, IV(0) = 10.
In the simulation, we consider the treatment rate as the protection rate upon the mass
administration of ivermectin.
3.8.2 Sensitivity analysis
Sensitivity analysis is introduced to study the strength of the basic reproduction num-
ber for the model parameters. Due to the unavailability of data, uniform distribution is
used for the set of parameters in Table 3.2 peaked at the median. Tornado plot for the
normalised sensitivity index for different parameters is given in Figure 3.4. If the sensi-
tivity index is positive, then R0 increases along with increasing value of the parameter.
On the other hand, if the sensitivity index is negative, then R0 decreasing with the in-
creasing value of the parameter. The transmission contact rates in human and the vector
have the greatest effect on the disease transmission. The results in Figure 3.4 indicate
that the basic reproduction number increases with increase in the transmission contact
rate in both the human (host) and the vector whereas the basic reproduction number
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Table 3.2: Parameters used for numerical simulation. The rates are given per day.
Parameter Range Point value Source
b1 0.0000819-0.001085 0.001 Estimated.
µh 0.0000391-0.0000548 0.000052 [35, 85].
βh 0.0-0.0180 0.00214 Estimated.
γ 0.00137-0.00365 0.0023 [52, 66, 76].
α 0-1.0 0.0165 [94].
ϕ 0.01-0.1 0.0013 [89].
κ 0.00-1.0 0.002 Estimated.
ρ 0.0-0.1.0 0.012 Estimated.
δ 0.00-1.0 0.001 Estimated.
b2 0.0177-0.0871 0.0643 Estimated .
βv 0.0-0.0245 0.00104 Estimated.
η 0.0714-0.1667 0.074 [52, 72, 76].
µv 0.0118-0.0714 0.065 [31, 68].
decreases with increase in the vector death rate. The results therefore suggest that if the
transmission of onchocerciasis in both the vector and the human (host) can be reduced
and the vector death rate increased, then the disease can be easily controlled. On the
other hand, Fig. 3.5 shows that an increase in both κ and δ increases R0. Thus, the ef-
fectiveness of ivermectin in the treatment of onchocerciasis is critical in eliminating new
cases of infections in the treated population.
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Figure 3.4: Tornado plots of partial rank correlation coefficients (PRCCs) of the parame-
ters that influence R0 for the input parameters using the values in Table 3.2. Parameters
with PRCC> 0 increases R0 when they are increased whereas parameters with PRCC< 0
decreases R0 when they are increased.
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Figure 3.5: Contour plot showing the effect of modification parameters δ and κ on R0.
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3.8.3 Simulation results
Figure 3.6, represents the population of susceptible, exposed, infected individuals (hu-
man) in two systems, (3.2.4) without control and (3.7.2) with control. The red line de-
notes the population of individuals in the system (3.2.4) without control while the blue
dotted line denotes the population of individuals in the system (3.7.2) with control. On-
chocerciasis infection is shown to be contained much earlier in time when appropriate
and aggressive optimal controls are applied to the onchocerciasis epidemic. Part (a) of
Figure 3.6 reveals that without controls, the susceptible human (hosts) population not
on ivermectin gets depleted at a higher rate due to unchecked transmission. However,
with controls, more individuals stay in the susceptible class (humans). In addition, part
(b) of Figure 3.6 shows that more susceptible individuals stay protected with ivermectin
when there is control as compared to when there is no control. Part (c) and (e) of Figure
3.6 show that the populations of exposed and infected individuals with control are more
decreased than the individuals without control. The results suggest that much less time
is taken to clear onchocerciasis disease when optimal control measures are applied than
without controls.
Figure 3.7 reveals that the population of the susceptible vector with optimal control is
more sharply decreased while the population without control grows and settles at en-
demic state. The population of susceptible vector with control decreases to zero. We
observe in Figure 3.7 (b) and (c) that the exposed and infected vector without control
rise during the initial stages of epidemic followed by a decrease then remains at en-
demic stage. However, in the presence of control we observe a decrease which ends at
onchocerciasis free stage. The results illustrate the importance of control in the reduc-
tion of onchocerciasis infection in the population.
Figure 3.8 shows the evolution of the control profiles over time. The results show that
the controls u1, u
∗
2 and u
∗
3 all start at the upper bound. However, the first control, u1,
declines after about 75 days and u∗3 declines after about 50 days. The control profile u2
maintains its upper bound and declines at near 400 days. This can be explained by the
fact that in the treatment of onchocerciasis with ivermectin, the drug is administered for
the entire period corresponding with the lifespan of filarial adult worms. The simula-
tion shows that a lot more emphasis should be put in reducing the contact that results
into onchocerciasis infection. More emphasis should be put on vector eradication that
posses danger on the continuous spread of the disease. We suggest that treatment ser-
vices should be patient specific, proper, efficient and timely.
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Figure 3.6: The plot represents population of susceptible not on ivermectin, exposed
not on ivermectin, infected not on ivermectin, susceptible on ivermectin, exposed on
ivermectin and infected on ivermectin human host both with control (blue dotted line)
and without control (red line).
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Figure 3.7: The plot represents population of susceptible , exposed and infected vector
both with control (blue dotted line) and without control (red line).
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Figure 3.8: Profiles of personal protection control u1 , the treatment efficiency control u2
and insecticide u3.
3.9 Conclusion
In this chapter, we investigated the application of optimal control strategies in the ochocer-
ciasis disease model. The model system formulated is composed of 6 variables describ-
ing the dynamics of the disease in the humans and 3 variables describing the dynamics
of the disease in the vectors (black-flies). Both the autonomous and the optimal con-
trol systems have been analysed. We have demonstrated that the autonomous model is
epidemiologically feasible and mathematically well-posed in the specific domain. The
basic reproduction number was determined and the existence of both the disease-free
and endemic equilibrium points studied. Our analysis showed that for R0 < 1, the
disease-free equilibrium is globally asymptotically stable and unstable otherwise. The
model is found to exhibit a backward bifurcation phenomenon which gives rise to exis-
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tence of multiple endemic equilibria. This implies that having R0 < 1 is not sufficient
to eliminate the disease from the population. Therefore reducing R0 below a certain
threshold, Rc0 is critical for effective disease control.
We performed the optimal analysis of the non-autonomous control model considering
three controls, one for black-fly-reduction strategies and the other two for personal (hu-
man) protection and enhanced mass administration of ivermectin respectively. A com-
parison between optimal control system and system without control is presented. The
numerical simulation results shows that optimal control system has desirable impact on
the reduction of the number of exposed and infected humans (hosts) and the vector pop-
ulation. The results indicate that treatment with ivermectin remains the most effective
and recommended methodology to control onchocerciasis disease. Thus, it would be
of great epidemiological significance for us to investigate the effect of mass administra-
tion of ivermectin in the treatment of onchocerciasis. This is done in the next chapter in
which is assumed that mass administration of ivermectin is carried out half-yearly and
hence motivating the use of impulsive differential equations.
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Application of impulsive differential
equations
4.1 Introduction
The theory of impulsive differential equations is relatively new. This theory has been
used in many areas where evolution process undergo rapid changes at certain times of
their development [5]. Quite often, ordinary differential equations are used in disease
modelling. They give continuous assessment of the disease dynamics in the population.
However, the ordinary differential equations ignore the assessment of periodic admin-
istration of treatment in the eradication of diseases [99]. On ther other hand, impulsive
differential equations give piece-wise continuous solutions to differential equations and
can be used to assess the impact of periodic treatment of infectious diseases [5]. Mass
administration of ivermectin is the most common form of treatment for onchocerciasis.
Initially, the strategy was to administer ivermectin annually. A change of strategy to six-
monthly was implemented to increase the probability of eliminating the parasite [6, 94].
Impulsive differential equations have been used to study the dynamics of some dis-
eases such as cutaneous leishmaniasis and bieber fever [12, 91]. For instance, authors in
[80] used impulsive differential equations to predict the potential impact of a cytotoxic
T-lymphocyte HIV vaccine. Their main objective was to determine how often should the
vaccination be done and how strong should the vaccine be? Impulsive differential equa-
tions have also been applied in modelling an outbreak of zombie infection [61]. How-
ever, onchocerciasis models with impulsive effects are not extensive. Pulse introduced
into ochocerciasis model greatly enriches the biological background and assessment of
45
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periodic treatments.
In this chapter, we extend the mathematical model for onchocerciasis disease transmis-
sion in chapter 3 to include pulse vaccination. The aim is to gain some insights into the
impact of periodic mass administration of ivermectin in the eradication of onchocercia-
sis. We examine the effects of mass administration of ivermectin using a mathematical
model of impulsive differential equations.We determine the threshold for the proportion
of the individuals with ochocerciasis that will reduce the infection of the onchocercia-
sis in the population. In addition, we determine the maximum interval for the mass
administration of ivermectin to eradicate onchocerciasis.
4.2 Model formulation
The infection by onchocerciasis is believed to be reduced by some proportion α. This
therefore results in a system of impulsive differential equations [5, 49]. We assume that
the mass administration of ivermectin is carried out at a fixed time tk. For the purposes
of our model, we assume that the effect of ivermectin is instantaneous, whereby the
solutions are continuous for t 6= tk. This satisfy the associated system of ordinary differ-
ential equations and undergo an instantaneous change in the state when t = tk. Given
the dynamics described in Figure 3.1 and the parameter values described in Chapter (3),
now allowing criss-cross interaction between humans and blackflies, the following sys-
tem of non-linear ordinary differential equations, with non-negative initial conditions,
describes the dynamics of onchocerciaisis epidemics.
˙SH = b1 + ϕST − βh IVSHN − µhSH,
E˙H =
βh IVSH
N
+ ϕET − (γ+ µh)EH,
˙IH = γEH + ϕIT − µh IH,
S˙T = −δβh IVSTN − (ϕ+ µh)ST,
E˙T =
δβh IVST
N
− (ργ+ ϕ+ µh)ET,
I˙T = ργET − (ϕ+ µh)IT,
S˙V = b2 − βv IHSVN −
κβv ITSV
N
− µvSV ,
E˙V =
βv IHSV
N
+
κβv ITSV
N
− (η + µv)EV ,
˙IV = ηEV − µv IV .

, t 6= tk, (4.2.1)
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subject to the following initial conditions.
SH(0) ≥ 0, EH(0) ≥ 0, IH(0) ≥ 0, ST(0) ≥ 0, ET(0) ≥ 0, IT(0) ≥ 0,
SV(0) ≥ 0, EV(0) ≥ 0, IV(0) ≥ 0.
The following are the impulsive conditions of the system of ODES described in Figure
3.1.
4SH = −αSH, 4EH = −αEH, 4IH = −αIH,
4ST = +αSH, 4ET = +αEH, 4IT = +αIH,
}
, t = tk, (4.2.2)
Here, it is assumed that treatments against onchocerciasis are given at a regular interval
time intervals (τ).
4.3 System without impulses
4.3.1 Well-posedness
The system (4.2.1) describes a human-vector population, it is therefore necessary to
prove that the solutions of the system (4.2.1) with positive initial conditions remain pos-
itive for all time t ≥ 0 and are bounded in the region
Ω =
{
(SH, EH, IH, ST, ET, IT) ∈ R6+ : N ≤
b1
µh
, (SV , EV , IV) ∈ R3+ : V ≤
b2
µv
}
. (4.3.1)
Theorem 4.3.1. For non-negative initial conditions of system (4.2.1), the solutions (SH, EH, IH,
ST, ET, IT, SV , EV , IV) of the system (4.2.1) are positive for all t ≥ 0. In addition, the region Ω
is positively invariant and all solutions starting in Ω approach, enter, or stay in Ω.
Proof. Let t∗ = sup{t > 0 : SH(t) > 0, EH(t) > 0, IH(t) > 0, ST(t) > 0, ET(t) >
0, IT(t) > 0, SV(t) > 0, EV(t) > 0, IV(t) > 0}. Thus, t∗ ≥ 0. Then, from the first equation
of our system (4.2.1), we obtain
˙SH = b1 + ϕST − βh IVSHN − µhSH ≥ −
(
λh + µh
)
SH,
SH(t∗) ≥ SH(0) exp
{
−
(∫ t∗
0
λh(m)dm + µht∗
)}
.
Similarly, one can show that EH ≥ 0, IH ≥ 0, ST ≥ 0, ET ≥ 0, IT ≥ 0, SV ≥ 0, EV ≥
0, IV ≥ 0. This completes the proof for positivity.
The total population of the human population N evolves according to the sum of the
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first six equations of system (4.2.1) and that of the vector population V evolves accord-
ing to the sum of the last three equations of system (4.2.1). Therefore the evolution of
these two populations is governed by
N˙ = b1 − µhN, V˙ = b2 − µvV. (4.3.2)
Therefore, it can be shown that,
lim
t→∞ sup N ≤
b1
µh
and lim
t→∞ sup V ≤
b2
µv
. (4.3.3)
Therefore N(t) and V(t) are bounded. Hence the domain of biological significance is
positively invariant and attracting. Thus, all solutions starting in Ω remain in Ω.
4.3.2 Maximal solution
Next we overestimate the number of infectious individuals in the population. From the
system (4.2.1), we have established that the total human (host) population is bounded
above by b1µh . Thus, from the fifth equation of the system (4.2.1) we have
dET
dt
=
δβh IVST
N
− (ργ+ ϕ+ µh)ET.
If we bound ST by the total human population and IV by the total vector population, we
have
dET
dt
≤ δβhb2
µv
− (ργ+ ϕ+ µh)ET. (4.3.4)
Solving the inequality in (4.3.4), we obtain
ET ≤ δβhb2
µv(ργ+ ϕ+ µh)
+
[
ET(0)− δβhb2
µv(ργ+ ϕ+ µh)
]
e−(ργ+ϕ+µh)t. (4.3.5)
As t approaches infinity, then the solution in (4.3.5) is bounded by
ET ≤ δβhb2
µv(ργ+ ϕ+ µh)
. (4.3.6)
Substituting the expression in (4.3.6) into the sixth equation of the system (4.2.1), we
have
dIT
dt
≤ δβhργb2
µv(ργ+ ϕ+ µh)
− (ϕ+ µh)IT,
whose solution can be expressed as
IT ≤ δβhργb2
µv(ϕ+ µh)(ργ+ ϕ+ µh)
. (4.3.7)
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Using the solutions obtained in (4.3.6) and (4.3.7) in the second and third equations in
the system (4.2.1) respectively, we have
EH ≤
[
βhb2
µv
+
δϕβhb2
µv(ργ+ ϕ+ µh)
]
, (4.3.8)
IH ≤ γ
[
βhb2
µv
+
δϕβhb2
µv(ργ+ ϕ+ µh)
]
+ ϕ
[
δβhργb2
µv(ϕ+ µh)(ργ+ ϕ+ µh)
]
. (4.3.9)
The significance of these inequalities is that they overestimate the number of people
with onchocerciasis in the population without necessarily solving the original systems
of the differential equations. We will make use of these overestimates shortly.
4.4 Stability of the model equilibria
4.4.1 Disease-free equilibria
The disease-free equilibrium (DFE) for the model without impulse is given by
E0 = (SˆH, EˆH, ˆIH, SˆT, EˆT, IˆT, SˆV , EˆV , IˆV) =
(
b1
µh
, 0, 0, 0, 0, 0,
b2
µv
, 0, 0
)
. (4.4.1)
4.4.2 The basic reproduction number
The basic reproduction number for the system (4.2.1) is obtained using the next genera-
tion method described [92]. This is given by
R0 =
√
R0 =
√
b2γηβhβv
b1µ2v (γ+ µh) (η + µv)
. (4.4.2)
From Theorem 2 of [26, 92], we have the following results.
Proposition 4.4.1. The disease-free equilibrium of the system (4.2.1) exists and is locally asymp-
totically stable ifR0 < 1, and unstable otherwise.
Theorem 4.4.2. The disease free equilibrium E0 is globally stable whenever,R0 < 1 and unsta-
ble otherwise
Proof. Let V = θ1EH + θ2 IH + θ3ET + θ4 IT + θ5EV + θ6 IV be a candidate Lyapunov func-
tion. The constants θ1 for i = 1, 2, 3, 4, 5, 6 are non negative. We can find the constants θi
such that the Lyapunov candidate is positive definite. The derivative of the Lyapunov
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function is given by
dV
dt
= θ1
dEH
dt
+ θ2
dIH
dt
+ θ3
dET
dt
+ θ4
dIT
dt
+ θ5
dEV
dt
+ θ6
dIV
dt
,
= θ1
[
βh IVSH
N
+ ϕET −Q1EH
]
+ θ2[γEH + ϕIT − µh IH ] + θ3
[
δβh IVST
N
−Q3ET
]
+ θ4[ργET −Q2 IT] + θ5
[
βv IHSV
N
+
κβv ITSV
N
−Q4EV
]
+ θ6[ηEV − µv IV ],
= [θ2γ− θ1Q1]EH +
[
θ5µhb2βv
µvb1
− θ2µh
]
IH + [θ1ϕ+ θ4ργ− θ3Q3]ET
+
[
θ2ϕ+
θ5κβvµhb2
µvb1
− θ4Q2
]
IT + [θ6η − θ5Q4]EV + [θ1βh − θ6µv]IV ,
where
Q1 = γ+ µh, Q2 = ϕ+ µh, Q3 = ργ+ ϕ+ µh, Q4 = η + µv.
Setting the coefficients to IH, ET, IT, EV and IV to zero, we obtain
θ1 =
Q4µv
βh
, θ2 =
b2βvη
b1µv
, θ3 =
b2ηκργµhβv
b1Q2Q3µv
+
b2ηργϕβv
b1Q2Q3µv
+
Q4ϕµv
Q3βh
,
θ4 =
b2βvη(κµh + ϕ)
Q2b1µv
, θ5 = η, θ6 = Q4.
(4.4.3)
We then use the coefficients obtained in (4.4.3) into the candidate Lyapunov function.
The derivative of the resulting Lyapunov function becomes
dV
dt
=
Q1Q4µv
βh
[R0 − 1]. (4.4.4)
We note that whenever R0 < 1 then dVdt < 0. Therefore, by the LaSalle Invariance
principle [50], the disease free equilibrium is globally stable whenever R0 < 1. This
completes the proof.
4.4.3 Endemic equilibrium
The endemic equilibrium points,E1, is found by equating the right-hand of the system
(4.2.1) to zero. Expressing all the variables in terms of IH, we get
S∗H = b1
(
1
µh
− b2ηβh I
∗
Hβv
b1Q4µv (b1µv + µh I∗Hβv) + b2ηβhµh I
∗
Hβv
)
,
E∗H =
b1b2ηβhµh I∗Hβv
Q1 (b1Q4µv (b1µv + µh I∗Hβv) + b2ηβhµh I
∗
Hβv)
, S∗T = E
∗
T = I
∗
T = 0,
S∗V =
b1b2
βvµh I∗H + b1µv
, E∗V =
b2βvµh I∗H
Q4(βvµh I∗H + b1µv)
, I∗V =
b2βvµhη I∗H
Q4µv(βvµh I∗H + b1µv)
.
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After some algebraic manipulations, we either have I∗H = 0 or
I∗H =
Q1Q4b21µ
2
v
Q1βvµh(b2βhη + Q4b1µv)
[R0 − 1] . (4.4.5)
The case where I∗H = 0, gives the disease-free equilibrium, treated earlier. From expres-
sion (4.4.5), one sees that when R0 < 1, then I∗H < 0, implying that the system (4.2.1)
has no positive solution. However, when R0 > 1, then I∗H > 0 and a unique endemic
equilibrium exists.
Theorem 4.4.3. The endemic E1, is locally asymptotically stable whenever R0 > 1 and unstable
otherwise.
Proof. The stability and and the direction of bifurcation R0 = 1 of the endemic equi-
librium is proved by the direct use of the Center Manifold Theory (CMT) as described
in [19]. We avoid re-stating the theorem and adopting notations as described in [19],
we compute the values of a and b whose signs determine local dynamics of the model
(4.2.1). The basic reproduction of the system (4.2.1) is established to be
R0 = b2γηβhβvb1µ2v (γ+ µh) (η + µv)
. (4.4.6)
Suppose, we choose θ = βh as the bifurcation parameter so that whenR0 = 1, we have
θ =
b1µ2v (γ+ µh) (η + µv)
b2γηβv
(4.4.7)
In order to apply the Center Manifold Theory (CMT), it is necessary to make the fol-
lowing changes to the state variables, we let SH = x1, EH = x2, IH = x3, ST = x4, ET =
x5, IT = x6, SV = x7, EV = x8, IV = x9. The system (4.2.1) can now be written in the
form d fdx = f (x), where x = (x1, x2, x3, x4, x5, x6, x7, x8, x9). The system (4.2.1) therefore
becomes
x˙1 = b1 + ϕx4 − βhx9x1N − µhx1,
x˙2 =
βhx9x1
N
+ ϕx5 −Q1x2,
x˙3 = γx2 + ϕx6 − µhx3,
x˙4 = − δβhx9x4N −Q2x4,
x˙5 =
δβhx9x4
N
−Q3x5,
x˙6 = ργx5 −Q2x6,
x˙7 = b2 − βvx3x7N −
κβvx6x7
N
− µvx7,
x˙8 =
βvx3x7
N
+
κβvx6x7
N
−Q4x8,
x˙9 = ηx8 − µvx9.

(4.4.8)
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The system (4.4.8) with the bifurcation point θ, has a simple zero eigenvalue. Thus,
it enables us to use the Center Manifold Theory to analyse the stability of the system
(4.4.8) near βh = θ. Therefore a right eigenvector w associated with zero eigenvalue has
components
w1 = −b1µ
2
v (γ+ µh) (η + µv)
b2γηµhβv
, w2 =
b1µ2v (η + µv)
b2γηβv
, w3 =
b1µ2v (η + µv)
b2ηµhβv
,
w4 = w5 = w6 = 0, w7 = − (η + µv)
η
, w8 =
µv
η
, w9 = 1.
(4.4.9)
Similarly, the corresponding left eigenvector v associated with zero eigenvalue has com-
ponents
v1 = v4 = v7 = 0, v2 = 1, v3 =
Q1
γ
,
v5 =
Q1κβvργµh + βvϕ(γ(ργ+ ϕ) + µh(γ+ ργ))
Q2Q3βvγ
,
v6 =
Q1βv(κµh + ϕ)
Q2βvγ
, v8 =
Q1b1µv
b2βvγ
, v9 =
Q1Q4b1µv
b2βvηγ
.
(4.4.10)
We now compute a and b as outlined in [19]. From the system (4.4.8), the non-zero
partial derivatives of f (x) associated with a are given by
∂2 f2
∂x1∂x9
=
θµh
b1
,
∂2 f8
∂x3∂x7
=
βvµh
b1
,
∂2 f8
∂x6∂x7
=
κβvµh
b1
. (4.4.11)
Thus, the expression for a is given by
a = v2w1w9
∂2 f2
∂x1∂x9
+ v8w3w7
∂2 f8
∂x3∂x7
+ v8w6w7
∂2 f8
∂x6∂x7
,
= −
(
b1µ3v (γ+ µh) (η + µv) 2 (µv (γ+ µh) + γκβv)
b22γ2η2β2v
)
< 0.
(4.4.12)
We finally compute the value of b. The non-zero partial derivatives of f (x) associated
with b is given by
∂2 f2
∂x9∂θ
= 1. (4.4.13)
Therefore the expression for b is given by
b = v2w9
∂2 f2
∂x9∂θ
= 1 > 0. (4.4.14)
Since, a < 0 and b > 0, we conclude from item (iv) of Center Manifold Theorem [19]
that the established endemic equilibrium E1 is locally asymptotically stable for R0 > 1
and there exists a positive unstable equilibrium. This completes the proof.
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4.5 Model with impulse
In this section, we present and analyse the system with pulse treatment of onchocerciasis
with ivermectin. Treatment occurs every six months. We therefore first examine the case
of fixed times tk, with individuals treated at rate α. This results in system of impulsive
differential equations [5, 49, 79]. The administration of ivermectin is thus approximated
by an instantaneous change.
4.5.1 General solution
Here, we overestimate the number of people infected with onchocerciasis in the pop-
ulation. Suppose the maximal number of individuals infected with onchgocerciasis is
given by inequality (4.3.9). Then the one-dimensional impulsive differential equation
given by
dIH
dt
= γ
[
βhb2
µv
+
δϕβhb2
µv(ργ+ ϕ+ µh)
]
+ ϕ
[
δβhργb2
µv(ϕ+ µh)(ργ+ ϕ+ µh)
]
− µh IH , t 6= tk,
4IH = −αIH , t = tk,
(4.5.1)
overestimates the number of infected individuals. Letting I = IH for notational sim-
plicity, from (4.5.1) we have
I+ − I− = −αI,
I+ = (1− α)I−.
Let Q5 = βhb2γ[δρϕ+Q2(δϕ+Q3)] and denote I+k = I(t
+
k ) and I
−
k = I(t
−
k ). Here, I(t
−
k )
is the population proportion of infected individuals immediately before the impulse and
I(t+k ) is the value immediately after the impulse. Hence, for a single impulsive cycle
tk ≤ t ≤ tk + 1, we have
I′(t) + µh I(t) =
Q5
Q2Q3µv
,
d
dt
(
eµht I
)
=
Q5
Q2Q3µv
(
eµht I
)
,
eµht I(t)− eµhtk I(t+k ) =
Q5
Q2Q3µhµv
eµht − Q5
Q2Q3µ2hµv
eµhtk ,
I(t) =
Q5
Q2Q3µhµv
(
1− eµh(tk−t)
)
+ I(t+k )e
µh(tk−t).
It therefore follows that
I−k+1 =
(
Q5
Q2Q3µhµv
)(
1− eµh(tk+1−tk)
)
+ I+k e
µh(tk+1−tk),
=
(
Q5
Q2Q3µhµv
)(
1− e−µh(tk+1−tk)
)
+ (1− α)I−k
(
e−µh(tk+1−tk)
)
.
(4.5.2)
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The solution obtained in (4.5.2) at the impulse points satisfies
I−1 =
Q5
Q2Q3µhµv
, I+1 = (1− α)
(
Q5
Q2Q3µhµv
)
,
I−2 = (1− α)
(
Q5
Q2Q3µhµv
)
e−µh(t2−t1) +
(
Q5
Q2Q3µhµv
)(
1− eµh(t2−t1)
)
,
I+2 = (1− α)I−2 = (1− α)2
(
Q5
Q2Q3µhµv
)
e−µh(t2−t1)
+ (1− α)
(
Q5
Q2Q3µhµv
)(
1− eµh(t2−t1)
)
,
I−3 =
Q5
Q2Q3µhµv
(
(1− α)2e−µh(t3−t1) + (1− α)e−µh(t3−t2)
+ 1− (1− α)e−µh(t3−t1) − e−µh(t3−t2)
)
,
I+3 = (1− α)I−3 =
Q5
Q2Q3µhµv
(
(1− α)3e−µh(t3−t1) + (1− α)2e−µh(t3−t2)
+ (1− α)− (1− α)2e−µh(t3−t1) − (1− α)e−µh(t3−t2)
)
,
I−4 =
Q5
Q2Q3µhµv
(
(1− α)3e−µh(t4−t1) + (1− α)2e−µh(t4−t2) + (1− α)e−µh(t4−t3)
+ 1− (1− α)2e−µh(t4−t1) − (1− α)e−µh(t4−t2) − e−µh(t4−t3)
)
,
I+4 = (1− α)I−4 .
Thus, the general solution becomes
I−n =
Q5
Q2Q3µhµv
(
(1− α)(n−1)e−µh(tn−t1) + (1− α)(n−2)e−µh(tn−2) + · · ·+ (1− α)e−µh(tn−tn−1)
+ 1− (1− α)(n−2)e−µh(tn−t1) − (1− α)(n−3)e−µh(tn−t2) − · · · − e−µh(tn−tn−1)
)
.
(4.5.3)
The general solution obtained in (4.5.3) defines the maximal number of people with
onchocerciasis immediately before the mass treatment with ivermectin. This solution
depends on the human and vector recruitment rates, the human-vector transmission
contact rate, the incubation period in the human, the waning rate of ivermectin, hu-
man and vector death rates, treatment times and the treatment effectiveness. A similar
approach can be employed to calculate the maximal number of latently infected indi-
viduals using the overestimate obtained in (4.3.8). For fixed mass administration of
ivermectin, (4.5.3) does not depend on time.
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4.5.2 Fixed administration of ivermectin
For a fixed time period τ = tn+1 − tn, we have
I−n =
Q5
Q2Q3µhµv
(
1+ (1− α)eµhτ + (1− α)2e−2µhτ + · · ·+ (1− α)(n−1)e−µh(n−1)τ
− e−µhτ
(
1+ (1− α)e−µhτ + · · ·+ (1− α)(n−2)e−µh(n−2)τ
))
,
=
Q5
Q2Q3µhµv
(
1− (1− α)neµhnτ
1− (1− α)eµhτ −
1− (1− α)(n−1)e−µh(n−1)τ
1− (1− α)eµhτ e
−µhτ
)
.
Thus
lim
n→∞ I
−
n =
Q5
Q2Q3µhµv
(
1
1− (1− α)e−µhτ −
1
1− (1− α)e−µhτ e
−µhτ
)
=
Q5
Q2Q3µhµv
(
1− e−µhτ
1− (1− α)e−µhτ
)
.
(4.5.4)
The solution obtained in (4.5.4) is the maximum population of the infected individuals.
Note that
lim
τ→0
n→∞
I−n = 0,
implying that the total number of infected humans shrinks to zero as the frequency of
mass treatment with ivermectin increases (although note that the impulsive assump-
tions would break down in this limit). In order to keep the infected individuals under a
threshold Iˆ, we have
Iˆ <
Q5
Q2Q3µhµv
(
1− e−µhτ
1− (1− α)e−µhτ
)
,
which implies that
τ <
1
µh
ln
[
Q5 − IˆQ2Q3µhµv(1− α)
Q5 − IˆQ2Q3µhµv
]
= τmax(α). (4.5.5)
The expression in (4.5.5) gives the maximum period of mass administration of iver-
mectin in the population to keep the infection of onchocerciasis below Iˆ. If we restrict
τ to 0 ≤ τ < τmax, then the disease can be controlled below the threshold Iˆ (but not
necessarily eradicated).
4.5.3 Non-fixed administration of ivermectin
In this section, we consider a situation in which the mass administration of ivermectin
is carried out at non-fixed times. However, this would require that the entire history
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of ivermectin administration is known, which is unlikely to be the case. Thus, we will
assume that ivermectin treatment occuring more than two events previously has a neg-
ligible effect on the number of currently treated individuals. That is,
e−µh(tn−tk) ≈ 0 for k > 2.
It then follows from (4.5.2) that
I−n <
Q5
Q2Q3µhµv
(
1− e−µh(tn−tn−1)
)
,
I−n+1 <
Q5
Q2Q3µhµv
(
1− e−µh(tn−tn−1)
)
+ (1− α)I−n e−µh(tn−tn−1),
<
Q5
Q2Q3µhµv
(
1− e−µh(tn+1−tn)
)
+ (1− α) Q5
Q2Q3µhµv
(
1− αe−µh(tn−tn−1)
)
e−µh(tn+1−tn).
The above inequality can be approximated as
Iˆ ≡ Q5
Q2Q3µhµv
(
1− e−µh(tn+1−tn)
)
+ (1− α) Q5
Q2Q3µhµv
(
1− αe−µh(tn−tn−1)
)
e−µh(tn+1−tn).
(4.5.6)
The expression in (4.5.6) gives the number of infected humans that will be below Iˆ based
on knowing the two previous mass administration times. Then the "next best" mass
treatment with ivermectin satisfies the following:
Q5
Q2Q3µhµv
(
1+ (1− α)
)
− Iˆ = e−µh(tn+1−tn)
(
Q5
Q2Q3µhµv
)(
1+ α(1− α)e−µh(tn+1−tn)
)
,
e−µh(tn+1−tn) =
2− α−Q5/Q2Q3µhµv
1+ α(1− α)e−µh(tn+1−tn) ,
tn+1 = tn − 1
µh
ln
(
2− α−Q5/Q2Q3µhµv
1+ α(1− α)e−µh(tn+1−tn)
)
.
Next we compare fixed and non-fixed mass treatment with ivermectin. Assuming that
the mass treatment times in the non-fixed case are constant, τˆ, then from (4.5.5), we have
τˆ =
1
µh
ln
(
Q5 − IˆQ2Q3µhµv(1− α)
Q5 − IˆQ2Q3µhµv
)
, (4.5.7)
τˆ|α=0 = 1
µh
ln
(
Q5 − IˆQ2Q3µhµv
Q5 − IˆQ2Q3µhµv
)
= 0, (4.5.8)
τˆ|α=1 = 1
µh
ln
(
Q5
Q5 − IˆQ2Q3µhµv
)
. (4.5.9)
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If there is no impulse, then from (4.5.1), we have limt→∞ I = Q5Q2Q3µhµv . Thus, we can
assume that Iˆ = Q5Q2Q3µhµv . Hence,
0 < 1− Q2Q3µhµv Iˆ
Q5
< 1, (4.5.10)
therefore, τˆα=1 > 0. Assuming that non-fixed mass treatment with ivermectin occurs in-
definitely and further letting τmax ≡ tn+1 − tn = tn − tn−1, then the minimum treatment
effectiveness satisfies
τmax =
1
µh
ln
(
2− α− IˆQ2Q3µhµv/Q5
1+ α(1− α)e−µhτmax
)
. (4.5.11)
If τmax = 0, then it follows that (4.5.11) becomes
1
µh
ln
(
2− α− IˆQ2Q3µhµv/Q5
1+ α(1− α)
)
= 0,
2− α− Iˆ Q2Q3µhµv
Q5
= 1+ α(1− α),
α = 1±
√
Q2Q3µhµv
Q5
.
The larger root exceeds 1 and hence can be discounted. It follows that the smaller root
α0 = 1−
√
Q2Q3µhµv
Q5
, satisfies 0 < α0 < 1 as stated in (4.5.10). This implies that the mass
treatment is only effective in the range α0 < α ≤ 1.
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Figure 4.1: Comparison of the actual infected individuals and the estimated infected
individuals.
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4.6 Numerical simulations
In this section, we carry out parameter estimation, sensitivity analysis of the model pa-
rameters, and numerical simulations for the system (4.2.1) to demonstrate the theoretical
results. The simulations are performed using the fourth order Runge-Kutta scheme in
Matlab 2014a with the given set of parameter values given in Table 4.1. We shall as-
sume some of the parameters in some realistic range with guidance from past literature
on onchocerciasis epidemics with reference to Ghana which is one of the onchocerciasis
foci.
4.6.1 Parameter estimation
In this section, we consider average parameter values that encompass features of on-
chocerciasis disease including rate of infection, incubation period, length of infections
period in the vector and host populations. Although estimates of some parameters are
given in Table 4.1, here we give additional explanation and description of some of the
parameters based on available literature and with reference to Ghana which is one of
the onchocerciasis endemic countries.
1. The average birthrate in Ghana was estimated to be 31.09 births/1,000 popula-
tion in 2015 and 30.60 births/1,000 population in 2014 according to the World Fact
Book by Central Intelligence Agency [85] and Ghana Statistical Service report on
Demographic and Health Survey [35] respectively. Thus, the recruitment rate is
estimated from the range (0.0000819 ≤ b1 ≤ 0.00108)N per day.
2. The natural human death rate is estimated based on average life of 50-70 years in
accordance to Central Intelligence Agency and 2014 demographic data released by
Ghana Statistical Service estimates of life expectancy at birth respectively [35, 85].
The black-fly death rate is estimated based on the average life span lasting for 2-3
weeks [31, 40].
3. It takes 34 to 2 years for the worm to mature and release enough microfilariae to be
detectable in the skin of the human host [40, 52, 66, 76]. Therefore, a reasonable
estimate of the incubation rate γ is 0.00137 ≤ γ ≤ 0.00365 per day. On the other
hand, the average incubation period in the black-fly is 1-2 weeks [40, 52, 72, 76].
Thus, a reasonable value for η is 0.0714 ≤ η ≤ 0.1667 per day.
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4. The modification parameters (κ, δ and ρ) have been estimated to be between 0 and
1 due to the reduced ability of individuals to cause infections following ivermectin
treatment.
5. The mass administration of ivermectin reduces the infection by α which is esti-
mated to be between 0% and 100%.
For illustration purpose, we consider the parameter values estimates given in Table 4.1
with N = 200, 000, V = 10, 000.
Table 4.1: Estimated parameter values in the model for onchocerciasis case. The rates
are given per day.
Parameter Range Point value Source
b1 0.0000819-0.0001085 0.00009/N Estimated.
µh 0.0000391-0.0000548 0.000052 [35, 85].
βh 0.0-0.001 0.00198 Assumed.
γ 0.00137-0.00365 0.00139 [40, 52, 66, 76].
α 0-1.0 [0.1, 0.65] [89, 94].
ϕ 0.01-0.1 0.0015 [89].
κ 0.00-1.0 0.0083 Assumed.
ρ 0.0-0.1.0 0.001 Assumed.
δ 0.00-1.0 0.002 Assumed.
b2 0.0214-0.4 0.144/V Assumed.
βv 0.0-0.001 0.00079 Assumed.
η 0.0714-0.1667 0.078 [40, 52, 72, 76].
µv 0.0118-0.0714 0.068 [31, 40].
4.6.2 Sensitivity analysis
Sensitivity analysis is the study of how uncertainty in the output of a system can be
apportioned to different sources of uncertainty in the model input [77, 78]. It is a tech-
nique for systematically varying model inputs and determining their effect on the model
output. We perform sensitivity analysis in order to investigate the contribution of vital
parameters on the model dynamics, specifically to establish the parameters that have
significant influence on the onchocerciasis dynamics. We use Latin Hypercube Sam-
pling (LHS), a stratified Monte Carlo sampling scheme applicable to many parameters
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from a multidimensional distribution [77, 78]. It allows for simultaneous determina-
tion of an unbiased estimate of the model output for a given set of model input. We
perform the sensitivity analysis by computing the Partial Rank Correlation Coefficients
(PRCCs) for each parameter value, sampled by the LHS scheme [15]. Parameters with
positive PRCCs will increase R0 when they are increased, whereas parameters with neg-
ative PRCCs will decrease R0 when they are increased. The outcome is the reproduction
number R0 derived from the theoretical model. We determine PRCCs with 1000 simula-
tions per run to determine parameters that have a significant influence on R0.
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Figure 4.2: Tornado plots of partial rank correlation coefficients (PRCCs) of the parame-
ters that influence R0 for the input parameters using the values in Table 4.1. Parameters
with PRCC> 0 increase R0 when they are increased whereas parameters with PRCC< 0
decrease R0 when they are increased.
The PRCCs results in Figure 4.2 illustrate the degree of the effect that each parameter has
on the outcome. The three parameters with the most influence on R0 are the transmis-
sion contact rate in humans, βh, the vector transmission contact rate, βv, and the vector
death rate µv.
Figure 4.3 displays 1000 Monte Carlo simulations for the input parameters with the
most effect on the basic reproduction number. Scatter plots show that R0 is monotone
increasing with increasing values of βh and βv and monotone decreasing with increas-
ing vector mortality rate, µv. However, R0 is only guaranteed to be less than unity when
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the human–vector and vector–human contact rates are sufficiently small. These results
also suggest that, even if vector death rate is extremely high, eradication is not possi-
ble. mission rates in both the human and the vector is another strategy of the disease
eradication.
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Figure 4.3: The Monte Carlo simulations for the three parameters with the greatest in-
fluence on the R0: the transmission contact rate in humans, the transmission contact rate
in the vector and the vector death rate for the input parameters using the values in Table
4.1 and 1000 simulations per run. Eradication is only possible if the transmissibilities are
extremely small or if the vector death rate is extremely high.
In order to gain more insight into the three parameters with the greatest influence on the
basic reproduction number, R0, all other parameters were fixed at their sample values.
A surface plot for R0 = 1 is shown in Figure 4.4. It is observed that for the disease
eradication, βh must be brought to extremely low levels.
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Figure 4.4: Eradication threshold for the three parameters with the greatest influence on
R0.
4.6.3 Simulation results
The results presented in this section demonstrate the dynamics of onchocerciasis for the
system (4.2.1) obtained using Matlab ODE45 solver, which employs simultaneously the
fourth and fifth order Runge–Kutta schemes. Unless otherwise stated, parameters are
as stated in Table 4.1. We give results of system (4.2.1) with impulses for both the cases
when R0 < 1 and when R0 > 1 as shown in Figures 4.7–4.10 and Figures 4.5–4.6, respec-
tively. In addition, we numerically make a comparison between fixed and non-fixed
mass administration of ivermectin in the treatment of onchocerciasis. In order to illus-
trate the effectiveness of ivermectin, we vary the reduction rate (α) for both the cases of
R0.
First, we examine the behaviour of the system (4.2.1) when the basic reproduction num-
ber, R0, is greater than unity for the fixed and non-fixed mass administration of iver-
mectin. It is seen in Figure 4.5 that when the effectiveness of ivermectin is low, that is,
α = 0.10, the disease spreads in the population. However, the results in Figure 4.6 show
that the endemicity of the disease is reduced when the effectiveness rate of mass ad-
ministration of ivermectin is increased. We also observe that fixed mass administration
yields a better outcome compared to non-fixed mass administration.
We then examine the case when the basic reproduction number is below unity for both
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the fixed and non-fixed mass administration of ivermectin. We examine two cases of
R0 < 1: when R0 is close to unity and where R0 is significantly less than unity. We
observe in Figure 4.7 that when R0 is less than but close to one, the disease may per-
sist in the population when the value of α is small. However an increment in the value
of α moves the system towards a disease-free state, but there is no eradication. This is
shown in Figure 4.8 with α = 0.65. The results in Figure 4.9 show the dynamics of the
population under both fixed and non-fixed mass administration of ivermectin at α = 0.1
keeping the interval τ = 182.5 days (6 monthly interval) for fixed mass administration.
We observe that the system with impulses attains its disease-free state, suggesting that
onchocerciasis dies out. These results are consistent with theorem (4.4.2). However,
when the ivermectin effectiveness is increased, the system attains the disease free equi-
librium much faster as shown in Figure 4.10.
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Figure 4.5: System behaviour for fixed and non-fixed mass administration of ivermectin
with α = 0.10, R0 = 1.2412, b1 = 0.0009, b2 = 0.35, βh = 0.00562, βv = 0.00243, ϕ =
0.025, µv = 0.012.
Stellenbosch University  https://scholar.sun.ac.za
65 4.6. Numerical simulations
Time (Days)
0 1000 2000 3000 4000 5000 6000 7000 8000
Su
sc
ep
tib
le
 h
um
an
 (h
os
ts)
,S
H
×105
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
1.8
2
(a) Fixed
Time (Days)
0 1000 2000 3000 4000 5000 6000 7000 8000
Su
sc
ep
tib
le
 h
um
an
 (h
os
ts)
,S
H
×105
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
1.8
2
(b) Non-fixed
Time (Days)
0 1000 2000 3000 4000 5000 6000 7000 8000
Ex
po
se
d 
hu
m
an
 (h
os
ts)
,E
H
×105
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
1.8
2
(c) Fixed
Time (Days)
0 1000 2000 3000 4000 5000 6000 7000 8000
Ex
po
se
d 
hu
m
an
 (h
os
ts)
,E
H
×105
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
1.8
2
(d) Non-fixed
Time (Days)
0 1000 2000 3000 4000 5000 6000 7000 8000
In
fe
ct
io
us
 h
um
an
 (h
os
ts)
,I H
×104
0
0.5
1
1.5
2
2.5
3
3.5
4
4.5
(e) Fixed
Time (Days)
0 1000 2000 3000 4000 5000 6000 7000 8000
In
fe
ct
io
us
 h
um
an
 (h
os
ts)
,I H
×104
0
0.5
1
1.5
2
2.5
3
3.5
4
4.5
(f) Non-fixed
Figure 4.6: System behaviour for fixed and non-fixed mass administration of ivermectin
with α = 0.65, R0 = 1.2412, b1 = 0.0009, b2 = 0.35, βh = 0.00562, βv = 0.00243, ϕ =
0.025, µv = 0.012. Note that increasing α improves the outcome but does not lead to
eradication.
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Figure 4.7: System behaviour for fixed and non-fixed mass administration of ivermectin
with α = 0.10, R0 = 0.9352, b1 = 0.0009, b2 = 0.35, βh = 0.00443, ϕ = 0.025, βv =
0.00175, µv = 0.012. Non-fixed adminsitration may produce lower overall numbers of
infected individuals, but the outcome is not predictable.
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Figure 4.8: System behaviour for fixed and non-fixed mass administration of ivermectin
with α = 0.65, R0 = 0.9352, b1 = 0.0009, b2 = 0.35, βh = 0.00443, ϕ = 0.025, βv =
0.00175, µv = 0.012. Non-fixed administration may produces bursts of infection, even if
the disease would be otherwise kept at low levels.
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Figure 4.9: System behaviour for fixed and non-fixed mass administration of ivermectin
with α = 0.1, R0 = 0.1181 using parameter values in Table 4.1. Note that non-fixed
administration may have a delaying or preventative effect on eradication.
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Figure 4.10: System behaviour for fixed and non-fixed mass administration of iver-
mectin with α = 0.65, R0 = 0.1181 using parameter values in Table 4.1. Increasing α
hastens eradication, in both the fixed and non-fixed case.
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4.7 Conclusion
In this chapter, we extend the mathematical model for onchocerciasis disease transmis-
sion in chapter 3 to include pulse vaccination. The aim was to gain some insights into
the impact of periodic mass administration of ivermectin in the eradication of onchocer-
ciasis. From the system without impulse, we were able to determine the basic reproduc-
tion number. Furthermore, we studied the existence of the disease free and the unique
endemic equilibrium points. Our analysis showed that for R0 < 1, the disease free equi-
librium is globally asymptotically stable and unstable otherwise. In addition, the unique
endemic equilibrium point only exists for R0 > 1 thus transcritical bifurcation.
We have provided the estimates for the necessary frequency and strength of mass ad-
ministration of ivermectin. We may conclude that the disease can be controlled through
mass administration with needed frequency and high strength of ivermectin. We have
observed from our numerical results that the eradication of onchocerciasis is possible
with tolerable regularity of mass administration of ivermectin provided the basic repro-
duction number is kept (far) below unity. We can conclude that, in the presence of mass
administration of ivermectin with six month intervals, the disease can be controlled.
Furthermore, if the frequency of mass administration is increased, the system moves
towards a better outcome. Our modelling results show that mass administration of iver-
mectin at regular interval is an effective method of onchocerciaisis eradication if other
parameters can be sufficiently controlled.
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Conclusion
5.1 Conclusion
The objective of this thesis was to determine the effect of mass administration of iver-
mectin on the dynamics of onchocerciasis. A deterministic model showing the dynamics
of onchocerciasis in human (host) and vector (black-fly) is presented. In the first part,
we analyse the onchocerciasis model without controls while in the second part, we in-
troduce time-dependent control variables (policies) to the onchocerciasis model. For
the model without controls, we establish the existence of equilibria points in terms of
the basic reproduction number R0. By constructing a suitable lyapunov function, the
analysis shows that the disease-free equilibrium of the onchocerciasis model is globally
asymptotically stable whenever R0 is less than unity. The epidemiological implications
of this observation is that keeping the reproduction numbers below one is necessary to
curb the spread of onchocerciasis disease. The inclusion of occurrence of infections in
the individuals protected with ivermectin resulted in the model exhibiting a backward
bifurcation. The existence of a backward bifurcation has important implications in the
design of policies and strategies to eradicate an epidemic. In the presence of a backward
bifurcation, classical policies on disease eradication need to be changed as onchocercia-
sis can persist even when the threshold parameter R0 , is less than unity.
We sought to determine control strategies that would minimize the exposed and infected
humans (hosts) as well as the vector population and their respective costs. In order to
achieve this objective, our model is extended to included three control strategies asso-
ciated with personal protection, enhanced mass treatment with ivermectin and vector
reduction strategies. The optimal control model has been analysed using the objective
functional J. The optimal controls u1, u2 and u3 where J was minimised was obtained.
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Pontrayagin’s Maximum Principle was used to analyse the optimal control system for
existence of an optimal control. The optimal control system was the solved numerically
using the state and adjoint system together with characterisation of the optimal control.
A comparison between optimal control system and system without control is presented.
It is easy to see that the optimal control system has desirable impact on the reduction
of the number of exposed and infected humans (hosts) and the vector population. The
results show that preventive practices are very effective in reducing the incidence of in-
fectious hosts and vectors.
To investigate the potential impact of mass administration of ivermectin on the dynam-
ics of onchocerciasis, impulsive differential equations are introduced. The analysis of
the model without pulse mass administration of ivermectin shows that, the disease-free
state exists if R0 < 1. On the other hand, if R0 > 1, the disease-free state loses its
stability and the system tends towards the endemic state. We have provided the esti-
mates for the necessary frequency and strength of mass administration of ivermectin.
We have observed that the threshold values of time interval with minimum degree of
effectiveness is obligatory for the mass administration of ivermectin for fixed time inter-
val. We conclude that the disease can be controlled through mass administration with
fixed frequency and high strength of ivermectin of more than 65%. Furthermore, our
results suggest that reducing the human-vector contact can be one way of eradicating
onchocerciasis from the population. This can be done by implementing personal pro-
tection practices such as wearing insect repellent, wearing long sleeves and long pants
during the day when black-flies bite. In addition, application of insecticides can be effec-
tive in reducing the presence of vector in the environment. If the human-vector contact
is reduced to extremely low values then eradication is assured.
We have observed from our numerical results that the eradication of onchocerciasis is
possible with tolerable regularity of mass administration of ivermectin provided the ba-
sic reproduction number is kept below unity. We can conclude that in the presence of
mass administration of ivermectin keeping six months interval, the disease can be easily
controlled. Furthermore, if the power of mass administration is increased, the system
moves towards better outcome. This implies that the effectiveness of mass administra-
tion of ivermectin enhances the system towards the disease-free state. We can conclude
that the final steps towards the eradication of onchocerciasis is possible within the next
few years in the Sub-Saharan Africa where the disease is endemic. Our modelling results
show that mass administration of ivermectin at regular interval is an effective method
of onchocerciaisis eradication.
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5.2 Recommendations
Based on our study findings, we recommend the following
• The use of both ivermectin in the treatment of onchocerciasis and use of insecti-
cides will greatly lead to onchocerciasis eradication.
• The use of personal protection strategies will greatly reduce the cases of infection
in the population thus facilitating the disease eradication.
5.3 Limitations and future work
In this thesis, we did not take into account the possibility of drug resistance. We as-
sumed that ivermectin is highly efficacious in the treatment of onchocerciasis. In ad-
dition we did take into account all the possible dynamics of onchocerciasis in order to
reduce on the complexity of the model. For instance, we did not include the individuals
with onchocerciasis in the acute phase. We assumed that the number of individuals that
progress to this class are few and can be ignored which is not entirely true. In addi-
tion, stochasticity that may be attributed to the climatic conditions which can influence
the infection dynamics of this disease was not considered. Consideration of such key
phenomenon may give a more realistic picture of the non-constant disease transmission
rates.
Mass administration of ivermectin is assumed to occur instantaneously. However, in
reality, there is usually a small delay as mass treatment reaches it maximum coverage. It
is important to note that the delays do not affect our results provided the time interval
of mass administration of ivermectin is significantly larger than the instantaneous ap-
proximation.
The major challenge we faced during this study was the fact that we were unable to
obtain data for onchocerciasis treatment. Availability of complete trusted dataset on
onchocerciasis epidemic would have aided in estimating the disease parameters and
testing possible control measures for future reference. Due to the unavailability of data,
obtaining of parameter values was a limitation to the study. We could not obtain data in
order to validate our models. In addition, our model did not consider the effect of cli-
matic changes in the transmission and dynamics of ochocerciasis. Therefore, for future
work, we suggest the following.
• Use of data to validate the model.
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• A model explaining the full dynamics of onchocerciasis in human (hosts).
• The impact of climate change on the transmission dynamics of onchocerciasis dis-
ease. This will allow the investigation of the relationship between the spread of
onchocerciasis and climate changes.
• A model that includes the classes of individuals who are resistant to the iver-
mectin.
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Abstract In this paper, we present a model for onchocerciasis that considers mass administration of iver-
mectin, contact prevention controls and vector elimination. The model equilibria are computed and stability
analysis carried out in terms of the basic reproduction number R0. The model is found to exhibit a backward
bifurcation so that for R0 less than unity is not sufficient to eradicate the disease from the population and
the need is to lower R0 to below a certain threshold, R
c
0 for effective disease control. Optimal control theory
is applied to investigate optimal control strategies for controlling onchocerciasis using insect repellent and
both insecticide and larvicide as system control variables. We use Pontryagins Maximum Principle to show
the necessary conditions for the optimal control of onchocerciasis. Numerical simulations of the model show
that restricted and proper use of control measures might considerably decrease the number of infections in
the human population.
Keywords Onchocerciasis · ivermectin · backward bifurcation · optimal control · simulations
1 Introduction
Onchocerciasis is a vector-borne parasitic disease. This is a human disease caused by the filirial (thread
like) worms Onchocerca volvulus in human hosts and is transmitted by the Simulium damnosum [38]. It
occurs close to oxygen rich flowing streams and rivers in the inter-tropical zones [8]. This is because the egg,
larvae and pupa stages of Simulium damnosum are aquatic. Studies show that about 90% of onchocerciasis
cases occur in Africa and is predominantly found in West Africa. It is also found in six countries in Latin
America and in Yemen in the Arabian Peninsula [43]. Onchocerciasis is a serious public health problem. It
is a major constraint to social and economic development [5,16]. It is responsible for ugly skin disease with
depigmentation, severe unrelenting itching and blindness [7,42].
In Sub-Sahara Africa, onchocerciasis remains a major health challenge. In Ghana for instance, 3, 400, 000 in
3204 communities in 66 endemic districts are at risk of acquiring onchocerciasis [25]. Many strategies have
been used to eradicate this disease from the population. Mass administration of ivermectin has remained the
main strategy in the fight against onchocerciasis. In Sub-Sahara Africa, the struggle to combat onchocerci-
asis is being led by the African Program of Onchocerciasis Control (APOC). The main control measure for
the eradication of onchocerciasis in the countries where the disease is endemic such as Ghana is through
community directed treatment with ivermectin. The drugs are distributed by MectizanTM Donation Pro-
gram (MDP) by Merck and Co., Inc., [6]. Ivermectin is an antimicrofilarial agent that acts as both the
primary and secondary form of prevention for individuals with onchocerciasis. It degenerates intrauterine
microfilariae thereby suppressing the release of new microfilariae for up to 3-4 months. However, when the
drug wanes the adult worm is still possible to continue producing microfilariae until it dies naturally [26].
Ivermectin shows no or, if any, little macrofilaricidal effects and therefore does not kill the adult worms [15].
For successful control of onchocerciasis, repeated treatment with ivermectin spanning for 10-15 years has to
be administered so as to correspond to the life span of adult worm.
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One of the purposes of modelling epidemics is to provide a rational basis for policies designed to control
the spread of a disease. The inclusion of practical optimal strategies in models allow for the assessment of
the intervention of public health authorities. Optimal control is a powerful mathematical tool in decision
making that involves employing appropriate strategies to eradicate epidemics from the population [24]. The
decisions include determining the proportion of the population that should be treated as time evolves in a
given epidemic to minimize both the number of infections in the population and the cost of the treatment
strategy implementation. Optimal control has been used to study the dynamics of some diseases such as
malaria and West Nile virus [2,3,31]. For instance, in [4,36] optimal control was used to investigate the best
strategy for educational campaigns during the outbreak of an epidemic and at the same time minimizing
the number of infected humans. It has also been applied in modelling Leukemia [1,27]. However, to the
author’s best knowledge, optimal control has not been applied to onchocerciasis disease transmission.
In this paper, we develop a mathematical model for onchocerciasis disease transmission with control strate-
gies. The aim is to gain some insights into the best intervention for minimizing and eventual elimination of
onchocerciasis from the population. The intervention strategies we incorporate into the model are, personal
protection against black-fly, enhanced treatment and insecticide spraying. Three control functions are used,
one for vector reduction, one for human protection and another for the reduction of microfilarie in the body
following treatment with ivermectin. We characterize the optimal control problem analytically by applying
Pontryagin Maximum Principle. We analyse the model analytically and numerically to find out the thresh-
old conditions under which it is optimal to eradicate the disease from the population
This paper, is organised as follows; in Section 2 we give the formulation of the model and provide the
mathematical analysis of the model. The optimal control strategies are introduced in Section 3 and numer-
ical simulation results presented in Section 4. Finally, we present the discussion and concluding remarks in
Section 5.
2 Mathematical model
2.1 Model formulation
We consider a habitat with two interacting populations. The two populations are humans (as hosts) and the
black-flies (as vectors). The total human population is partitioned into six compartments: the susceptible
human compartment; SH , referring to individuals not infected with onchocerciasis but are at risk of infec-
tion, the exposed compartment; EH , referring to the individuals that have been exposed to onchocerciaisis
through bites but not infectious, the infectious compartment; IH , referring to individuals with onchocer-
ciaisis infection, the susceptible human on ivermectin treatment compartment; ST , the exposed human on
ivermectin treatment compartment; ET , and the infectious human on ivermectin treatment compartment;
IT . The black-fly population is partitioned into three compartments: susceptible vector; SV , referring to
black-flies that have never been in contact with infected human and have not picked up microfilariae but
are at risk of picking up microfilariae during blood meal from an infected human, the exposed vector com-
partment; EV , referring to vector that has picked up microfilariae from an infective human during blood
meal but does not transmit the infection and the infective vector compartment; IV , referring to the vector
with the infective L3 larvae stage.
Individuals and the vector move from one compartment to another as their disease status evolve. The total
human and vector populations at any given time, t, are respectively given by;
N = SH(t) + EH(t) + IH(t) + ST (t) + ET (t) + IT (t) and V = SV (t) + EV (t) + IV (t). (1)
We assume that the transmission of onchocerciaisis in susceptible hosts is only through contact with infec-
tious vector. We also assume that susceptible vector becomes infectious as a result of contact with infectious
hosts during blood meal. The population under study is assumed to be large enough to be modelled deter-
ministically. The constant recruitments of new susceptible human and susceptible vector are given by b1 and
b2 respectively. Assuming β is the black-fly biting rate, that is, the average number of bites per black-fly
per unit, the rate of infection per susceptible black-fly can be represented by
λv(t) =
qβ(IH + κIT )
N
, (2)
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where q is the transmission probability from infectious human to black-flies and κ is the modification
parameter which measures the relative ability of individuals in class IT to cause new infections relative
to those in compartment IH . We assume here that the individuals under treatment have a slightly lower
probability to initiate new infections, thus, 0 ≤ κ ≤ 1. Assuming that the total number of bites made by
black-flies equals to the number of bites received by humans, then the average number of bites per human
per unit time is βVN . Assuming that the transmission probability per bite from infectious black-flies to human
is p, the rate of infection per susceptible human is given by
λh(t) =
pβV
N
IV
V
=
pβIV
N
. (3)
We then introduce βh = pβ and βv = qβ parameters to simplify the infection rates per susceptible human and
vector respectively. The individuals in class EH progress to the infectious class IH at the rate γ. Individuals
on ivermectin treatment in class ST acquire infection at the rate δλh. Here, δ ∈ [0, 1], defines the reduced
effect of infection of the susceptible individuals on ivermectin as a result of treatment. Individuals in class
ET progress to infectious class on ivermectin IT at the rate ργ, where ρ ∈ [0, 1] is the reduced effect of
progression to class IT as a result of treatment. The rate of treatments for individuals is given by α. We
assume relapse of individuals under treatment due to waning of the drug at the rate ϕ. We also assume
natural mortality rates given by µh and µv for the human and vector populations respectively.
We further assume that individuals under treatment have no immunity to the disease upon treatment. In
addition, we assume that infected vectors and human do not recover from the infection during the modelling
time. The dynamics in the human hosts and vector populations is represented in the schematic diagram in
Fig. 1.
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Fig. 1: A compartmental representation of the model for onchocerciasis and its treatment.
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2.2 Model equations
Given the dynamics described in Fig. 1, the following system of non-linear ordinary differential equations,
with non-negative initial conditions, describes the dynamics of onchocerciaisis epidemics.
˙SH = b1 + ϕST − λhSH − (α+ µh)SH ,
E˙H = λhSH + ϕET − (α+ γ + µh)EH ,
˙IH = γEH + ϕIT − (α+ µh)IH ,
S˙T = αSH − δλhST − (ϕ+ µh)ST ,
E˙T = αEH + δλhST − (ργ + ϕ+ µh)ET ,
˙IT = αIH + ργET − (ϕ+ µh)IT ,
˙SV = b2 − λvSV − µvSV ,
E˙V = λvSV − (η + µv)EV ,
˙IV = ηEV − µvIV ,

(4)
subject to the following initial conditions
SH(0) ≥ 0, EH(0) ≥ 0, IH(0) ≥ 0, ST (0) ≥ 0, ET (0) ≥ 0, IT (0) ≥ 0, SV (0) ≥ 0, EV (0) ≥ 0, IV (0) ≥ 0. (5)
2.3 Model assumptions
1. There is a constant recruitment to the susceptible human population as well as the susceptible black-fly
population.
2. Transmission takes place only from infectious black-flies to susceptible humans and from infectious
humans to susceptible black-flies.
3. Infected black-flies do not live long enough to recover from infection.
4. human hosts do not have immunity to the disease.
5. The waning of the ivermectin after the mass treatment occurs at the same rate in all the treated classes.
2.4 Model analysis
In this section, we analyse the general properties of the system (4) with positive initial conditions. The
system (4) describes the population dynamics both in human and black-fly populations. The system is
biologically relevant in the set given by
Ω =
{
(SH , EH , IH , ST , ET , IT ) ∈ R6+ : N ≤ b1
µh
, (SV , EV , IV ) ∈ R3+ : V ≤ b2
µv
}
. (6)
2.4.1 Positivity of solutions of the model
The system (4) describes the human host and blackflies vector population. It is therefore important to show
that all the state variables describing the dynamics of the populations will be non-negative. In particular,
we prove that all solutions of the system (4) with non-negative initial conditions will remain non-negative
for all t > 0. We thus have the following theorem.
Theorem 1 For non-negative initial conditions of system (4), the solutions (SH , EH , IH , ST , ET , IT , SV ,
EV , IV ) of the system (4) are all non-negative for all time t ≥ 0.
Proof For the equations in our system, let us take t∗ as the maximum time for the epidemics. This implies
that;
t∗ = sup{t > 0 : SH > 0, EH > 0, IH > 0, ST > 0, ET > 0, IT > 0, SV > 0, EV > 0, IV > 0}.
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Thus, t∗ ≥ 0. Then, from the first equation of the system (4), we obtain
˙SH = b1 + ϕST − λhSH − (α+ µh)SH ≥ −
(
λh + (α+ µh)
)
SH ,
SH(t
∗) ≥ SH(0) exp
{
−
(∫ t∗
0
λh(m)dm+ (α+ µh)t
∗
)}
.
This implies that SH(t
∗) ≥ 0 for all time t ≥ 0. Similarly, from the seventh equation of the system (4), we
have
˙SV = b2 − λvSV − µvSV = b2 − (λv + µv)SV . (7)
Equation (7) can be written as
d
dt
(
SV exp
{∫ t
0
λv(u)du+ µvt
})
= b2 exp
{∫ t
0
λv(u)du+ µv(t)
}
,
Integrating both sides from t = 0 to t = t∗, we obtain
SV (t
∗) exp
{∫ t∗
0
λv(u)du+ µvt
∗
}
− SV (0) =
∫ t∗
0
b2 exp
{∫ x
0
λv(x)dx+ µvy
}
dy,
then multiplying both sides by exp
{
−
∫ t∗
0
λv(u)du− µvt∗
}
, we have
SV (t
∗) = SV (0) exp
{
−
∫ t∗
0
λv(u)du− µvt∗
}
+ exp
{
−
∫ t∗
0
λv(u)du− µvt∗
}
×
∫ t∗
0
b2 exp
{∫ x
0
λv(x)dx+ µvy
}
dy > 0.
Hence, SV (t
∗) ≥ 0 for all t∗ ≥ 0. Therefore, SH(t∗) and SV (t∗) being the sum of positive terms are all
positive. Using the same argument, it can be shown that the quantities EH , IH , ST , ET , IT , EV , and IV are
positive for all t > 0. Thus the solutions of (4) remain positive for all t ≥ 0.
2.4.2 Invariant region
Lemma 1 Let (SH , EH , IH , ST , ET , IT , SV , EV , IV ) be the solutions of the system (4) with initial condi-
tions given in (5) and the biological feasible region given by the set Ω = ΩH ×ΩV where
ΩH =
{
(SH , EH , IH , ST , ET , IT ) ∈ R6+ : N ≤ b1
µh
}
, ΩV =
{
(SV , EV , IV ) ∈ R3+ : V ≤ b2
µv
}
.
Proof Adding the equations in the system (4) gives
N˙ = b1 − µhN, V˙ = b2 − µvV. (8)
It can then be shown that
lim
t→∞ supN ≤
b1
µh
and lim
t→∞ supV ≤
b2
µv
. (9)
Hence, the set Ω is positively invariant, that is, all the solutions in Ω remain in Ω for t > 0. We thus
conclude that Ω is an attracting set.
Therefore every solution of the system (4), with initial condition in Ω remains there for t > 0. In addition,
in Ω, the usual existence, uniqueness and continuation results hold for the system. The system (4) is thus
both mathematically and epidemiologically well-posed in the region Ω. Hence, it is sufficient to study the
dynamics of the flow generated by the system (4) in Ω. The the right hand side of the system (4) is locally
Lipschitz continuous implying that the local existence and uniqueness of solutions is ascertained.
Stellenbosch University  https://scholar.sun.ac.za
6 Evans Otieno Omondi, Farai Nyabadza
2.5 Existence and stability of the equilibrium points
2.5.1 Disease-free equilibrium
The disease-free equilibrium (DFE) points are steady state solutions that depict the absence of infection in
both the human host and black-fly vector populations, i.e, onchocerciasis does not exist in the population.
This implies that at onchocerciasis-free equilibrium (E0), EH = IH = ET = IT = EV = IV = 0. Solving
the first, forth and seventh equations of the system (4) we obtain
E0 =
(
b1
Q1 (1− Φ1) , 0, 0,
b1α
Q1Q3 (1− Φ1) , 0, 0,
b2
µv
, 0, 0
)
, (10)
where
Q1 = α+ µh, Q2 = α+ γ + µh, Q3 = ϕ+ µh, Q4 = ργ + ϕ+ µh, Q5 = η + µv, Φ1 =
ϕα
Q1Q3
.
2.5.2 Basic reproduction number
The basic reproduction number is defined as the average number of secondary cases of human/vector on-
chocerciasis infections generated by a typical infected human/vector in an otherwise disease free population
[9]. The basic reproduction number (R0) of our system (4) is computed using the next generation matrix
method and is given by
R0 =
√R0 =
√
Rh0R
v
0 , (11)
where
Rh0 =
βhγµ
2
h(Φ3 + αδ(ακϕ+Q2ρ(Q1κ+ ϕ)))
b1Q21Q2Q
2
3Q4(1− Φ1)2(1− Φ2)
, Rv0 =
b2βvη
Q5µ2v
, Φ2 =
αϕ
Q2Q4
,
Φ3 = Q3[αϕ(δ + ρ) +Q1ακρ+Q4(Q3 + ακ)].
The basic reproduction number R0, determines whether onchocerciasis dies out or persists in the population.
The square root in (11) agrees with the findings of [22]. Note that Rv0 is the contribution of the vector
population to the overall infection while Rh0 is the contribution of the human population. The following
theorem follows directly from [9].
Theorem 2 The disease-free equilibrium of the system (4) exists and is locally asymptotically stable if
R0 < 1, and unstable otherwise.
2.6 Existence of the disease persistent steady states
Let S∗H , E
∗
H , I
∗
H , S
∗
T , E
∗
T , I
∗
T , S
∗
V , E
∗
V , I
∗
V be non-trivial the solutions to the endemic equilibrium points.
Setting all the equations of the system (4) to zero and expressing the state variables in terms of the forces
of infections λh and λv, we have
S∗H =
b1(Q3 + δλ
∗
h)
Q1Q3(1− Φ1) + λ∗h(Q1δ +Q3 + δλ∗h)
,
E∗H =
b1λ
∗
h(αδϕ+Q4(Q3 + δλ
∗
h))
Q2Q4(1− Φ2)(Q1Q3(1− Φ1) + λ∗h(Q1δ +Q3 + δλ∗h))
,
I∗H =
γb1λ
∗
h(δλ
∗
h (αρϕ+Q3Q4) +Q2αδρϕ+Q3 (αϕ(δ + ρ) +Q3Q4))
Q1Q2Q3Q4(1− Φ1)(1− Φ2)(Q1Q3(1− Φ1) + λ∗h(Q1δ +Q3 + δλ∗h))
,
S∗T =
αb1
Q1Q3(1− Φ1) + λ∗h(Q1δ +Q3 + δλ∗h)
,
E∗T =
αb1λ
∗
h(Q3 + δ(Q2 + λ
∗
h))
Q2Q4(1− Φ2)(Q1Q3(1− Φ1) + λ∗h(Q1δ +Q3 + δλ∗h))
,
I∗T =
αb1γλ
∗
h (αδϕ+Q4 (δλ
∗
h +Q3) + ρQ1 (δ (λ
∗
h +Q2) +Q3))
Q1Q2Q3Q4(1− Φ1)(1− Φ2)(Q1Q3(1− Φ1) + λ∗h(Q1δ +Q3 + δλ∗h))
,
S∗V =
b2
λ∗v + µv
, E∗V =
b2λ
∗
v
Q5(λ∗v + µv)
, I∗V =
b2ηλ
∗
v
Q5µv(λ∗v + µv)
.

(12)
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From the results in (12), we have the following two cases describing the existence of the steady states;
Case 1: λ∗h = λ
∗
v = 0.
This corresponds to the disease-free state treated in (10), where there is no infection in the population.
Case 2: λ∗h 6= λ∗v 6= 0.
This is the scenario in which there is infection in both the population (hosts and vector populations). We
describe this state using the following denotation.
E1 = (S
∗
H , E
∗
H , I
∗
H , S
∗
T , E
∗
T , I
∗
T , S
∗
V , E
∗
V , I
∗
V ).
Substituting the expressions for the state variables I∗V , I
∗
H and I
∗
T in (12) into the expressions for the forces
of infection in (2) and (3) then simplifying we obtain the following polynomial.
Ψ2λ
∗2
h + Ψ1λ
∗
h + Ψ0 = 0, (13)
where
Ψ2 = Q5b1δµv[Q1Q2Q3Q4µv(1− Φ1)(1− Φ2) + βvµhγ(αρ (κQ1 + ϕ) +Q4 (ακ+Q3))],
Ψ1 = −[b2γδηβhµ2hβv(αρ(κQ1 + ϕ) +Q4(ακ+Q3))− b1Q5µv(γµhβv(α2δκϕ+ αδρQ2(κQ1 + ϕ)
+Q3(αϕ(δ + ρ) + ακρQ1 +Q4(ακ+Q3))) +Q1Q2Q3Q4(1− Φ1)(1− Φ2)(δQ1 +Q3)µv)],
Ψ0 = b1Q
2
1Q2Q
2
3Q4Q5µ
2
v(1− Φ1)2(1− Φ2)[1−R0].
The existence and the number of endemic equilibria for the system (4) is determined by the existence of, and
the number of positive roots of the quadratic equation given in (13). The roots to the quadratic equation
(13) can be obtained by the quadratic formula given by
(λ∗h)1,2 =
−Ψ1 ±
√
Ψ21 − 4Ψ2Ψ0
2Ψ2
. (14)
We note that Ψ0 > 0 ifR0 < 1, Ψ0 = 0 ifR0 = 1 and Ψ0 < 0 ifR0 > 1. If Ψ0 <, then ∆ = Ψ21−4Ψ2Ψ0 > 0 and
equation (13) has a unique positive solution hence the model system (4) has a unique endemic equilibrium
. If R0 < 1 then Ψ0 > 0 and by adding the conditions Ψ1 < 0 and ∆ > 0, we get two positive real equilibria
. If R0 = 1, then Ψ0 = 0 and there is a unique non-zero solution of (13) which is positive if and only if
Ψ1 < 0. The following theorem summarizes the existence of the endemic equilibria of the system (4).
Theorem 3 The system (4)
1. has no endemic equilibrium if R0 < Rc0 where Rc0 is referred to as critical R0.
2. has a unique endemic equilibrium in Ω if R0 > 1.
3. has two endemic equilibria for some parameter values of Rc0 < R0 < 1. In this range, one endemic
equilibrium and the disease-free equilibrium are locally stable.
4. has one positive equilibrium for R0 = 1 provided Ψ1 < 0 and ∆ > 0, otherwise there is no positive
equilibrium.
5. has no endemic equilibrium otherwise.
Proposition 1 The system (4) has a backward bifurcation at R0 = 1 if and only if Ψ1 < 0 and ∆ > 0.
Epidemiologically, proposition 1 implies that bringing R0 below unity does not suffice for the eradication
of onchocerciasis. From the analysis of the existence of the endemic equilibrium, we have established that
the system (4) exhibits backward bifurcation when R0 < 1. The existence of backward bifurcation indicates
that in the neighbourhood of 1, for R0 < 1, a stable disease-free equilibrium coexists with two endemic
equilibria, that is , a smaller equilibrium (smaller number of infectious individuals) which is unstable and
a larger equilibrium (with a larger number of infectious individuals) which is stable. These two endemic
equilibria disappear by saddle-node bifurcation when the basic reproduction R0 is decreased below the
critical value Rc0. In order to achieve a epidemiological goal of disease eradication, R0 must be brought
below the critical value Rc0. To obtain the critical value Rc0, we set the discriminant ∆ of the polynomial
(13) to zero and make R0 the subject of the relation. Thus, we have
Rc0 = 1− Ψ
2
1
4Ψ2[b1Q21Q2Q
2
3Q4Q5µ
2
v(1− Φ1)2(1− Φ2)] . (15)
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2.7 Bifurcation analysis
This is a qualitative change in the behaviour of a dynamical system produced by varying a parameter in the
equation [29]. Backward bifurcation is an important phenomenon in compartmental epidemiological models.
This phenomenon has been observed in numerous disease transmission models [10,13,18,40]. Wang [40]
studied backward bifurcation of an epidemic model with treatment. He demonstrated that his model exhibits
backward bifurcation behaviour. The existence of such a bifurcation suggests that the basic reproduction
number itself is not enough to characterize or decide whether onchocerciasis will prevail or not and if
the disease will become endemic also depends on the initial sizes of the involved population. Thus, it is
important to identify the backward bifurcations and establish the threshold for that bifurcation. We carry out
bifurcation analysis to study the behaviour of the system (4) based on the results in (13) through numerical
simulation over chosen parameter values. It is important to note that the existence of bi-stability is not easy
to simulate numerically. This is because a small interval of R0 is required for the occurrence of backward
bifurcation and very small range of parameters has to be chosen. The qualitative backward bifurcation
diagram describing the behaviour of R0 = 1 is presented in Figure 2 where βh is taken as the bifurcation
parameter. The result indicates that in the backward bifurcation, if R0 is below unity then the disease
control depends on the initial sizes of the various sub-populations of the system (4). However, reducing R0
below the saddle-node bifurcation value Rc0, may result in disease eradication. This is guaranteed provided
that the disease-free equilibrium is globally asymptotically stable. Figure 3 is obtained after increasing
the rate of mass administration of ivermectin to 1. The biological interpretation of this is that increasing
treatment can lead to disappearance of backward bifurcation curve and in this case lowering R0 below one
is sufficient to eliminate the disease from the population. So when the rate of mass treatment is high enough
we will have a forward bifurcation and lowering R0 below unity would be sufficient to make the disease-free
equilibrium globally stable.
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Fig. 2: Variation of the equilibrium level of λ∗h with βh showing the backward bifurcation of the system (4).
We considered b1 = 10, b2 = 50, µh = 0.000150, γ = 0.0097, βv = 0.000127, µv = 0.09800, η = 0.0884, ϕ =
0.002, α = 0.40, κ = 0.005, δ = 0.0025, ρ = 0.0013.
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Fig. 3: Description of forward bifurcation of the system (4) for parameter values κ = 0.020, α = 1 and all
other parameters as used in Figure 2.
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2.8 Global stability of the disease-free equilibrium
Since the system (4) has two endemic equilibria when R0 < Rc0, it implies that the disease-free equilibrium
is globally stable if and only if R0 < Rc0. We therefore establish the global stability of the disease-free
equilibrium, E0 using a Lyapunov function for R0 < Rc0.
Theorem 4 The disease-free equilibrium E0 of system (4) is globally asymptotically stable if R0 < Rc0 and
unstable otherwise.
Proof Let L(EH , IH , ET , IT , EV , IV ) = Φ4EH + Φ5IH + Φ6ET + Φ7IT + Φ8EV + Φ9IV , be a candidate
Lyapunov function for some non-negative values of Φ4, Φ5, Φ6, Φ7, Φ8 and Φ9. The time derivative of L is
given by;
L˙ = Φ4E˙H + Φ5 ˙IH + Φ6E˙T + Φ7 ˙IT + Φ8E˙V + Φ9 ˙IV ,
= Φ4
(
βhIV SH
N
+ ϕET −Q2EH
)
+ Φ5(γEH + ϕIT −Q1IH) + Φ6
(
αEH +
δβhIV ST
N
−Q4ET
)
+ Φ7(αIH + ργET −Q3IT ) + Φ8
(
βvIHSV
N
+
κβvITSV
N
−Q5EV
)
+ Φ9(ηEV − µvIV ),
= (Φ5γ + Φ6α− Φ4Q2)EH +
(
Φ7α+ Φ8
βvb2µh
µvb1
− Φ5Q1
)
IH + (Φ4ϕ+ Φ7ργ − Φ6Q4)ET
+
(
Φ5ϕ+ Φ8
κβvb2µh
µvb1
− Φ7Q3
)
IT + (Φ9η − Φ8Q5)EV
+
(
Φ4
βhµh
Q1(1− Φ1) + Φ6
βhδαµh
Q1Q3(1− Φ1) − Φ9µv
)
IV .
Evaluating the coefficients of the suitable Lyapunov function such that the coefficients of IH , ET , IT , EV ,
and IV are equal to zero we obtain
Φ4 =
Q21Q
2
3b1(1− Φ1)2Q4Q5µ2v − βhβvµ2hb2ηγαδρ(Q1κ+ ϕ)
Q1Q3βhb1µhµv(1− Φ1)(Q3Q4 + αϕδ) , Φ5 =
βvµhb2η(Q3 + ακ)
Q1Q3b1µv(1− Φ1) ,
Φ6 =
Q21Q
2
3(1− Φ1)2Q5b1µ2vϕ−Q3βhβvb2ηγρ(Q1κ+ ϕ)
Q1Q3βhb1µhµv(1− Φ1)(Q3Q4 + αϕδ) , Φ7 =
βvµhb2η(ϕ+Q1κ)
Q1Q3b1µv(1− Φ1) ,
Φ8 = η, Φ9 = Q5.
Using these coefficients, the time derivative of the Lyapunov function is given by
L˙ =
(
Q1Q2Q3Q4Q5µv(1− Φ1)(1− Φ2)
βhµh(Q3Q4 + αϕδ)
)
[R0 − 1]EH < 0, (16)
It follows that L˙ < 0 for R0 < Rc0 and L˙ = 0 if and only if IH = ET = IT = EV = IV = 0. Therefore, L is
a Lyapunov function in Ω = (SH , EH , IH , ST , ET , IT , SV , EV , IV ). Since, Ω is invariant and attracting, it
follows that the largest possible invariant set in {(SH , EH , IH , ST , ET , IT , SV , EV , IV ) ∈ Ω : L˙ = 0}, is the
singleton {E0f}. According to La-Salle’s invariance principle [19], E0 is globally attractive. Therefore, the
disease-free equilibrium E0 is globally asymptotically stable when R0 < Rc0. This completes the proof.
In the case of the occurrence of a backward bifurcation in the system (4), the above result shows that in
order to eliminate onchocerciasis, the basic reproduction R0 must be lower than the threshold Rc0 which is
strictly less than unity.
3 Application of optimal control
3.1 Formulation of optimal control
In this section, we formulate a model framework that minimizes onchocerciasis infection in the human
population. In the system (4), the recruitment rates in each susceptible population is modified to include
the density effects. Thus, the density dependent factors for the recruitment rates are b1(N) for the host
population and b2(V ) for the vector population. Personal protection efforts through wearing insect repellents
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such as N,N-Diethyl-meta-toluamide (DEET) on exposed skin, wearing long sleeves and long pants during
the day when black-flies bite, and wearing permethrin-treated clothing minimizes or eliminates black-fly-
human contacts [32]. Insecticide spraying with larvicide and adulticide ensures that the breeding sites of the
black-flies are minimized. We thus define some linear control functions ui(t) such that ui(t) = 1, i = 1, 2, 3.
It is important to note that controls are fully effective when ui(t) = 1 and not effective control when
ui(t) = 0. The forces of infection λh and λv corresponding to human population and vector population
respectively are reduced by factor (1−u1), where u1(t) measures the level of successful exposure prevention
efforts. The control u1(t) represents the use of alternative prevention measures to minimize or eliminate the
black-fly-human contacts. Such measures include the use of insect repellents, wearing protective coats and
long sleeves and wearing permethrin-treated clothing amongst other. The mass administration of ivermectin
as a control is modelled by u2. The factor u2 can be viewed as the coverage of ivermectin. The factor u3(t),
represents the level of larvicide and adulticide use for the elimination of black-flies from the breeding sites.
This implies that the reproduction rate of the black-fly population is reduced by a factor of (1 − u3(t)).
We assume that, larvicidal spraying increases the mortality rate of the black-flies at a rate proportional to
the control factor u3(t). It is further assumed that the per capita mortality rate of the vector is r0u3(t),
where 0 ≤ r0 ≤ 1 is the proportion of effective adulticide spraying. Taking into account the assumptions
and extensions made above, we therefore find the most effective strategy that reduces the onchocerciasis
infection in the population at a minimum cost. Using bounded lebesgue measurable control, the objective
functional to be minimized is given by
J(u1, u2, u3) =
∫ T
0
(A1EH +A2IH +A3V +
1
2
(B1u
2
1 +B2u
2
2 +B3u
2
3))dt (17)
subject to the state system given in (4). The dynamics of the control that minimizes the objective functional
J(u1, u2, u3) is given by
˙SH = b1N + ϕST − λhSH(1− u1)− (u2α+ µh)SH ,
E˙H = λhSH(1− u1) + ϕET − (u2α+ γ + µh)EH ,
˙IH = γEH + ϕIT − (u2α+ µh)IH ,
S˙T = u2αSH − δλhST (1− u1)− (ϕ+ µh)ST ,
E˙T = u2αEH + δλhST (1− u1)− (ργ + ϕ+ µh)ET ,
˙IT = u2αIH + δγET − (ϕ+ µh)IT ,
˙SV = b2V (1− u3)− λvSV (1− u1)− µvSV − r0u3SV ,
E˙V = λvSV (1− u1)− (η + µv)EV − r0u3EV ,
˙IV = ηEV − µvIV − r0u3IV ,

(18)
with the following initial conditions
SH(0) ≥ 0, EH(0) ≥ 0, IH(0) ≥ 0, ST (0) ≥ 0, ET (0) ≥ 0, IT (0) ≥ 0, SV (0) ≥ 0, EV (0) ≥ 0, IV (0) ≥ 0.
(19)
We endeavour to minimize the exposed and infectious human populations (EH , IH), the black-fly population
and the cost of implementing the control by use of possible minimum variables ui, i = 1, 2, 3. This functional
includes the number of exposed, infectious and the total number of black-fly populations, respectively, as well
as the social costs related to the resources needed for personal protection 12B1u
2
1, the coverage of ivermectin
1
2B2u
2
2 and spraying of larvicide and adulticide operations
1
2B3u
2
3. This implies that we are minimizing
the number of exposed, infectious human and susceptible, exposed and infectious black-fly populations as
well as the cost based on the implementation of the control functions. The quantities A1 and A2 represent
the cost associated with minimizing the exposed and infected human population respectively while A3
represent the cost associated with minimizing total black-fly population. The quantity T is the time period
of intervention. The quantities B1, B2 and B3 represent the weight constants for personal protection, the
coverage of ivermectin and spraying of larvicide and adulticide operations. According to [17,31] the costs
associated with A1EH , A2IH and A3V are linear while the cost control functions
1
2B1u
2
1,
1
2B2u
2
2 and
1
2B3u
2
3
should be non-linear and take the quadratic form. We assume that the costs of implementation of the
control policies are proportional to the square of the corresponding control function. We seek to minimize
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the objective functional over the given time interval [0, T ]. In particular, the aim of the optimal control
problem is to seek optimal control functions (u∗1(t), u
∗
2(t), u
∗
3(t)) such that
J(u∗1, u
∗
2, u
∗
3(t)) = min
U
J(u1, u2, u3), (20)
where U = {u1, u2, u3|0 ≤ ui(t) ≤ 1, i = 1, 2, 3} is the control set and is Lebesgue measurable. Pontryagin’s
Maximum Principle is used to solve this optimal control problem and the derivation of the necessary
conditions. First we prove the existence of an optimal control for the system (18) and then derive the
optimality system.
3.2 Existence of control problem
In order to find the optimal solution, we first find the Lagrangian and Hamiltonian for the optimal control
problem (17) and (18). The Lagrangian of the optimal control problem is given by
L = A1EH +A2IH +A3V +
1
2
(B1u
2
1 +B2u
2
2 +B3u
2
3). (21)
We seek for the Lagrangian minimum value. In order to accomplish this, we define the Hamiltonian, H for
the control problem. This is given by
H = L(EH , IH , V, u1, u2, u3) + λ1 ˙SH + λ2E˙H + λ3 ˙IH + λ4S˙T + λ5E˙T + λ6 ˙IT + λ7 ˙SV + λ8E˙V + λ9 ˙IV ,
= A1EH +A2IH +A3V +
1
2
(B1u
2
1 +B2u
2
2 +B3u
2
3)
+ λ1
[
b1N + ϕST − λhSH(1− u1)− (u2α+ µh)SH)
]
+ λ2
[
λhSH(1− u1) + ϕET − (u2α+ γ + µh)EH
]
+ λ3
[
γEH + ϕIT − (u2α+ µh)IH
]
+ λ4
[
u2αSH − δλhST (1− u1)− (ϕ+ µh)ST
]
+ λ5
[
u2αEH + δλhST (1− u1)− (ργ + ϕ+ µh)ET
]
+ λ6
[
u2αIH + δγET − (ϕ+ µh)IT
]
+ λ7
[
b2NV (1− u3)− λvSV (1− u1)− µvSV − r0u3SV
]
+ λ8
[
λvSV (1− u1)− (η + µv)EV − r0u3EV
]
+ λ9
[
ηEV − µvIV − r0u3IV
]
.

(22)
Theorem 5 There exists an optimal control u∗ = (u∗1, u
∗
2, u
∗
3) ∈ U such that
J(u∗1, u
∗
2, u
∗
3) = min
(u1,u2,u3)∈U
J(u1, u2, u3), (23)
subject to the control system (18) with the initial conditions (19).
Proof We prove the existence of the optimal problem following the results in [12,23]. It is clear that the
system of equations given by (18) is bounded and the state variables are non-negative. In this minimizing
problem, the control set U is convex and closed by definition. The optimal system is bounded which
determines the compactness needed for the existence of the optimal control. The integrand in the objective
functional, A1EH+A2IH+A3V +
1
2 (B1u
2
1+B2u
2
2+B3u
2
3), is clearly convex on the control set U. Moreover,
we can easily see that, there exists, β > 1 and positive numbers c1, c2 satisfying
J(u1, u2, u3) ≥ c1(|u1|2 + |u2|2 + |u3|2)
β
2 − c2, (24)
because, the state variables are bounded. This completes the proof.
3.3 Optimality of the system
In order to find the optimal solution, we employ Pontryagin’s Maximum Principle [34] to the Hamiltonian
(22), such that if (x, u) is an optimal solution of an optimal control problem, then there exists a non-trivial
vector λ = (λ1, λ2, · · · , λn) satisfying the following inequalities.
dx
dt
=
∂H(t, x, u, λ)
∂λ
, 0 =
∂H(t, x, u, λ)
∂u
, λ
′
= −∂H(t, x, u, λ)
∂x
. (25)
We, now derive the necessary conditions to the Hamiltonian in (22) that optimal control functions and
corresponding states must satisfy.
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Theorem 6 Let S∗H , E
∗
H , I
∗
H , S
∗
T , E
∗
T , I
∗
T , S
∗
V , E
∗
V and I
∗
V be the solutions of the corresponding optimal con-
trol problem (17)-(18) associated with the optimal control variables (u∗1, u
∗
2, u
∗
3). Then, there exists adjoint
variables λi, i = 1, 2, · · · , 9 satisfying
dλ1(t)
dt
=
βh
N
(λ1 − λ2)(1− u1)IV + (λ1 − λ4)u2α+ λ1µh,
dλ2(t)
dt
= (λ2 − λ3)γ + (λ2 − λ5)u2α+ λ2µh −A1,
dλ3(t)
dt
= (λ3 − λ6)u2α+ βv
N
(λ7 − λ8)(1− u1)SV + λ3µh −A2,
dλ4(t)
dt
=
δβh
N
(λ4 − λ5)IV (1− u1) + (λ4 − λ1)ϕ+ λ4µh,
dλ5(t)
dt
= (λ5 − λ2)ϕ+ (λ5 − λ6)ργ + λ5µh,
dλ6(t)
dt
= (λ6 − λ3)ϕ+ λ6µh + βvκ
N
(λ7 − λ8)SV (1− u1),
dλ7(t)
dt
= −b2λ7(1− u3) + βv
N
(λ7 − λ8)(1− u1) (IH + κIT ) + λ7µv + λ7r0u3 −A3,
dλ8(t)
dt
= −b2λ7(1− u3) + (λ8 − λ9)η + λ8µv + λ8r0u3 −A3,
dλ9(t)
dt
= −b2λ7(1− u3) + βh
N
(λ1 − λ2)(1− u1)SH + δβh
N
(λ4 − λ5)(1− u1)ST + λ9µv + λ9r0u3 −A3,

(26)
with transversality conditions (or boundary conditions)
λi(T ) = 0, i = 1, 2, · · · , 9, (27)
expressed as
u∗i =

0 if ui ≤ 0,
ui if 0 < ui < 1,
1 if ui ≥ 1.
(28)
In addition, the control functions u∗1, u
∗
2 and u
∗
3 are represented by
u∗1 = max
{
min
{
βh(λ2 − λ1)I∗V S∗H + δβh(λ4 − λ5)I∗V S∗T + βv(λ8 − λ7)(I∗H + κI∗T )S∗V
NB1
, 1
}
, 0
}
, (29)
u∗2 = max
{
min
{
α[(λ1 − λ4)S∗H + (λ2 − λ5)E∗H + (λ3 − λ6)I∗H ]
B2
, 1
}
, 0
}
, (30)
u∗3 = max
{
min
{
λ7b2V
∗ + r0(λ7S∗V + λ8E
∗
V + λ9I
∗
V )
B3
, 1
}
, 0
}
. (31)
Proof To determine the adjoint equations and the transversality conditions, we minimize the Hamiltonian
H with respect to the controls (u∗1, u
∗
2, u
∗
3) at the optimal control functions. Setting SH(t) = S
∗
H(t), EH(t) =
E∗H(t), IH(t) = I
∗
H(t), ST (t) = S
∗
T (t), ET (t) = E
∗
T (t), IT (t) = I
∗
T (t), SV (t) = S
∗
V (t), EV (t) = E
∗
V (t) and IV (t) =
I∗V (t) and differentiating the Hamiltonian (22) with respect to SH , EH , IH , ST , ET , IT , SV , EV and IV , re-
spectively, we obtain (26). Solving the equations
∂H
∂u1
= 0,
∂H
∂u2
= 0,
∂H
∂u3
= 0, (32)
on the interior of the control set using the optimality conditions and the property of the control set U, we
derive (29)-(31). Due to the fact that the state and the adjoint functions are bounded and the Lipschitz
structure of the ordinary differential equations, we obtain the uniqueness of the optimal control. This
completes the proof.
The formulas (29)-(31) for u∗ are the characteristics of the optimal control. The optimal control are found
by solving the optimality system, that consists of the state system (18), the adjoint system (26), the initial
conditions (19), boundary conditions (27) and the characteristic of the optimal control (29)-(31). In order to
solve the optimality system, we use the initial and transversality conditions alongside the characterization of
the optimal control (u∗1, u
∗
2, u
∗
3) given in (29)-(31). Furthermore, the second derivative of the Lagrangian with
respect to u1, u2 and u3, respectively, are positive indicating that the optimal control problem is minimum
at controls u∗1, u
∗
2 and u
∗
3. We thus obtain the optimal control through numerical simulation.
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4 Numerical simulation
In this section, we discuss the numerical solutions of the optimality system (18) and the corresponding
optimal control strategies. In order to solve the optimality system we employ the standard two-boundary
point method described in [20]. In our numerical simulations, we first start by solving the state equations
(18) using Runge-Kutta forth order forward in time with a guess for the controls over simulated time.
Based on the transversality conditions (27), the adjoint equations are solved by backward method. The
time varying control values are found by entering the calculated values of the state and adjoint variables in
the characterization of optimal controls (29)-(31). Convex combination is used to update the control values.
In this case, the average of the new and old control values is taken. The convergence is acquired when the
values of the variables in the new iteration and the previous iteration are insignificantly close.
4.1 Parameter estimation
In this section, we consider average parameter values that encompass features of onchocerciasis disease
including rate of infection, incubation period, length of infections period in the vector and host populations.
Although estimates of some parameters are given in Table 1, here we give additional explanation and
description of some of the parameters based on available literature and with reference to Ghana which is
one of the onchocerciasis endemic countries.
1. The average birthrate in Ghana was estimated to be 31.09 births/1,000 population in 2015 and 30.60
births/1,000 population in 2014 according to the World Fact Book by Central Intelligence Agency [37]
and Ghana Statistical Service report on Demographic and Health Survey [14] respectively. Thus, the
recruitment rate is estimated from the range 0.0000819 ≤ b1 ≤ 0.000108 per day.
2. The natural human death rate is estimated based on average life of 50-70 years in accordance to Central
Intelligence Agency and 2014 demographic data released by Ghana Statistical Service estimates of life
expectancy at birth respectively [14,37]. The black-fly death rate is estimated based on the average life
span lasting for 2-3 weeks, to as long as 85 days [11,30].
3. It takes 34 to 2 years for the worm to mature and release enough microfilariae to be detectable in
the skin of the human host [21,28,35]. Therefore, a reasonable estimate of the incubation rate γ is
0.00137 ≤ γ ≤ 0.00365 per day. On the other hand, the average incubation period in the black-fly is 1-2
weeks [21,33,35]. Thus, a reasonable value for η is 0.0714 ≤ η ≤ 0.1667 per day.
4. The modification parameters (κ, δ and ρ) have been estimated to be between 0 and 1 due to the reduced
ability of individuals to cause infections following ivermectin treatment.
5. The rate of protection following mass administration of ivermectin α is estimated to be between 0% and
100%.
6. We balance the host populations and control functions by arbitrarily choosing weight contstant values
A1 = A2 = A3 = 1, B1 = 20, B2 = 20, B3 = 20 in the objective functional (17). These weight
parameters determine the importance of variables in the objective functional [20]. The estimate for rate
constant r0 is given as 0.06.
For illustration purpose, we consider the parameter estimates in Table 1 with the following initial conditions;
SH(0) = 16200, EH(0) = 1500, IH(0) = 100, ST (0) = 2000, ET (0) = 300,
IT (0) = 10, SV (0) = 2500, EV (0) = 250, IV (0) = 10.
In the simulation, we consider the treatment rate as the protection rate upon the mass administration of
ivermectin.
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Table 1: Parameters used for numerical simulation. The rates are given per day.
Parameter Description Range Point value Source
b1 Human recruitment rate 0.0000819-0.001085 0.001 Estimated
µh Death rate of the human 0.0000391-0.0000548 0.000052 [14,37]
βh The rate of transmission of the
disease from black-fly to human 0.0-0.02 0.00214 Estimated
γ Transfer rate from EH to IH class 0.00137-0.00365 0.0023 [21,28,35]
α Ivermectin treatment rate 0-1.0 0.0165 [41]
ϕ Waning rate of ivermectin 0.01-0.1 0.0013 [39]
κ Modification parameter 0.00-1.0 0.002 Estimated
ρ Modification parameter 0.0-0.1.0 0.012 Estimated
δ Modification parameter 0.00-1.0 0.001 Estimated
b2 Vector recruitment rate 0.0177-0.0871 0.0643 Estimated
βv The rate of transmission of the
disease from human to black-fly 0.0-0.02 0.00104 Estimated
η Transfer rate from EV to IV class 0.0714-0.1667 0.074 [21,33,35]
µv Death rate of the black-fly 0.0118-0.0714 0.065 [11,30]
4.2 Sensitivity analysis
Sensitivity analysis is introduced to study the strength of the basic reproduction number for the model
parameters. Due to the unavailability of data, uniform distribution is used for the set of parameters in
Table 1 peaked at the median. Tornado plot for the normalised sensitivity index for different parameters
is given in Fig. 4. If the sensitivity index is positive, then R0 increases along with increasing value of the
parameter. On the other hand, if the sensitivity index is negative, then R0 decreasing with the increasing
value of the parameter. The transmission contact rates in human and the vector have the greatest effect
on the disease transmission. The results in Fig. 4 indicate that the basic reproduction number increases
with increase in the transmission contact rate in both the human (host) and the vector whereas the basic
reproduction number decreases with increase in the vector death rate. The results therefore suggest that if
the transmission of onchocerciasis in both the vector and the human (host) can be reduced and the vector
death rate increased, then the disease can be easily controlled. On the other hand, Fig. 5 shows that an
increase in both κ and δ increases R0. Thus, the effectiveness of ivermectin in the treatment of onchocerciasis
is critical in eliminating new cases of infections in the treated population.
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Fig. 4: Tornado plots of partial rank correlation coefficients (PRCCs) of the parameters that influence R0
for the input parameters using the values in Table 1. Parameters with PRCC> 0 increases R0 when they
are increased whereas parameters with PRCC< 0 decreases R0 when they are increased.
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Fig. 5: Contour plot showing the effect of modification parameters δ and κ on R0.
4.3 Simulation results
Fig. 6, represents the population of susceptible, exposed, infected individuals (human) in two systems, (4)
without control and (18) with control. The red line denotes the population of individuals in the system
(4) without control while the blue dotted line denotes the population of individuals in the system (18)
with control. Onchocerciasis infection is shown to be contained much earlier in time when appropriate and
aggressive optimal controls are applied to the onchocerciasis epidemic. Part (a) of Fig. 6 reveals that without
controls, the susceptible human (hosts) population not on ivermectin gets depleted at a higher rate due to
unchecked transmission. However, with controls, more individuals stay in the susceptible class. In addition,
part (b) of Fig. 6 shows that more susceptible individuals stay protected with ivermectin when there is
control as compared to when there is no control. Part (c) and (e) of Fig. 6 show that the populations
of exposed and infected individuals with control are more decreased than the individuals without control.
The results suggest that much less time is taken to clear onchocerciasis disease when optimal control
measures are applied than without controls. Fig. 7 reveals that the population of the susceptible vector
with optimal control is more sharply decreased while the population without control grows and settles at
endemic state. The population of susceptible vector with control decreases to zero. We observe in Fig. 7
(b) and (c) that the exposed and infected vector without control rise during the initial stages of epidemic
followed by a decrease then remains at endemic stage. However, in the presence of control we observe a
decrease which ends at onchocerciasis free stage. The results illustrate the importance of control in the
reduction of onchocerciasis infection in the population. Fig. 8 shows the evolution of the control profiles
over time. The results show that the controls u1, u
∗
2 and u
∗
3 all start at the upper bound. However, the
first and third controls, u1 and u
∗
3, decline after about 100 days and vanish in the 250
th day. The control
profile u2 maintains its upper bound and vanishes when the epidemics ends. This can be explained by the
fact that in the treatment of onchocerciasis with ivermectin, the drug is administered for the entire period
corresponding with the lifespan of filarial adult worms. The simulation shows that a lot more emphasis
should be put in reducing the contact that results into onchocerciasis infection. More emphasis should be
put on vector eradication that posses danger on the continuous spread of the disease. We suggest that
treatment services should be patient specific, proper, efficient and timely.
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Fig. 6: The plot represents population of susceptible not on ivermectin, exposed not on ivermectin, infected
not on ivermectin, susceptible on ivermectin, exposed on ivermectin and infected on ivermectin human host
both with control (blue dotted line) and without control (red line).
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Fig. 7: The plot represents population of susceptible , exposed and infected vector both with control (blue
dotted line) and without control (red line).
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Fig. 8: Profiles of personal protection control u1 , the treatment efficiency control u2 and insecticide u3.
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5 Conclusion
In this paper, a deterministic model for onchocerciasis disease dynamics that incorporates compartment
with treatment was developed. The model was extended to account for density dependent parameters and
control functions to assess the impact of control measures using optimal control techniques with important
epidemiological features. The model properties and stability analysis were examined. We have shown that
there exist multiple endemic equilibrium when the basic reproduction is less than unity. The model is
shown to exhibit backward bifurcation implying that R0 < 1 is not sufficient to eliminate the disease from
the population and hence we need another threshold parameter less than one and R0 should be reduced
below this threshold to eliminate the disease from the population. This behaviour has been shown using the
bifurcation diagram. In addition, it is established that the rate of mass administration of ivermectin plays
an important role in the occurrence of backward bifurcation. An increase in the rate of mass administration
of ivermectin results in the forward bifurcation and in this case reducing R0 below 1 becomes sufficient to
eliminate the disease from the population.
We also determined the cost effective strategies for combating the spread of onchocerciasis infection in
the population. By application of Pontryagins Maximum Principle, we performed the optimal analysis of
the non-autonomous control model considering three controls, one for black-fly-reduction strategies and
the other two for personal (human) protection and the coverage of ivermectin respectively. In addition, we
minimised the exposed and infectious hosts as well as the total vector population by using the three control
variables. We have investigated the dynamics by an efficient numerical scheme based on optimal control
to identify the best strategy of onchocerciasis control. A comparison between optimal control system and
system without control is presented. It is easy to see that the optimal control system has desirable impact
on the reduction of the number of exposed and infected humans (hosts) and the vector population. The
results indicate that treatment with ivermectin remains the most effective and recommended methodology to
control onchocerciasis disease. In addition, application of vector control can produce more desirable results
and enhance the disease eradication. Thus, the results support the hypothesis that preventive practices are
very efficient in reducing the incidence of exposed and infectious hosts as well as the vector.
As with many models, the model presented in this article should be treated with circumspection because of
the difficulty in the estimation of model parameters. The weights on cost considered in this paper are mainly
for illustration. More realistic results can be obtained if data on the costs of the implementation of control
strategies area available. Despite these shortcomings, the model still provides some useful insights into the
control of onchocerciasis through the implementation of the discussed control measures. Note that the same
model could be used to investigate the emergence of drug resistance in the treatment of onchocerciasis
with ivermectin. The model can also be used to investigate the impulsive effect of mass administration of
ivermectin in the treatment of onchocerciasis.
In summary, the fight to eradicate onchocerciasis from the population depends on the mass administration
of ivermectin as well as vector control. The elimination of black-fly is critical in eliminating new infections
that may result due to human-blackfly contact. Therefore, the model discussed here is much suitable for
onchocerciasis and it can readily be extended to incorporate climatic conditions on the transmission of this
disease.
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Abstract
Onchocerciasis (river blindness) is a disease spread from blackflies to humans that causes chronic mor-
bidity in sub-Saharan Africa. Treatment occurs through twice-yearly mass administration of ivermectin, a
drug that is effective in the short term but which wanes quickly. We used a system of impulsive differential
equations to model both fixed and non-fixed administration of ivermectin. In the absence of treatment, we
determined the threshold for eradication R0 but showed that the disease is unlikely to be eradicated without
extremely low transmission levels or strong vector control. If treatment is included, then treatment at fixed
intervals can control but not eradicate the disease. Treatment at non-fixed intervals may produce bursts
of infection. Six-monthly mass administration can only lead to significant reduction of onchocerciasis if
human–vector contact is sufficiently reduced and vector-control programs are implemented.
Keywords: Onchocerciasis, river blindness, ivermectin, mathematical model, impulsive differential
equations.
1. Introduction
Onchocerciasis (also known as river blindness) is a neglected tropical disease caused by the filirial worms
Onchocerca volvulus in human hosts [1]. The disease is transmitted by the blackfly (Simulium damno-
sum) [2]. Simulium breeds close to oxygen-rich flowing streams and rivers in inter-tropical zones [3, 4].
Onchocerciasis-endemic areas thus tend to include the most agriculturally fertile land available. he mi-
gration and deaths of microfilariae damage sur- rounding tissue or organs, causing intense itching and
disfigurement; ocular degeneration and blindness occur when microfilariae migrate to the eyes [4]
The infection of onchocerciasis begins at the third larvae stage in the human host after the vector’s
blood meal. The larvae develop into adult filariae in the subcutaneous tissues from which microfilariae mi-
grate throughout the body, predominantly within the skin [5]. This produces an intense itching of the skin
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and a chronic dermatitis that leads to skin atrophy and depigmentation [6]. The migration of microfilariae
through the anterior and posterior segments of the eye precipitates inflammatory reactions that may lead
to loss of vision and sometimes blindness [4, 7].
Various onchocerciasis control strategies have achieved dramatic success in reducing onchocerciasis
transmission [8, 9]. The strategies have employed both the use of larvicide spraying at blackfly breeding
sites and the periodic mass drug administration of ivermectin to affected human populations. The control
programmes have been spearheaded by three international programmes: the Onchocerciasis Control Pro-
gram (OCP), the Onchocerciasis Elimination Programme in the Americas (OEPA) and the African Program
for Onchocerciasis Control (APOC). Transmission of onchocerciasis was interrupted in Guatemala and in
several hyper-endemic foci of Mali and Senegal following six-monthly mass administration of ivermectin
[10]. In 2014, Columbia and Ecuador were declared free of onchocerciasis following the implementation of
the control strategies for decades by the WHO [11].
A number of epidemiological models have been formulated and mathematically analysed to describe
the behaviour of onchocerciasis in the population. Mapocha and Thieme [7] developed a model to ac-
count for both human and bovine onchocerciasis. They considered cross-reactive immunity in response
to inocculation of cattle by larvae. They showed that if parasites are wasted on the “wrong" hosts, then the
reproduction number is lowered,while cross-reactive immunity can lead to classical competition phenom-
ena. Basáñez and Ricárdez-Esquinca [12, 13] developed a model to describe the population biology and
control of human onchocerciasis. Their aim was to evaluate various interventions combining the removal
of adult worms (nodulectomy) and the microfilaricidal and sterilizing effects of ivermectin. They derived a
threshold condition for disease control involving the vector biting rate and the basic reproduction number.
They estimated that the annual biting rate for the Simulium onchraceum s.l is 7665 bites per person per year.
This is the minimum below which human onchocerciasis would be unable to become endemic in Central
America since the basic reproduction number, R0, would be less than unity. They recommended that if the
worm is sterilised and the vector population is condensed, then the epidemic could be restricted. In Africa,
several field studies have achieved significant reduction in the transmission of infection by repeated annual
mass treatment with ivermectin [14, 15, 16]. Alley et al. [17] used a microsimulation model to examine the
possibility of switching treatment from the microfilaricide ivermectin to a hypothetical macrofilaricide. The
showed that elimination was possible using a macrofilaricide, but that high coverage levels were critical. Fil-
ipe et al. [18] developed an age- and sex-structured model for intensity of infection with parasite regulation
within humans and vectors. They showed that heterogeneous age and sex exposure could explain location-
specific infection patterns of onchocerciasis. Poolman and Galvani [19] incorporated host heterogeneity
into a model in order to evalu- ate intervention strategies targeting specific populations for treatment with
ivermectin. They found that targeted allocation of ivermectin in a highly heterogeneous population could
2
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reduce the public-health burden of onchocerciasis using 20–25% of the doses of untargeted allocation.
Mass administration of ivermectin is the main strategy used in the control of onchocerciasis in sub-
Saharan Africa [9, 20]. Mass treatment with ivermectin was initially carried out annually. However, a change
in strategy to six-monthly mass treatment was adopted to increase the probability of disease eradication
[9, 21]. Although substantial epidemiological work has been done on the study of onchocerciasis trans-
mission dynamics, few mathematical models have been developed. Our aim is to examine the effects of
mass administration of ivermectin using a mathematical model of impulsive differential equations. The
model focuses on the effect of fixed and non-fixed mass administration of ivermectin in the treatment of
onchocerciasis to account for the reduction of infection of onchocerciasis in the human population. Thus,
we endeavour to address the following research questions: 1. Can we determine the critical threshold for
the proportion of individuals with ochocerciasis that will reduce the infection of the onchocerciasis in the
population? 2. Can mass administration of ivermectin eradicate onchocerciasis? 3. Does control of on-
chocerciasis depend on administration occurring at fixed times?
2. Themathematical model
2.1. Model formulation
We develop a model to better understand the transmission dynamics of onchocerciasis and its treatment.
We consider a habitat with two interacting populations. The two populations are humans (hosts) and black-
flies (vectors). The total human population is partitioned into six compartments: the susceptible human
compartment, SH , referring to individuals not infected with onchocerciasis but who are at risk of infec-
tion; the exposed compartment, EH , referring to the individuals that have been exposed to onchocerciaisis
through bites; the infectious compartment, IH , referring to individuals with onchocerciaisis infection; sus-
ceptible humans undergoing ivermectin treatment, ST ; exposed humans undergoing ivermectin treatment,
ET ; and the infectious humans undergoing ivermectin treatment, IT . The blackfly population is partitioned
into three compartments: susceptible vectors, SV , referring to blackflies that have not picked up microfi-
lariae but are at risk of picking up microfilariae during a blood meal; the exposed vector compartment, EV ,
referring to blackflies that have picked up microfilariae from an infected human during blood meal; and
the infective vector compartment, IV .
The total human and vector populations at any given time, t , are respectively given by;
N (t )= SH (t )+EH (t )+ IH (t )+ST (t )+ET (t )+ IT (t ), V (t )= SV (t )+EV (t )+ IV (t ). (1)
We assume that the transmission of onchocerciaisis in susceptible hosts is only through contact with an
infectious vector. We also assume that susceptible vectors become infectious as a result of contact with
infectious hosts during a blood meal. The population under study is assumed to be large enough to be
3
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modelled deterministically. The recruitment of new susceptible individuals and susceptible vectors is given
by b1 and b2 respectively. Assuming β is the black-fly biting rate, that is, the average number of bites per
black-fly per unit, the rate of infection per susceptible black-fly can be represented by
λv (t )= qβ(IH +κIT )
N
, (2)
where q is the transmission probability from infectious human to black-flies and κ is the modification pa-
rameter which measures the relative ability of individuals in class IT to cause new infections relative to
those in compartment IH . We assume here that the individuals under treatment have a slightly lower prob-
ability to initiate new infections, thus, 0≤ κ≤ 1. Assuming that the total number of bites made by black-flies
equals to the number of bites received by humans, then the average number of bites per human receives per
unit time is βVN . Assuming that the transmission probability per bite from infectious black-flies to human is
p, the rate of infection per susceptible human is given by
λh(t )=
pβV
N
IV
V
= pβIV
N
. (3)
We then introduce βh = pβ and βv = qβ parameters to simplify the infection rates per susceptible human
and vector respectively. Individuals in class EH progress to the infectious class IH at rate γ. Individuals
undergoing ivermectin treatment in class ST acquire infection at the rate δλh , where δ defines the reduced
effect of infection of the susceptible individuals as a result of treatment. Individuals in class ET progress
to the infectious treated class IT at the rate ργ, where ρ is the reduced effect of progression to class IT as
a result of treatment. Immediately following treatment, infection in the human population is assumed to
be reduced by some proportion α. This therefore results in a system of impulsive differential equations
[22, 23]. Individuals undergoing treatment will relapse due to waning of the drug at the rate ϕ. We include
natural mortality rates given by µh and µv for the human and vector populations respectively.
We further assume that individuals under treatment have no immunity to the disease upon treatment.
In addition, we assume that infected vectors and human do not recover from the infection during the mod-
elling time. The dynamics in the host and vector populations are represented in the schematic diagram in
Figure 1.
4
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Fig. 1: A compartmental representation of the epidemics and treatment of onchocerciasis.
2.2. Model equations
The following system of nonlinear ordinary differential equations, with nonnegative initial conditions, de-
scribes the dynamics of onchocerciaisis epidemics:
˙SH = b1+ϕST − βh IV SH
N
−µhSH ,
E˙H = βh IV SH
N
+ϕET − (γ+µh)EH ,
˙IH = γEH +ϕIT −µh IH ,
S˙T = −δβh IV ST
N
− (ϕ+µh)ST ,
E˙T = δβh IV ST
N
− (ργ+ϕ+µh)ET ,
˙IT = ργET − (ϕ+µh)IT ,
S˙V = b2− βv IH SV
N
− κβv IT SV
N
−µv SV ,
E˙V = βv IH SV
N
+ κβv IT SV
N
− (η+µv )EV ,
˙IV = ηEV −µv IV .

, t 6= tk , (4)
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subject to the following initial conditions:
SH (0)> 0,EH (0)> 0, IH (0)> 0,ST (0)> 0,ET (0)> 0, IT (0)> 0,SV (0)> 0,EV (0)> 0, IV (0)> 0. (5)
The impulsive conditions are
4SH =−αSH , 4EH =−αEH , 4IH =−αIH ,
4ST =+αSH , 4ET =+αEH , 4IT =+αIH ,
 , t = tk . (6)
Treatment may occur at either fixed or non-fixed intervals.
3. Systemwithout impulses
3.1. Well-posedness
System (4) describes a human–vector population, so it is therefore necessary to prove that the solutions of
system (4) with nonnegative initial conditions remain nonnegative for all time t ≥ 0 and are bounded in the
region
Ω=
{
(SH ,EH , IH ,ST ,ET , IT ) ∈R6+ : N ≤
b1
µh
, (SV ,EV , IV ) ∈R3+ : V ≤
b2
µv
}
. (7)
Theorem 3.2. Let SH ≥ 0,EH ≥ 0, IH ≥ 0,ST ≥ 0,ET ≥ 0, IT ≥ 0,SV ≥ 0,EV ≥ 0, IV ≥ 0. Then the solutions
SH (t ),EH (t ), IH (t ),ST (t ),ET (t ), IT (t ),SV (t ),EV (t ), IV (t ) of the system (4) are positive for all t ≥ 0. In addition,
the regionΩ is positively invariant, and all solutions starting inΩ approach, enter or stay inΩ.
Proof. Let t∗ = sup{t > 0 : SH (t ) > 0,EH (t ) > 0, IH (t ) > 0,ST (t ) > 0,ET (t ) > 0, IT (t ) > 0,SV (t ) > 0,EV (t ) >
0, IV (t )> 0}. Thus t∗ ≥ 0. Then, from the first equation of our system (4), we obtain
˙SH = b1+ϕST − βh IV SH
N
−µhSH ≥−
(
λh +µh
)
SH ,
SH (t
∗)≥ SH (0)exp
{
−
(∫ t∗
0
λh(m)dm+µh t∗
)}
.
Similarly, one can show that EH ≥ 0, IH ≥ 0,ST ≥ 0,ET ≥ 0, IT ≥ 0,SV ≥ 0,EV ≥ 0, IV ≥ 0. This completes the
proof for positivity.
The total population of the humans N and that of the vector population V is governed by
N˙ = b1−µh N , V˙ = b2−µv V. (8)
Hence
lim
t→∞sup N ≤
b1
µh
and lim
t→∞supV ≤
b2
µv
. (9)
Therefore N (t ) and V (t ) are bounded and the domain of biological significance is positively invariant and
attracting. Thus all solutions starting inΩ remain inΩ.
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3.3. Maximal solution
Next we overestimate the number of infectious individuals in the population. From the system (4), we have
established that the total human (host) population is bounded above by b1µh . Thus, from the fifth equation
of the system (4) we have
dET
d t
= δβh IV ST
N
− (ργ+ϕ+µh)ET .
If we bound ST by the total human population and IV by the total vector population, we have
dET
d t
≤ δβhb2
µv
− (ργ+ϕ+µh)ET . (10)
Solving the inequality in (10), we obtain
ET ≤ δβhb2
µv (ργ+ϕ+µh)
+
[
ET (0)− δβhb2
µv (ργ+ϕ+µh)
]
e−(ργ+ϕ+µh )t . (11)
As t approaches infinity, then the solution in (11) is bounded by
ET ≤ δβhb2
µv (ργ+ϕ+µh)
. (12)
Substituting the expression in (12) into the sixth equation of the system (4), we have
d IT
d t
≤ δβhργb2
µv (ργ+ϕ+µh)
− (ϕ+µh)IT ,
whose solution can be expressed as
IT ≤ δβhργb2
µv (ϕ+µh)(ργ+ϕ+µh)
. (13)
Using the solutions obtained in (12) and (13) in the second and third equations in the system (4) respec-
tively, we have
EH ≤
[
βhb2
µv
+ δϕβhb2
µv (ργ+ϕ+µh)
]
, (14)
IH ≤ γ
[
βhb2
µv
+ δϕβhb2
µv (ργ+ϕ+µh)
]
+ϕ
[
δβhργb2
µv (ϕ+µh)(ργ+ϕ+µh)
]
. (15)
The significance of these inequalities is that they overestimate the number of people with onchocerciasis in
the population without necessarily solving the original systems of the differential equations. We will make
use of these overestimates shortly.
3.4. Stability of the model equilibria
3.4.1. Disease-free equilibria
The disease-free equilibrium (DFE) for the system without impulses is given by
E0 = (SˆH , EˆH , IˆH , SˆT , EˆT , IˆT , SˆV , EˆV , IˆV )=
(
b1
µh
,0,0,0,0,0,
b2
µv
,0,0
)
. (16)
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3.4.2. The basic reproduction number
The basic reproduction number for the system (4) is obtained using the next-generation method described
in [24]. It is given by
R0 =
√
R0 =
√
b2γηβhβv
b1µ2v
(
γ+µh
)(
η+µv
) .
Note that this expression is a threshold, not necessarily the average number of secondary infections [25].
Theorem 3.5. The disease-free equilibrium, E0, given in (16) of the system (4) is globally stable if R0 < 1
otherwise unstable.
Proof. Let V = θ1EH +θ2IH +θ3ET +θ4IT +θ5EV +θ6IV be a candidate Lyapunov function. The constants
θ1 for i = 1,2,3,4,5,6 are nonnegative. We can find the constants θi such that the Lyapunov candidate is
positive definite. The derivative of the Lyapunov function is given by
dV
d t
= θ1 dEH
d t
+θ2 d IH
d t
+θ3 dET
d t
+θ4 d IT
d t
+θ5 dEV
d t
+θ6 d IV
d t
,
= θ1
[
βh IV SH
N
+ϕET −Q1EH
]
+θ2[γEH +ϕIT −µh IH ]+θ3
[
δβh IV ST
N
−Q3ET
]
+θ4[ργET −Q2IT ]
+θ5
[
βv IH SV
N
+ κβv IT SV
N
−Q4EV
]
+θ6[ηEV −µv IV ],
= [θ2γ−θ1Q1]EH +
[
θ5µhb2βv
µv b1
−θ2µh
]
IH + [θ1ϕ+θ4ργ−θ3Q3]ET +
[
θ2ϕ+ θ5κβvµhb2
µv b1
−θ4Q2
]
IT
+ [θ6η−θ5Q4]EV + [θ1βh −θ6µv ]IV ,
where
Q1 = γ+µh , Q2 =ϕ+µh , Q3 = ργ+ϕ+µh , Q4 = η+µv .
Setting the coefficients to IH ,ET , IT ,EV and IV to zero, we obtain
θ1 = Q4µv
βh
, θ2 = b2βvη
b1µv
, θ3 = b2ηκργµhβv
b1Q2Q3µv
+ b2ηργϕβv
b1Q2Q3µv
+ Q4ϕµv
Q3βh
, θ4 = b2βvη(κµh +ϕ)
Q2b1µv
,
θ5 = η, θ6 =Q4.
(17)
We then use the coefficients obtained in (17) into the candidate Lyapunov function. The derivative of the
resulting Lyapunov function becomes
dV
d t
= Q1Q4µv
βh
[
R0−1
]
. (18)
We note that, wheneverR0 < 1, then dVd t < 0. Therefore, by LaSalle’s Invariance principle [26], the disease-
free equilibrium is globally stable wheneverR0 < 1.
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3.5.1. Endemic equilibrium
The endemic equilibrium point, E1, is found by equating the right-hand of the system (4) to zero. Expressing
all the variables in terms of IH , we get
S∗H = b1
(
1
µh
− b2ηβh I
∗
Hβv
b1Q4µv
(
b1µv +µh I∗Hβv
)+b2ηβhµh I∗Hβv
)
,E∗H =
b1b2ηβhµh I
∗
Hβv
Q1
(
b1Q4µv
(
b1µv +µh I∗Hβv
)+b2ηβhµh I∗Hβv ) ,
S∗T = E∗T = I∗T = 0, S∗V =
b1b2
βvµh I∗H +b1µv
, E∗V =
b2βvµh I
∗
H
Q4(βvµh I∗H +b1µv )
, I∗V =
b2βvµhηI
∗
H
Q4µv (βvµh I∗H +b1µv )
.
After some algebraic manipulations, we either have I∗H = 0 or
I∗H =
Q1Q4b21µ
2
v
Q1βvµh(b2βhη+Q4b1µv )
[R0−1] . (19)
The case where I∗H = 0, gives the disease-free equilibrium, treated earlier. From expression (19), one sees
that whenR0 < 1, then I∗H < 0, implying that the system (4) has no positive solution. However, whenR0 > 1,
then I∗H > 0 and a unique endemic equilibrium exists.
Theorem3.6. IfR0 > 0, then E0 is unstable and the unique endemic equilibrium E1 is locally asymptotically
stable in the interior of the feasible regionΩ.
Proof. The stability and and the direction of bifurcation R0 = 1 of the endemic equilibrium is proved by
the direct use of the Center Manifold Theory (CMT) as described in [27]. We avoid re-stating the theorem
and adopting notations as described in [27], we compute the values of a and b whose signs determine local
dynamics of the model (4). The basic reproduction of the system (4) is established to be
R0 = b2γηβhβv
b1µ2v
(
γ+µh
)(
η+µv
) . (20)
Suppose, we choose θ =βh as the bifurcation parameter so that whenR0 = 1, we have
θ = b1µ
2
v
(
γ+µh
)(
η+µv
)
b2γηβv
(21)
In order to apply the Center Manifold Theory (CMT), it is necessary to make the following changes to the
state variables, we let SH = x1,EH = x2, IH = x3,ST = x4,ET = x5, IT = x6,SV = x7,EV = x8, IV = x9. The
system (4) can now be written in the form d fd x = f (x), where x = (x1, x2, x3, x4, x5, x6, x7, x8, x9). The system
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(4) therefore becomes
x˙1 = b1+ϕx4−
βh x9x1
N
−µh x1,
x˙2 =
βh x9x1
N
+ϕx5−Q1x2,
x˙3 = γx2+ϕx6−µh x3,
x˙4 = −
δβh x9x4
N
−Q2x4,
x˙5 =
δβh x9x4
N
−Q3x5,
x˙6 = ργx5−Q2x6,
x˙7 = b2−
βv x3x7
N
− κβv x6x7
N
−µv x7,
x˙8 =
βv x3x7
N
+ κβv x6x7
N
−Q4x8,
x˙9 = ηx8−µv x9.

(22)
The system (22) with the bifurcation point θ, has a simple zero eigenvalue. Thus, it enables us to use the
Center Manifold Theory to analyse the stability of the system (22) near βh = θ. Therefore a right eigenvector
w associated with zero eigenvalue has components
w1 =−
b1µ2v
(
γ+µh
)(
η+µv
)
b2γηµhβv
, w2 =
b1µ2v
(
η+µv
)
b2γηβv
, w3 =
b1µ2v
(
η+µv
)
b2ηµhβv
,
w4 =w5 =w6 = 0, w7 =− (η+µv )
η
, w8 = µv
η
, w9 = 1.
(23)
Similarly, the corresponding left eigenvector v associated with zero eigenvalue has components
v1 = v4 = v7 = 0, v2 = 1, v3 = Q1
γ
, v5 = Q1κβvργµh +βvϕ(γ(ργ+ϕ)+µh(γ+ργ))
Q2Q3βvγ
,
v6 = Q1βv (κµh +ϕ)
Q2βvγ
, v8 = Q1b1µv
b2βvγ
, v9 = Q1Q4b1µv
b2βvηγ
.
(24)
We now compute a and b as outlined in [27]. From the system (22), the non-zero partial derivatives of f (x)
associated with a are given by
∂2 f2
∂x1∂x9
= θµh
b1
,
∂2 f8
∂x3∂x7
= βvµh
b1
,
∂2 f8
∂x6∂x7
= κβvµh
b1
. (25)
Thus, the expression for a is given by
a= v2w1w9 ∂
2 f2
∂x1∂x9
+ v8w3w7 ∂
2 f8
∂x3∂x7
+ v8w6w7 ∂
2 f8
∂x6∂x7
,
= −
(
b1µ3v
(
γ+µh
)(
η+µv
)
2
(
µv
(
γ+µh
)+γκβv )
b22γ
2η2β2v
)
< 0.
(26)
We finally compute the value of b. The non-zero partial derivatives of f (x) associated with b is given by
∂2 f2
∂x9∂θ
= 1. (27)
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Therefore the expression for b is given by
b= v2w9 ∂
2 f2
∂x9∂θ
= 1> 0. (28)
Since, a < 0 and b > 0, we conclude from item (i v) of Center Manifold Theorem [27] that the established
endemic equilibrium E1 is locally asymptotically stable forR0 > 1 and there exists a positive unstable equi-
librium. This completes the proof.
4. Model with impulses
In this section, we present and analyse the system with pulse treatment of onchocerciasis with ivermectin.
Treatment occurs every six months. We therefore first examine the case of fixed times tk , with individuals
treated at rate α. This results in system of impulsive differential equations [22, 23, 28]. The administration
of ivermectin is thus approximated by an instantaneous change.
4.1. General solution
Here, we overestimate the number of people infected with onchocerciasis in the population. Suppose the
maximal number of individuals infected with onchgocerciasis is given by inequality (15). Then the one-
dimensional impulsive differential equation given by
d IH
d t
= γ
[
βhb2
µv
+ δϕβhb2
µv (ργ+ϕ+µh)
]
+ϕ
[
δβhργb2
µv (ϕ+µh)(ργ+ϕ+µh)
]
−µh IH , t 6= tk ,
4IH =−αIH , t = tk ,
(29)
overestimates the number of infected individuals.
Letting I = IH for notational simplicity, from (29) we have
I+− I− =−αI ,
I+ = (1−α)I−.
Let Q5 = βhb2γ[δρϕ+Q2(δϕ+Q3)] and denote I+k = I (t+k ) and I−k = I (t−k ). Here, I (t−k ) is the population
proportion of infected individuals immediately before the impulse and I (t+k ) is the value immediately after
the impulse. Hence, for a single impulsive cycle tk ≤ t ≤ tk +1, we have
I ′(t )+µh I (t )=
Q5
Q2Q3µv
,
d
d t
(
eµh t I
)= Q5
Q2Q3µv
(
eµh t I
)
,
eµh t I (t )−eµh tk I (t+k )=
Q5
Q2Q3µhµv
eµh t − Q5
Q2Q3µ2hµv
eµh tk ,
I (t )= Q5
Q2Q3µhµv
(
1−eµh (tk−t ))+ I (t+k )eµh (tk−t ).
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It therefore follows that
I−k+1 =
(
Q5
Q2Q3µhµv
)(
1−eµh (tk+1−tk )
)
+ I+k eµh (tk+1−tk ),
=
(
Q5
Q2Q3µhµv
)(
1−e−µh (tk+1−tk )
)
+ (1−α)I−k
(
e−µh (tk+1−tk )
)
.
(30)
The solution obtained in (30) at the impulse points satisfies
I−1 =
Q5
Q2Q3µhµv
, I+1 = (1−α)
(
Q5
Q2Q3µhµv
)
,
I−2 = (1−α)
(
Q5
Q2Q3µhµv
)
e−µh (t2−t1)+
(
Q5
Q2Q3µhµv
)(
1−eµh (t2−t1)) ,
I+2 = (1−α)I−2 = (1−α)2
(
Q5
Q2Q3µhµv
)
e−µh (t2−t1)+ (1−α)
(
Q5
Q2Q3µhµv
)(
1−eµh (t2−t1)) ,
I−3 =
Q5
Q2Q3µhµv
(
(1−α)2e−µh (t3−t1)+ (1−α)e−µh (t3−t2)+1− (1−α)e−µh (t3−t1)−e−µh (t3−t2)
)
,
I+3 = (1−α)I−3 =
Q5
Q2Q3µhµv
(
(1−α)3e−µh (t3−t1)+ (1−α)2e−µh (t3−t2)+ (1−α)− (1−α)2e−µh (t3−t1)
− (1−α)e−µh (t3−t2)
)
,
I−4 =
Q5
Q2Q3µhµv
(
(1−α)3e−µh (t4−t1)+ (1−α)2e−µh (t4−t2)+ (1−α)e−µh (t4−t3)+1− (1−α)2e−µh (t4−t1)
− (1−α)e−µh (t4−t2)−e−µh (t4−t3)
)
, I+4 = (1−α)I−4 .
Thus, the general solution becomes
I−n =
Q5
Q2Q3µhµv
(
(1−α)(n−1)e−µh (tn−t1)+ (1−α)(n−2)e−µh (tn−2)+·· ·+ (1−α)e−µh (tn−tn−1)
+1− (1−α)(n−2)e−µh (tn−t1)− (1−α)(n−3)e−µh (tn−t2)−·· ·−e−µh (tn−tn−1)
)
.
(31)
The general solution obtained in (31) defines the maximal number of people with onchocerciasis immedi-
ately before the mass treatment with ivermectin. This solution depends on the human and vector recruit-
ment rates, the human-vector transmission contact rate, the incubation period in the human, the waning
rate of ivermectin, human and vector death rates, treatment times and the treatment effectiveness. A sim-
ilar approach can be employed to calculate the maximal number of latently infected individuals using the
overestimate obtained in (14). For fixed mass administration of ivermectin, (31) does not depend on time.
4.2. Fixed administration of ivermectin
For a fixed time period τ= tn+1− tn , we have
I−n =
Q5
Q2Q3µhµv
(
1+ (1−α)eµhτ+ (1−α)2e−2µhτ+·· ·+ (1−α)(n−1)e−µh (n−1)τ
−e−µhτ
(
1+ (1−α)e−µhτ+·· ·+ (1−α)(n−2)e−µh (n−2)τ
))
,
= Q5
Q2Q3µhµv
(
1− (1−α)neµh nτ
1− (1−α)eµhτ −
1− (1−α)(n−1)e−µh (n−1)τ
1− (1−α)eµhτ e
−µhτ
)
.
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Thus
lim
n→∞ I
−
n =
Q5
Q2Q3µhµv
(
1
1− (1−α)e−µhτ −
1
1− (1−α)e−µhτ e
−µhτ
)
= Q5
Q2Q3µhµv
(
1−e−µhτ
1− (1−α)e−µhτ
)
. (32)
The solution obtained in (32) is the maximum population of the infected individuals. Note that
lim
τ→0
n→∞
I−n = 0,
implying that the total number of infected humans shrinks to zero as the frequency of mass treatment with
ivermectin increases (although note that the impulsive assumptions would break down in this limit). In
order to keep the infected individuals under a threshold Iˆ , we have
Iˆ < Q5
Q2Q3µhµv
(
1−e−µhτ
1− (1−α)e−µhτ
)
,
which implies that
τ< 1
µh
ln
[
Q5− IˆQ2Q3µhµv (1−α)
Q5− IˆQ2Q3µhµv
]
= τmax(α). (33)
The expression in (33) gives the maximum period of mass administration of ivermectin in the population
to keep the infection of onchocerciasis below Iˆ . If we restrict τ to 0 ≤ τ < τmax, then the disease can be
controlled below the threshold Iˆ (but not necessarily eradicated).
4.3. Non-fixed administration of ivermectin
In this section, we consider a situation in which the mass administration of ivermectin is carried out at
non-fixed times. However, this would require that the entire history of ivermectin administration is known,
which is unlikely to be the case. Thus, we will assume that ivermectin treatment occuring more than two
events previously has a negligible effect on the number of currently treated individuals. That is,
e−µh (tn−tk ) ≈ 0 for k > 2.
It then follows from (30) that
I−n <
Q5
Q2Q3µhµv
(
1−e−µh (tn−tn−1)
)
,
I−n+1 <
Q5
Q2Q3µhµv
(
1−e−µh (tn−tn−1)
)
+ (1−α)I−n e−µh (tn−tn−1),
< Q5
Q2Q3µhµv
(
1−e−µh (tn+1−tn )
)
+ (1−α) Q5
Q2Q3µhµv
(
1−αe−µh (tn−tn−1)
)
e−µh (tn+1−tn ).
The above inequality can be approximated as
Iˆ ≡ Q5
Q2Q3µhµv
(
1−e−µh (tn+1−tn )
)
+ (1−α) Q5
Q2Q3µhµv
(
1−αe−µh (tn−tn−1)
)
e−µh (tn+1−tn ). (34)
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The expression in (34) gives the number of infected humans that will be below Iˆ based on knowing the
two previous mass administration times. Then the "next best" mass treatment with ivermectin satisfies the
following:
Q5
Q2Q3µhµv
(
1+ (1−α)
)
− Iˆ = e−µh (tn+1−tn )
(
Q5
Q2Q3µhµv
)(
1+α(1−α)e−µh (tn+1−tn )
)
,
e−µh (tn+1−tn ) = 2−α−Q5/Q2Q3µhµv
1+α(1−α)e−µh (tn+1−tn ) ,
tn+1 = tn − 1
µh
ln
(
2−α−Q5/Q2Q3µhµv
1+α(1−α)e−µh (tn+1−tn )
)
.
Next we compare fixed and non-fixed mass treatment with ivermectin. Assuming that the mass treatment
times in the non-fixed case are constant, τˆ, then from (33), we have
τˆ= 1
µh
ln
(
Q5− IˆQ2Q3µhµv (1−α)
Q5− IˆQ2Q3µhµv
)
, (35)
τˆ|α=0 = 1
µh
ln
(
Q5− IˆQ2Q3µhµv
Q5− IˆQ2Q3µhµv
)
= 0, (36)
τˆ|α=1 = 1
µh
ln
(
Q5
Q5− IˆQ2Q3µhµv
)
. (37)
If there is no impulse, then from (29), we have limt→∞ I = Q5Q2Q3µ2hµv . Thus, we can assume that Iˆ =
Q5
Q2Q3µhµv
.
Hence,
0< 1− Q2Q3µhµv Iˆ
Q5
< 1, (38)
therefore, τˆα=1 > 0. Assuming that non-fixed mass treatment with ivermectin occurs indefinitely and fur-
ther letting τmax ≡ tn+1− tn = tn − tn−1, then the minimum treatment effectiveness satisfies
τmax = 1
µh
ln
(
2−α− IˆQ2Q3µhµv /Q5
1+α(1−α)e−µhτmax
)
. (39)
If τmax = 0, then it follows that (39) becomes
1
µh
ln
(
2−α− IˆQ2Q3µhµv /Q5
1+α(1−α)
)
= 0,
2−α− Iˆ Q2Q3µhµv
Q5
= 1+α(1−α),
α= 1±
√
Q2Q3µhµv
Q5
.
The larger root exceeds 1 and hence can be discounted. It follows that the smaller root α0 = 1−
√
Q2Q3µhµv
Q5
,
satisfies 0 < α0 < 1 as stated in (38). This implies that the mass treatment is only effective in the range
α0 <α≤ 1.
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Fig. 2: Comparison of the actual infected individuals and the estimated infected individuals.
5. Numerical simulations
In this section, we carry out parameter estimation, sensitivity analysis of the model parameters and numer-
ical simulations for system (4) to demonstrate the theoretical results. The simulations are performed using
the fourth order Runge–Kutta scheme in Matlab 2014a with the set of parameter values given in Table 1. We
consider the parameters in realistic ranges with guidance from past literature on onchocerciasis epidemics
in Ghana.
5.1. Parameter estimation
We consider average parameter values that encompass features of onchocerciasis disease including the rate
of infection, the incubation period and the length of infections period in the vector and host populations.
Although estimates of some parameters are given in Table 1, here we give additional explanations and de-
scriptions of some of the parameters.
1. The average birthrate in Ghana was estimated to be 31.09 births/1,000 population in 2015 and 30.60
births/1,000 population in 2014 according to the World Fact Book by Central Intelligence Agency [29]
and Ghana Statistical Service report on Demographic and Health Survey [30] respectively. Owing to
unchecked immigration, the recruitment rate is therefore estimated to be in the range (0.0000819 ≤
b1 ≤ 0.00108)N per day.
2. The natural human death rate is estimated based on average life of 50–70 years in accordance with
Central Intelligence Agency data and 2014 demographic data released by Ghana Statistical Service
estimates of life expectancy at birth [29, 30]. The average blackfly lifespan is 2–3 weeks [20, 31].
3. It takes 34 to 2 years for the worm to mature and release enough microfilariae to be detectable in the
skin of the human host [20, 32, 33, 34]. Therefore a reasonable estimate of the incubation rate γ is
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0.00137≤ γ≤ 0.00365 per day. On the other hand, the average incubation period in the blackfly is 1–2
weeks [20, 33, 34, 35]. Thus, a reasonable value for η is 0.0714≤ η≤ 0.1667 per day.
4. The modification parameters (κ,δ and ρ) are strictly between 0 and 1 due to the reduced ability of
individuals to cause infections following ivermectin treatment.
5. The mass administration rate α is estimated to be between 0% and 100%.
For illustration purpose, we consider the parameter values estimates given in Table 1 with N = 200,000
and V = 10,000.
Table 1: Estimated parameter values in the model for onchocerciasis case. The rates are given per day.
Parameter Definition Range Point value (assumed) Source
b1 Human recruitment rate 0.0000819–0.001085 0.00009/N Estimated
µh Death rate of humans 0.0000391–0.0000548 0.000052 [29, 30]
βh The rate of transmission of the 0–0.01 0.00198 Assumed
disease from blackflies to humans
γ Transfer rate from EH to IH class 0.00137–0.00365 0.00139 [20, 32, 33, 34]
α Ivermectin treatment rate 0–1 [0.1,0.65] [9, 36]
ϕ Waning rate of ivermectin 0.01–0.1 0.0015 [36]
κ Modification parameter 0–1 0.0083 Assumed
ρ Modification parameter 0–0.1 0.001 Assumed
δ Modification parameter 0–1 0.002 Assumed
b2 Vector recruitment rate 0.0214–0.4 0.144/V Assumed
βv The rate of transmission of the 0–0.01 0.00079 Assumed
disease from humans to blackflies
η Transfer rate from EV to IV class 0.0714–0.1667 0.078 [20, 33, 34, 35]
µv Death rate of blackflies 0.0118–0.0714 0.068 [20, 31]
5.2. Sensitivity analysis
Sensitivity analysis is the study of how uncertainty in the output of a system can be apportioned to different
sources of uncertainty in the model input [37, 38]. It is a technique for systematically varying model inputs
and determining their effect on the model output. We perform sensitivity analysis in order to investigate the
contribution of vital parameters on the model dynamics, specifically to establish the parameters that have
significant influence on the onchocerciasis dynamics. We use Latin Hypercube Sampling (LHS), a strati-
fied Monte Carlo sampling scheme applicable to many parameters from a multidimensional distribution
[37, 38]. It allows for simultaneous determination of an unbiased estimate of the model output for a given
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set of model input. We perform the sensitivity analysis by computing the Partial Rank Correlation Coeffi-
cients (PRCCs) for each parameter value, sampled by the LHS scheme [39]. Parameters with positive PRCCs
will increase R0 when they are increased, whereas parameters with negative PRCCs will decrease R0 when
they are increased. The outcome is the reproduction number R0 derived from the theoretical model. We
determine PRCCs with 1000 simulations per run to determine parameters that have a significant influence
on R0.
-0.8 -0.6 -0.4 -0.2 0 0.2 0.4
b1
7h
b2
7
v
-h
-
v
.
2
Fig. 3: Tornado plots of partial rank correlation coefficients (PRCCs) of the parameters that influence R0 for the input parameters using
the values in Table 1. Parameters with PRCC> 0 increase R0 when they are increased whereas parameters with PRCC< 0 decrease R0
when they are increased.
The PRCCs results in Figure 3 illustrate the degree of the effect that each parameter has on the outcome.
The three parameters with the most influence on R0 are the transmission contact rate in humans, βh , the
vector transmission contact rate, βv , and the vector death rate µv .
Figure 4 displays 1000 Monte Carlo simulations for the input parameters with the most effect on the
basic reproduction number. Scatter plots show that R0 is monotone increasing with increasing values of βh
and βv and monotone decreasing with increasing vector mortality rate, µv . However, R0 is only guaranteed
to be less than unity when the human–vector and vector–human contact rates are sufficiently small. These
results also suggest that, even if vector death rate is extremely high, eradication is not possible.
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Fig. 4: The Monte Carlo simulations for the three parameters with the greatest influence on the R0: the transmission contact rate in
humans, the transmission contact rate in the vector and the vector death rate for the input parameters using the values in Table 1
and 1000 simulations per run. Eradication is only possible if the transmissibilities are extremely small or if the vector death rate is
extremely high.
In order to gain more insight into the three parameters with the greatest influence on the basic repro-
duction number, R0, all other parameters were fixed at their sample values. A surface plot for R0 = 1 is
shown in Figure 5.
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Fig. 5: Eradication threshold for the three parameters with the greatest influence on R0.
5.3. Simulation results
The results presented in this section demonstrate the dynamics of onchocerciasis for the system (4) ob-
tained using Matlab ODE45 solver, which employs simultaneously the fourth and fifth order Runge–Kutta
schemes. Unless otherwise stated, parameters are as stated in Table 1. We give results of system (4) with
impulses for both the cases when R0 < 1 and when R0 > 1 as shown in Figures 8–11 and Figures 6–7, respec-
tively. In addition, we numerically make a comparison between fixed and non-fixed mass administration of
ivermectin in the treatment of onchocerciasis. In order to illustrate the effectiveness of ivermectin, we vary
the reduction rate (α) for both the cases of R0.
First, we examine the behaviour of the system (4) when the basic reproduction number, R0, is greater
than unity for the fixed and non-fixed mass administration of ivermectin. It is seen in Figure 6 that when
the effectiveness of ivermectin is low, that is, α= 0.10, the disease spreads in the population. However, the
results in Figure 7 show that the endemicity of the disease is reduced when the effectiveness rate of mass
administration of ivermectin is increased. We also observe that fixed mass administration yields a better
outcome compared to non-fixed mass administration.
We then examine the case when the basic reproduction number is below unity for both the fixed and
non-fixed mass administration of ivermectin. We examine two cases of R0 < 1: when R0 is close to unity
and where R0 is significantly less than unity. We observe in Figure 8 that when R0 is less than but close
to one, the disease may persist in the population when the value of α is small. However an increment in
the value of α moves the system towards a disease-free state, but there is no eradication. This is shown
in Figure 9 with α = 0.65. The results in Figure 10 show the dynamics of the population under both fixed
and non-fixed mass administration of ivermectin at α= 0.1 keeping the interval τ= 182.5 days (6 monthly
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interval) for fixed mass administration. We observe that the system with impulses attains its disease-free
state, suggesting that onchocerciasis dies out. These results are consistent with theorem (3.5). However,
when the ivermectin effectiveness is increased, the system attains the disease free equilibrium much faster
as shown in Figure 11.
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Fig. 6: System behaviour for fixed and non-fixed mass administration of ivermectin with α = 0.10,R0 = 1.2412,b1 = 0.0009,b2 =
0.35,βh = 0.00562,βv = 0.00243,ϕ= 0.025,µv = 0.012.
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Fig. 7: System behaviour for fixed and non-fixed mass administration of ivermectin with α = 0.65,R0 = 1.2412,b1 = 0.0009,b2 =
0.35,βh = 0.00562,βv = 0.00243,ϕ = 0.025,µv = 0.012. Note that increasing α improves the outcome but does not lead to eradica-
tion.
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Fig. 8: System behaviour for fixed and non-fixed mass administration of ivermectin with α = 0.10,R0 = 0.9352,b1 = 0.0009,b2 =
0.35,βh = 0.00443,ϕ = 0.025,βv = 0.00175,µv = 0.012. Non-fixed adminsitration may produce lower overall numbers of infected
individuals, but the outcome is not predictable.
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Fig. 9: System behaviour for fixed and non-fixed mass administration of ivermectin with α = 0.65,R0 = 0.9352,b1 = 0.0009,b2 =
0.35,βh = 0.00443,ϕ = 0.025,βv = 0.00175,µv = 0.012. Non-fixed administration may produces bursts of infection, even if the dis-
ease would be otherwise kept at low levels.
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Fig. 10: System behaviour for fixed and non-fixed mass administration of ivermectin with α= 0.1,R0 = 0.1181 using parameter values
in Table 1. Note that non-fixed administration may have a delaying or preventative effect on eradication.
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Fig. 11: System behaviour for fixed and non-fixed mass administration of ivermectin withα= 0.65,R0 = 0.1181 using parameter values
in Table 1. Increasing α hastens eradication, in both the fixed and non-fixed case.
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6. Conclusion
Onchocerciasis is one of the neglected tropical diseases that is still to be eradicated. In connection with the
WHO’s plan of onchocerciasis elimination, mass administration of ivermectin is the most efficient approach
towards this effort. This is spearheaded by APOC in sub-Saharan Africa where the disease is endemic. In
order to investigate the effectiveness of ivermectin in the control of onchocerciasis, we formulated a de-
terministic model that captures the dynamics of this disease in humans and blackflies. The analysis of the
model without pulse mass administration of ivermectin shows that, the disease-free state exists and is sta-
ble if R0 < 1. On the other hand, if R0 > 1, the disease-free state loses its stability and the system tends
towards the endemic state.
We have provided the estimates for the necessary frequency and strength of mass administration of
ivermectin. We may conclude that the disease can be controlled through mass administration with needed
frequency and high strength of ivermectin. Furthermore, our results suggest that reducing human–vector
contact can be one way of reducing but not eradicating onchocerciasis from the population. This can be
done by implementing personal protection practices such as wearing insect repellent, wearing long sleeves
and long pants during the day when blackflies bite. In addition, application of insecticides can be effective
in reducing the presence of vector in the environment.
We have observed from our numerical results that the eradication of onchocerciasis is possible with tol-
erable regularity of mass administration of ivermectin provided the basic reproduction number is kept (far)
below unity. We can conclude that, in the presence of mass administration of ivermectin with six month
intervals, the disease can be controlled. Furthermore, if the frequency of mass administration is increased,
the system moves towards a better outcome. Our modelling results show that mass administration of iver-
mectin at regular interval is an effective method of onchocerciaisis eradication if other parameters can be
sufficiently controlled.
The model presented in this paper has a number of limitations. Mass administration of ivermectin is as-
sumed to occur instantaneously. However, in reality, there is usually a small delay as mass treatment reaches
it maximum coverage. It is important to note that the delays do not affect the impulsive assumptions, pro-
vided the time interval of mass administration of ivermectin is significantly larger than the instantaneous
approximation. Unavailability of experiential data poses a challenge for model verification. Despite the
shortcomings, the model still provides some useful insights into the control of onchocerciasis through the
implementation of regular mass administration of ivermectin in conjunction with transmission reduction
and the implementation of vector-control measures.
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